<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Supportive therapy for schizophrenia - Buckley, LA - 2015 | Cochrane Library</title> <meta content="Supportive therapy for schizophrenia - Buckley, LA - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004716.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Supportive therapy for schizophrenia - Buckley, LA - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004716.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004716.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Supportive therapy for schizophrenia" name="citation_title"/> <meta content="Lucy A Buckley" name="citation_author"/> <meta content="Northumberland, Tyne and Wear NHS Foundation Trust" name="citation_author_institution"/> <meta content="Lucy.Buckley@ntw.nhs.uk" name="citation_author_email"/> <meta content="Nicola Maayan" name="citation_author"/> <meta content="Cochrane" name="citation_author_institution"/> <meta content="Karla Soares‐Weiser" name="citation_author"/> <meta content="Cochrane" name="citation_author_institution"/> <meta content="Clive E Adams" name="citation_author"/> <meta content="The University of Nottingham" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD004716.pub4" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/04/14" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004716.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004716.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004716.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antipsychotic Agents [therapeutic use]; Family Therapy; Intention to Treat Analysis; Mental Health Services; Patient Satisfaction; Psychotherapy [methods]; Randomized Controlled Trials as Topic; Schizophrenia [*therapy]; Schizophrenic Psychology; Social Support" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004716.pub4&amp;doi=10.1002/14651858.CD004716.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="kKvAiZoF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004716\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004716\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","ms","hr","zh_HANS","ja","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004716.pub4",title:"Supportive therapy for schizophrenia",firstPublishedDate:"Apr 14, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004716.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004716.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004716.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004716.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004716.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004716.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004716.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004716.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004716.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004716.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6740 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004716.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0319"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0119"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-sec-0302"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/appendices#CD004716-sec-0335"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/table_n/CD004716StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/table_n/CD004716StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Supportive therapy for schizophrenia</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#CD004716-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Lucy A Buckley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#CD004716-cr-0003">Nicola Maayan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#CD004716-cr-0004">Karla Soares‐Weiser</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information#CD004716-cr-0005">Clive E Adams</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information/en#CD004716-sec-0341">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 14 April 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004716.pub4">https://doi.org/10.1002/14651858.CD004716.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004716-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004716-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004716-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004716-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004716-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004716-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004716-abs-0001" lang="en"> <section id="CD004716-sec-0001"> <h3 class="title" id="CD004716-sec-0001">Background</h3> <p>Supportive therapy is often used in everyday clinical care and in evaluative studies of other treatments. </p> </section> <section id="CD004716-sec-0002"> <h3 class="title" id="CD004716-sec-0002">Objectives</h3> <p>To review the effects of supportive therapy compared with standard care, or other treatments in addition to standard care for people with schizophrenia. </p> </section> <section id="CD004716-sec-0003"> <h3 class="title" id="CD004716-sec-0003">Search methods</h3> <p>For this update, we searched the Cochrane Schizophrenia Group's register of trials (November 2012). </p> </section> <section id="CD004716-sec-0004"> <h3 class="title" id="CD004716-sec-0004">Selection criteria</h3> <p>All randomised trials involving people with schizophrenia and comparing supportive therapy with any other treatment or standard care. </p> </section> <section id="CD004716-sec-0005"> <h3 class="title" id="CD004716-sec-0005">Data collection and analysis</h3> <p>We reliably selected studies, quality rated these and extracted data. For dichotomous data, we estimated the risk ratio (RR) using a fixed‐effect model with 95% confidence intervals (CIs). Where possible, we undertook intention‐to‐treat analyses. For continuous data, we estimated the mean difference (MD) fixed‐effect with 95% CIs. We estimated heterogeneity (I<sup>2</sup> technique) and publication bias. We used GRADE to rate quality of evidence. </p> </section> <section id="CD004716-sec-0006"> <h3 class="title" id="CD004716-sec-0006">Main results</h3> <p>Four new trials were added after the 2012 search. The review now includes 24 relevant studies, with 2126 participants. Overall, the evidence was <i>very low quality</i>. </p> <p>We found no significant differences in the primary outcomes of relapse, hospitalisation and general functioning between supportive therapy and standard care. </p> <p>There were, however, significant differences favouring other psychological or psychosocial treatments over supportive therapy. These included hospitalisation rates (4 RCTs, n = 306, RR 1.82 CI 1.11 to 2.99, <i>very low quality of evidence</i> ), clinical improvement in mental state (3 RCTs, n = 194, RR 1.27 CI 1.04 to 1.54, <i>very low quality of evidence</i> ) and satisfaction of treatment for the recipient of care (1 RCT, n = 45, RR 3.19 CI 1.01 to 10.7, <i>very low quality of evidence</i>). For this comparison, we found no evidence of significant differences for rate of relapse, leaving the study early and quality of life. </p> <p>When we compared supportive therapy to cognitive behavioural therapy CBT), we again found no significant differences in primary outcomes. There were very limited data to compare supportive therapy with family therapy and psychoeducation, and no studies provided data regarding clinically important change in general functioning, one of our primary outcomes of interest. </p> </section> <section id="CD004716-sec-0007"> <h3 class="title" id="CD004716-sec-0007">Authors' conclusions</h3> <p>There are insufficient data to identify a difference in outcome between supportive therapy and standard care. There are several outcomes, including hospitalisation and general mental state, indicating advantages for other psychological therapies over supportive therapy but these findings are based on a few small studies where we graded the evidence as <i>very low quality</i>. Future research would benefit from larger trials that use supportive therapy as the main treatment arm rather than the comparator. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004716-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004716-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004716-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004716-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004716-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004716-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004716-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004716-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004716-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004716-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004716-abs-0004" lang="en"> <h3>Supportive therapy for schizophrenia</h3> <p>Schizophrenia is a severe mental illness with ‘positive symptoms’ such as hallucinations (hearing voices and seeing things) and delusions (having strange beliefs). People with schizophrenia also suffer from disorganisation and ‘negative symptoms’ (such as tiredness, apathy and loss of emotion). People with schizophrenia may find it hard to socialise and find employment. Schizophrenia is considered one of the most burdensome illnesses in the world. For some people it can be a lifelong condition. Most people with schizophrenia will be given antipsychotic medications to help relieve the symptoms. In addition to this they can also receive therapy, of which there are various types.<br/> <br/> One therapy often given to people with schizophrenia is supportive therapy, where typically after a person is established in the care of mental health services, they will receive general support rather than specific talking therapies such as cognitive behavioural therapy (CBT). For example, in consultations with health professionals there will often be time given to listening to people’s concerns, providing encouragement, or even arranging basic help with daily living. Many people with schizophrenia also receive support from their family and friends. Supportive therapy has been described as the treatment of choice for most people with mental illness and may be one of the most commonly practiced therapies in mental health services. </p> <p>It is, however, difficult to answer the question of exactly what supportive therapy is. It is difficult to find a widely accepted definition of supportive therapy. For the purposes of this review, supportive therapy includes any intervention from a single person aimed at maintaining a person’s existing situation or assisting in people’s coping abilities. This includes interventions that require a trained therapist, such as supportive psychotherapy, as well as other interventions that require no training, such as 'befriending'. Supportive therapy does not include interventions that seek to educate, train or change a person’s way of coping. </p> <p>The aim of this review is to assess the effectiveness of supportive therapy compared to other specific therapies or treatment as usual. This update is based on a search run in 2012; the review now includes 24 randomised studies with a total of 2126 people. The studies compared supportive therapy either with standard care alone or a range of other therapies such as CBT, family therapy and psychoeducation. The participants continued to receive their antipsychotic medication and any other treatment they would normally receive during the trials. Overall, the quality of evidence from these studies was very low. There is not enough information or data to identify any real therapeutic difference between supportive therapy and standard care. There are several outcomes, including hospitalisation, satisfaction with treatment and general mental state, indicating advantages for other psychological therapies over supportive therapy. However, these findings are limited because they are based on only a few small studies where the quality of evidence is very low. There was very limited information to compare supportive therapy with family therapy and psychoeducation as most studies in this review focused on other psychological therapies, such as CBT. Apart from one study presenting data on death, there was no information on the adverse effects of supportive therapy. In summary, there does not seem to be much difference between supportive therapy, standard care and other therapies. Future research would benefit from larger studies where supportive therapy is the main treatment. </p> <p>Ben Gray, Senior Peer Researcher, McPin Foundation: <a href="http://mcpin.org/" target="_blank">http://mcpin.org/</a> </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004716-sec-0319" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004716-sec-0319"></div> <h3 class="title" id="CD004716-sec-0320">Implications for practice</h3> <section id="CD004716-sec-0320"> <section id="CD004716-sec-0321"> <h5 class="title">1. For people with schizophrenia</h5> <p>The evidence presented in this review does not allow us to conclude that supportive therapy has any substantial benefit over standard care. Although there is no evidence of a treatment effect when comparing supportive therapy with standard care, the small number and small size of trials means that a treatment effect, either favouring supportive therapy or standard care, cannot be ruled out. This rather unsatisfactory conclusion also applies to other comparisons where supportive therapy is directly compared with several other psychological therapies, including cognitive behavioural therapy (CBT). At present there is not really conclusive evidence for people with schizophrenia to choose one of the other therapies over a more simple supportive approach. </p> </section> <section id="CD004716-sec-0322"> <h5 class="title">2. For clinicians</h5> <p>Guidance encourages use of family and cognitive therapy for people with schizophrenia. From this review, one cannot conclude that supportive therapy offers anything different to other forms of psychological intervention. For some outcomes, including hospitalisation, general mental state and affective symptoms, data suggest an advantage for other therapies over supportive therapy but due to the small amount of data and the lack of consistency between outcomes measuring similar variables, firm conclusions should not be drawn from these results. </p> </section> <section id="CD004716-sec-0323"> <h5 class="title">3. For mangers and policy makers</h5> <p>Unfortunately, the paucity of data means no clear recommendations for clinical practice can be made on the basis of this review. At present, there is no evidence from this review of a beneficial effect for supportive therapy over standard care, although such a beneficial or harmful effect cannot be ruled out. There is some evidence to suggest a disadvantage of supportive therapy in comparison with other therapies but this is scarce and is often derived from studies that may have some inherent bias towards the other therapies. Certainly, these data require replication in large, clinically meaningful randomised controlled trials before they can be used to guide clinical practice. It is important to highlight the lack of data regarding harmful or adverse effects of supportive therapy. This would be deemed unacceptable in a trial relating to a specific medication. </p> </section> </section> <h3 class="title" id="CD004716-sec-0324">Implications for research</h3> <section id="CD004716-sec-0324"> <section id="CD004716-sec-0325"> <h5 class="title">1. General</h5> <p>As with similar studies, public registration of a study before anyone is randomised would ensure that participants could be confident that people would know that the study had at least taken place. Unique study numbers would help researchers to identify single studies from multiple publications and reduce the risk of duplicating the reporting of data. Compliance with CONSORT (<a href="./references#CD004716-bbs2-0293" title="MoherD , SchulzKF , AltmanD . The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomized trials. JAMA2001;285:1987‐91. ">Moher 2001</a>), both on the part of authors and editors, would help to clarify methodology and many outcomes. Failure to comply with such standard guidelines results in both loss of data and confusion in the results, neither of which help clinicians, patients or managers. </p> <p>Intention‐to‐treat analysis should be performed on all outcomes and all trial data should be made easily accessible. A minimal requirement should be that all data should, at least, be presented as numbers. In addition, continuous data should be presented with means, standard deviations (or standard errors) and the number of participants. Data from graphs, 'P' values of differences and statements of significant or non‐significant differences are of limited value. Unfortunately, in spite of the large numbers of participants randomised, we were unable to use most of the data in the trials included in this review due to the poor data reporting. </p> </section> <section id="CD004716-sec-0326"> <h5 class="title">2. Specific</h5> <section id="CD004716-sec-0327"> <h6 class="title">2.1 Reviews</h6> <p>Many of the excluded studies suggest new comparisons relevant to future reviews (<a href="./references#CD004716-sec-0348" title="">Characteristics of excluded studies</a>), too many for this exhausted group of systematic review authors to currently list. </p> </section> <section id="CD004716-sec-0328"> <h6 class="title">2.2 Trials</h6> <p>Supportive therapy can be usefully investigated using randomised controlled trials. Of course, evidence from randomised controlled trials should be considered alongside evidence from other forms of research, but larger trials do seem warranted and preferably undertaken by those with clear equipoise. A suggestion for the design is outlined in <a href="#CD004716-tbl-0006">Table 1</a>. </p> <div class="table" id="CD004716-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Design of a future study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: centralised sequence generation with table of random numbers or computer‐generated code, stratified by severity of illness, sequence concealed till interventions assigned.<br/> Blinding: those recruiting and assigning participants, those assessing outcomes, all blind to allocated group, blinding could be tested.<br/> Duration: minimum of 24 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: schizophrenia, if operational criteria used these should be in the context of routine care.<br/> N = 450*.<br/> Age: adults.<br/> Sex: men and women.<br/> Setting: anywhere. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Supportive therapy: the nature and frequency of this approach should be clearly described. N = 150.<br/> 2. Routine therapy. N = 150. This also should be clearly described. </p> <p>3. Cognitive behavioural therapy. N = 150.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life: healthy days,** SF‐36***.<br/> Service outcomes: days in hospital, time attending psychiatric outpatient clinic.<br/> Satisfaction with care: patients/carers.<br/> Global state: CGI.***<br/> Mental state: CGI.<br/> Social functioning: to include occupational status.<br/> Adverse effects: including mortality.<br/> Economic data. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* size of study to detect a 10% difference in improvement with 80% certainty.<br/> <br/> ** Primary outcome.<br/> <br/> *** If scales are used to measure outcome then there should be binary cut off points, defined before study starts, of clinically important improvement. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>N = number of participants, BPRS = Brief Psychiatric Rating Scale, CGI = Clinical Global Impressions Scale </p> </div> </div> <section id="CD004716-sec-0329"> <p><b>2.2.1 Methods</b></p> <p>Allocation concealment is vital in the design of future randomised controlled trials to minimise bias. The randomisation process should also be described fully. It is probably not possible to use double‐blind methodology in trials of psychological and psychosocial interventions. However, bias can be minimised by ensuring therapists and people are blind to the specific study hypothesis where feasible, and by using blinded or independent outcome raters. </p> </section> <section id="CD004716-sec-0330"> <p><b>2.2.2 Participants</b></p> <p>We would suggest that inclusion criteria for participants in such a study would be broad and that the therapy be given in the context of everyday practice. </p> </section> <section id="CD004716-sec-0331"> <p><b>2.2.3 Interventions</b></p> <p>2.2.3.1 Supportive therapy</p> <p>Future trials should clearly explain whether practitioners who deliver supportive therapy have been specifically trained, and if so how. It may make the results more applicable if the therapists are trained but in the context of routine career development, rather than specific highly‐trained specialised practitioners. In addition, using a therapy manual or protocol and attempting to ensure adherence to the model may at least increase internal validity of the trial. Ideally, different therapists should be used for different therapies. Finally, it is important to clearly define supportive therapy. We have found no standard definition and it would be beneficial if a standard definition for this commonly practiced intervention were to be developed. </p> <p>2.2.3.2 Comparison group</p> <p>Further data comparing supportive therapy both with standard care and with other treatments are needed. These should be clearly defined within the trial, even if it is routine care. </p> </section> <section id="CD004716-sec-0332"> <p><b>2.2.4 Outcomes</b></p> <p>Outcomes chosen should be clinically relevant and widely used. Outcomes such as relapse or hospitalisation are less vulnerable to bias than scale data, and may therefore be preferable. Little data are available presently on adverse effects, social functioning, occupational status, quality of life, and economic outcomes, all of which would be of interest. Such outcomes are often not difficult to record over the short, medium or long term. </p> </section> </section> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004716-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004716-sec-0029"></div> <div class="table" id="CD004716-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SUPPORTIVE THERAPY versus STANDARD CARE for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus STANDARD CARE for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus STANDARD CARE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>321 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (141 to 678) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.44 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low</b><sup>1,2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (3 to 628) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1</b> <br/> (0.07 to 15.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: no clinically important improvement</b> <br/> Follow‐up: 1 to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>898 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>853 per 1000</b> <br/> (736 to 997) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.95</b> <br/> (0.82 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 10 weeks to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b> <br/> (88 to 232) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.86</b> <br/> (0.53 to 1.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> <br/> GAS<br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean general functioning in the intervention groups was<br/> <b>1.4 higher</b> <br/> (5.09 lower to 7.89 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment: Recipient of care not satisfied with treatment</b> <br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>238 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>436 per 1000</b> <br/> (179 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.83</b> <br/> (0.75 to 4.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> WBS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>2.73 lower</b> <br/> (6.04 lower to 0.58 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>260<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>2</sup> Publication bias: strongly suspected ‐ four studies or fewer reported data for this outcome.<br/> <sup>3</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation, allocation concealment and blinding.<br/> <sup>4</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation and allocation concealment; two studies had an unclear risk for blinding.<br/> <sup>5</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for blinding.<br/> <sup>6</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004716-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY<br/> <b>Comparison:</b> ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>435 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>517 per 1000</b> <br/> (287 to 939) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.19</b> <br/> (0.66 to 2.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 12 weeks to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>122 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>222 per 1000</b> <br/> (135 to 365) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.82</b> <br/> (1.11 to 2.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: No clinically important improvement</b> <br/> Follow‐up: 1 to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>594 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>754 per 1000</b> <br/> (618 to 915) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/> (1.04 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 10 weeks to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>249 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>257 per 1000</b> <br/> (217 to 302) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b> <br/> (0.87 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1412<br/> (19 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> <br/> GAF and GAS<br/> Follow‐up: 12 to 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,8,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was very high heterogeneity for this outcome so data were not pooled. <sup>11</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment: Recipient of care not satisfied with treatment</b> <br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>435 per 1000</b> <br/> (138 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.19</b> <br/> (1.01 to 10.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,12,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> QLS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>0.07 lower</b> <br/> (21.11 lower to 20.97 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,10,13,14</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: serious ‐ four studies had an unclear risk of bias for randomisation and allocation concealment. All studies had an unclear risk of bias for blinding of participants and two had a high risk of bias for blinding of outcome assessments.<br/> <sup>2</sup> Inconsistency: serious ‐ there was high heterogeneity for this outcome.<br/> <sup>3</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>4</sup> Publication bias: strongly suspected ‐ four studies or fewer reported data for this outcome.<br/> <sup>5</sup> Risk of bias: serious ‐ three studies had an unclear risk of bias for randomisation and allocation concealment. All studies had an unclear risk of bias for blinding of participants and two were unclear for blinding of outcome assessments.<br/> <sup>6</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation. All studies had an unclear risk of bias for blinding of participants and one had an unclear risk of bias for blinding of outcome assessments.<br/> <sup>7</sup> Risk of bias: serious ‐ 13 studies had an unclear risk of bias for randomisation and 14 for allocation concealment. Fifteen studies had an unclear risk of bias for blinding of participants and one had a high risk of bias. Three studies two had a high risk of bias for blinding of outcome assessments and eight were unclear. One study had a high risk of bias for incomplete outcome data, and in three it was unclear.<br/> <sup>8</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for allocation concealment. Both studies had an unclear risk of bias for blinding of participants and outcome assessments.<br/> <sup>9</sup> Inconsistency: very serious ‐ there was high heterogeneity for this outcome and data were not pooled.<br/> <sup>10</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available.<br/> <sup>11</sup> One study found no difference in general functioning on the GAS, the other study found a difference in favour of supportive therapy on the GAF.<br/> <sup>12</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for blinding of participants and outcome assessors.<br/> <sup>13</sup> Imprecision: very serious ‐ relatively few participants were included and few events; confidence intervals are very wide.<br/> <sup>14</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for blinding of participants and outcome assessments. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004716-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> COGNITIVE BEHAVIOURAL THERAPY </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>429 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>471 per 1000</b> <br/> (219 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.1</b> <br/> (0.51 to 2.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 12 weeks to 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>249 per 1000</b> <br/> (132 to 468) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.6</b> <br/> (0.85 to 3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: No clinically important improvement</b> <br/> Follow‐up: 1 to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>594 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>731 per 1000</b> <br/> (529 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.23</b> <br/> (0.89 to 1.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 10 weeks to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>158 per 1000</b> <br/> (116 to 217) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> <br/> (0.77 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>812<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> <br/> GAF and GAS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,8,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was very high heterogeneity for this outcome so data were not pooled. <sup>11</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment: Recipient of care not satisfied with treatment</b> <br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>435 per 1000</b> <br/> (138 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.19</b> <br/> (1.01 to 10.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,12,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> RSES<br/> Follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>1.7 lower</b> <br/> (5.19 lower to 1.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: serious ‐ three trials had an unclear risk of bias for randomisation and allocation concealment. All studies had an unclear risk for blinding of participants, while two studies were rated as high risk for blinding of outcome assessors.<br/> <sup>2</sup> Inconsistency: serious ‐ there was high heterogeneity for this outcome.<br/> <sup>3</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>4</sup> Publication bias: strongly suspected ‐ four studies or fewer reported data for this outcome.<br/> <sup>5</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation and two for allocation concealment. All were unclear risk for blinding of participants and two for blinding of outcome assessors.<br/> <sup>6</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation. All three had an unclear risk of blinding of participants and one for blinding of outcome assessors.<br/> <sup>7</sup> Risk of bias: serious ‐ seven studies had an unclear risk of bias for randomisation and allocation concealment. Nine studies had an unclear risk of bias for blinding of participants. Two studies two had a high risk of bias for blinding of outcome assessments and four were unclear.<br/> <sup>8</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for allocation concealment. Both studies had an unclear risk of bias for blinding of participants and outcome assessments.<br/> <sup>9</sup> Inconsistency: very serious ‐ there was high heterogeneity for this outcome and data were not pooled.<br/> <sup>10</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available.<br/> <sup>11</sup> One study found no difference in general functioning on the GAS, the other study found a difference in favour of supportive therapy on the GAF.<br/> <sup>12</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for blinding of participants and outcome assessors.<br/> <sup>13</sup> Imprecision: very serious ‐ relatively few participants were included and few events; confidence intervals are very wide. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004716-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">SUPPORTIVE THERAPY versus FAMILY THERAPY for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus FAMILY THERAPY for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> FAMILY THERAPY </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus FAMILY THERAPY</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was high heterogeneity for this outcome and data were not pooled.<sup>5</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>300 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> <br/> (267 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.93</b> <br/> (0.89 to 4.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: Episode of affective symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>292 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>499 per 1000</b> <br/> (239 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.71</b> <br/> (0.82 to 3.6) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>182 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>231 per 1000</b> <br/> (102 to 525) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/> (0.56 to 2.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning: No paid work</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>600 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>576 per 1000</b> <br/> (342 to 978) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.57 to 1.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,6,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for satisfaction with treatment.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: very serious ‐ both studies had an unclear risk of bias for randomisation, allocation concealment and blinding of participants. One study was rated high risk of bias for blinding of outcome assessors.<br/> <sup>2</sup> Inconsistency: very serious ‐ there was high heterogeneity for this outcome and data were not pooled.<br/> <sup>3</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>4</sup> Publication bias: strongly suspected ‐ two studies or fewer reported data for this outcome.<br/> <sup>5</sup> One study found no difference in relapse rates, the other study found a difference in favour of family therapy.<br/> <sup>6</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants.<br/> <sup>7</sup> Risk of bias: very serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants. It was rated high risk of bias for blinding of outcome assessors.<br/> <sup>8</sup> Indirectness: serious ‐ we wanted to collect binary data for no clinical improvement in general symptoms, however, only a proxy measure was available.<br/> <sup>9</sup> Indirectness: serious ‐ we wanted to collect binary data for no overall improvement in general functioning, however, only a proxy measure was available. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004716-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHOEDUCATION for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus PSYCHOEDUCATION for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> PSYCHOEDUCATION </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus PSYCHOEDUCATION</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data on relapse.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>87 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (4 to 429) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.48</b> <br/> (0.05 to 4.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state. No clinically important improvement</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>600 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>966 per 1000</b> <br/> (576 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.61</b> <br/> (0.96 to 2.68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> <br/> (52 to 385) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.57</b> <br/> (0.21 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for general functioning.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for satisfaction with treatment.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> QLS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>0.07 lower</b> <br/> (21.11 lower to 20.97 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants and outcome assessors.<br/> <sup>2</sup> Imprecision: very serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>3</sup> Publication bias: strongly suspected ‐ two studies or fewer reported data for this outcome.<br/> <sup>4</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants.<br/> <sup>5</sup> Risk of bias: serious ‐ both studies had an unclear risk of bias for randomisation, allocation concealment and blinding of participants and one study was unclear risk for outcome assessors.<br/> <sup>6</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004716-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004716-sec-0030"></div> <section id="CD004716-sec-0031"> <h3 class="title" id="CD004716-sec-0031">Description of the condition</h3> <p>One of the common features of psychotherapies and professional interventions for people with schizophrenia is to provide support. For example, in an out‐patient consultation there will often be time allocated to listening to patients' concerns, giving encouragement, or even arranging basic help with day to day living, such as access to local resources. The key elements of support are to maintain an existing situation, or assist pre‐existing coping abilities. Supportive therapy has been described as the treatment model of choice for most patients (<a href="./references#CD004716-bbs2-0272" title="HellersteinDJ , PinskerH , RosenthalRN , KleeS . Supportive therapy as the treatment model of choice. Journal of Psychotherapy Practice and Research1994;3(4):300‐6. ">Hellerstein 1994</a>), and may be the most commonly practiced intervention in the mental health service. </p> </section> <section id="CD004716-sec-0032"> <h3 class="title" id="CD004716-sec-0032">Description of the intervention</h3> <p>It is, however, difficult to answer the question of exactly what is supportive therapy? A starting point is to look at the literature on supportive psychotherapy, which has been defined as "a dyadic treatment characterised by the use of direct measures to ameliorate symptoms and to maintain, restore or improve self esteem, adaptive skills and ego function" (<a href="./references#CD004716-bbs2-0300" title="PinskerH , RosenthalR , McCulloughL . Dynamic supportive therapy. Handbook of Short‐term Dynamic Psychotherapy. New York: BasicBooks, 1991:220‐47. ">Pinsker 1991</a>). There may also be a difference in the practice of supportive therapy according to country (<a href="./references#CD004716-bbs2-0277" title="HolmesJ . Supportive psychotherapy. The search for positive meanings. British Journal of Psychiatry1995;167(4):439‐45; 446‐7. [MEDLINE: 96113855] ">Holmes 1995</a>). In the UK, supportive therapy implies a frequency of less than once a week, whereas in America, some practitioners would regard any psychodynamic intervention at a frequency of less than four or five times a week as supportive psychotherapy (<a href="./references#CD004716-bbs2-0310" title="WermanD . The Practice of Supportive Therapy. New York: Brunner, 1994. ">Werman 1994</a>). </p> </section> <section id="CD004716-sec-0033"> <h3 class="title" id="CD004716-sec-0033">How the intervention might work</h3> <p>Even though there is no internationally agreed definition, one of the key features is that supportive therapy aims to enhance, rather than challenge, current psychological defence mechanisms. An alternative view is to identify supportive therapy according to the components of the therapy (<a href="./references#CD004716-bbs2-0292" title="MischDA . Basic strategies of dynamic supportive therapy. Journal of Psychotherapy Practice and Research2000;9(4):173‐89. ">Misch 2000</a>). For example, one expert proposes seven distinct components; reassurance, explanation, guidance, suggestion, encouragement, affecting change in the environment, and permission for catharsis (<a href="./references#CD004716-bbs2-0252" title="BlochS . Introduction to the Psychotherapies. 3rd Edition. Oxford University Press, 1996. ">Bloch 1996</a>). Bloch also argues that supportive therapy must be a long‐term intervention. The difficulty of this proposal is that there is no clear reason why a specific component of therapy should be regarded as supportive. Possible solutions include defining supportive therapy according to outcome, according to the perception of the client or by identifying a feature of therapy that is inherently supportive, regardless of its impact on a client (<a href="./references#CD004716-bbs2-0247" title="BarberJP , StrattR , HalperinG , ConnollyMB . Supportive techniques: are they found in different therapies?. Journal of Psychotherapy Practice and Research2001;10(3):165‐72. ">Barber 2001</a>). </p> <p>There are many other forms of support that can be given which are distinct from the psychodynamic tradition. For example, there are mental health workers who have the job title of support worker whose role is often to provide practical support such as reminders and transport for other services, or to spend time befriending a client. </p> </section> <section id="CD004716-sec-0034"> <h3 class="title" id="CD004716-sec-0034">Why it is important to do this review</h3> <p>Ultimately, the lack of a widely accepted definition of supportive therapy means we are not able to avoid an arbitrary element in the definition used for this review. Our definition (see <a href="#CD004716-sec-0040">Types of interventions</a>) is influenced by the potential usefulness of this review, which could be: </p> <p> <ol id="CD004716-list-0001"> <li> <p>to give information on the effectiveness of a therapy that is commonly used as the control arm of clinical trials for psychotherapies in schizophrenia; </p> </li> <li> <p>to help clinicians with the decision of whether to offer a supportive intervention;</p> </li> <li> <p>to help clinicians understand the value of supportive elements of their individual interactions with people who have schizophrenia. </p> </li> </ol> </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004716-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004716-sec-0035"></div> <p>To review the effects of supportive therapy compared with standard care, or other treatments in addition to standard care for people with schizophrenia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004716-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004716-sec-0036"></div> <section id="CD004716-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004716-sec-0038"> <h4 class="title">Types of studies</h4> <p>We sought all relevant randomised controlled trials. Where a trial was described as 'double‐blind', but it was only implied that the study was randomised, we included these trials in a sensitivity analysis. If there was no substantive difference within primary outcomes (see '<a href="#CD004716-sec-0044">Types of outcome measures</a>') when these 'implied randomisation' studies were added, then we included them in the final analyses. If there was a substantive difference, then we only used clearly randomised trials and the results of the sensitivity analysis were described in the text. We excluded quasi‐randomised studies, such as those allocating by using alternate days of the week. </p> </section> <section id="CD004716-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included people with schizophrenia or schizophrenia‐like illnesses using any criteria. We included trials where it was implied that the majority of participants had a severe mental illness that was likely to be schizophrenia. We did not exclude trials due to age, nationality, gender, duration of illness or treatment setting. </p> </section> <section id="CD004716-sec-0040"> <h4 class="title">Types of interventions</h4> <section id="CD004716-sec-0041"> <h5 class="title">1. Supportive therapy and supportive care</h5> <p>We have used the phrase 'supportive therapy and supportive care' here to indicate that this review covers a wider variety of interventions than supportive psychotherapy alone. However, for the sake of simplicity, we used the term 'supportive therapy' elsewhere in this review. These interventions are provided by a single person with the main purpose of maintaining current functioning or assisting pre‐existing coping abilities in people who have a diagnosis of schizophrenia or schizophrenia‐like illness. The therapies can be aimed at individuals or groups of people. If the content of the therapy was not sufficiently clear after reading a clinical study, then we included any therapy that had supportive or support in its title. We have included advocacy as a form of supportive therapy. Advocacy is a narrower intervention than other interventions included in the review, but it nevertheless fits our definition as it assists people with their communication and interaction with mental health workers. </p> <p>A number of common therapies are excluded as they are designed to teach new skills or change pre‐existing skills. These include cognitive behavioural therapy<b>(</b> CBT<b>)</b> (<a href="./references#CD004716-bbs2-0256" title="CormacI , JonesC , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD000524.pub2] ">Cormac 2004</a>), social skills training, psycho‐education (<a href="./references#CD004716-bbs2-0298" title="PekkalaE , MerinderL . Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews2002, Issue 2. [DOI: 10.1002/14651858.CD002831] ">Pekkala2002</a>), compliance therapy (<a href="./references#CD004716-bbs2-0291" title="McIntoshAM , ConlonL , LawrieSM , StanfieldAC . Compliance therapy for schizophrenia. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD003442.pub2] ">McIntosh 2006</a>) and problem‐solving therapy. </p> <p>Some therapies or schemes have been excluded as they involve a team approach rather than an individual worker, or because they are designed to alter a person's environment, rather than to help the person cope with their environment. These include family placement (<a href="./references#CD004716-bbs2-0299" title="PharoahFM , RathboneJ , MariJJ , StreinerD . Family intervention for schizophrenia. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD000088.pub2] ">Pharoah 2006</a>), supported employment and supported accommodation (<a href="./references#CD004716-bbs2-0255" title="ChilversR , MacdonaldGM , HayesAA . Supported housing for people with severe mental disorders. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD000453.pub2; CD000453] ">Chilvers 2006</a>) . An exception was to include an intervention if it was clear that it consisted of a practitioner whose main purpose was to help a client cope with their current situation, rather than alter the situation to make it easier for the client.<br/> <br/> We have also excluded counselling (unlike the meta‐analysis from the National Institute of Clinical Excellence on supportive therapy (<a href="./references#CD004716-bbs2-0296" title="The National Collaborating Centre for Mental Health. Schizophrenia. Full national clinical guideline on core interventions in primary and secondary care. London: Gaskell, The Royal College of Psychiatrists, 2003. ">NICE 2003</a>)). The main purpose of counselling is to give an opportunity for a client to explore, discover and clarify ways of living (<a href="./references#CD004716-bbs2-0261" title="Department of Health. Treatment Choice in Psychological Therapies and Counselling Evidence Based Clinical Practice Guideline. London: Department of Health, 2001. ">DoH 2001</a>). Counselling employs a wide variety of techniques, and the purpose may be to facilitate a change in someone's life rather than to maintain the current situation. As counselling has such a broad scope, an exception was to include a clinical trial if there was a clear indication that the main purpose of counselling was to provide support rather than facilitate change or give an opportunity to explore personal issues. </p> </section> <section id="CD004716-sec-0042"> <h5 class="title">2. Standard care</h5> <p>This is defined as the care a person would normally receive had they not been included in the research trial. This would include interventions such as medication, hospitalisation, community psychiatric nursing input and/or day hospital. </p> </section> <section id="CD004716-sec-0043"> <h5 class="title">3. Other treatments</h5> <p>This would include any other treatment (biological, psychological or social) such as medication, problem‐solving therapy, psycho‐education, social skills training, CBT, family therapy or psychodynamic psychotherapy. </p> </section> </section> <section id="CD004716-sec-0044"> <h4 class="title">Types of outcome measures</h4> <p>We reported outcomes for the short term (up to 12 weeks), medium term (13 to 26 weeks), and long term (more than 26 weeks) </p> <section id="CD004716-sec-0045"> <h5 class="title">Primary outcomes</h5> <section id="CD004716-sec-0046"> <h6 class="title">1. Global state</h6> <p>1.1 Relapse</p> </section> <section id="CD004716-sec-0047"> <h6 class="title">2. Service outcomes</h6> <p>2.1 Hospitalisation</p> </section> <section id="CD004716-sec-0048"> <h6 class="title">5. General functioning</h6> <p>5.1 No clinically important change in general functioning</p> </section> </section> <section id="CD004716-sec-0049"> <h5 class="title">Secondary outcomes</h5> <section id="CD004716-sec-0050"> <h6 class="title">1. Global state</h6> <p>1.2 Time to relapse<br/> 1.3 No clinically important change in global state<br/> 1.4 Not any change in global state<br/> 1.5 Average endpoint global state score<br/> 1.6 Average change in global state scores </p> </section> <section id="CD004716-sec-0051"> <h6 class="title">2. Service outcomes</h6> <p>2.2 Time to hospitalisation</p> </section> <section id="CD004716-sec-0052"> <h6 class="title">3. Mental state</h6> <p>3.1 No clinically important improvement<br/> 3.2 Not any change in general mental state<br/> 3.3 Average endpoint general mental state score<br/> 3.4 Average change in general mental state scores<br/> 3.5 No clinically important change in specific symptoms<br/> 3.6 Not any change in specific symptoms<br/> 3.7 Average endpoint specific symptom score<br/> 3.8 Average change in specific symptom scores </p> </section> <section id="CD004716-sec-0053"> <h6 class="title">4. Leaving the study early</h6> <p>4.1 For specific reasons<br/> 4.2 For general reasons </p> </section> <section id="CD004716-sec-0054"> <h6 class="title">5. General functioning</h6> <p>5.2 Not any change in general functioning<br/> 5.3 Average endpoint general functioning score<br/> 5.4 Average change in general functioning scores<br/> 5.5 No clinically important change in specific aspects of functioning, such as social or life skills<br/> 5.6 Not any change in specific aspects of functioning, such as social or life skills<br/> 5.7 Average endpoint specific aspects of functioning, such as social or life skills<br/> 5.8 Average change in specific aspects of functioning, such as social or life skills </p> </section> <section id="CD004716-sec-0055"> <h6 class="title">6. Satisfaction with treatment</h6> <p>6.1 Recipient of care not satisfied with treatment<br/> 6.2 Recipient of care average satisfaction score<br/> 6.3 Recipient of care average change in satisfaction scores<br/> 6.4 Carer not satisfied with treatment<br/> 6.5 Carer average satisfaction score<br/> 6.6 Carer average change in satisfaction scores </p> </section> <section id="CD004716-sec-0056"> <h6 class="title">7. Quality of life</h6> <p>7.1 No clinically important change in quality of life<br/> 7.2 Not any change in quality of life<br/> 7.3 Average endpoint quality of life score<br/> 7.4 Average change in quality of life scores<br/> 7.5 No clinically important change in specific aspects of quality of life<br/> 7.6 Not any change in specific aspects of quality of life<br/> 7.7 Average endpoint specific aspects of quality of life<br/> 7.8 Average change in specific aspects of quality of life </p> </section> <section id="CD004716-sec-0057"> <h6 class="title">8. Death ‐ suicide and natural causes</h6> </section> <section id="CD004716-sec-0058"> <h6 class="title">9. Behaviour</h6> <p>9.1 No clinically important change in general behaviour<br/> 9.2 Not any change in general behaviour<br/> 9.3 Average endpoint general behaviour score<br/> 9.4 Average change in general behaviour scores<br/> 9.5 No clinically important change in specific aspects of behaviour<br/> 9.6 Not any change in specific aspects of behaviour<br/> 9.7 Average endpoint specific aspects of behaviour<br/> 9.8 Average change in specific aspects of behaviour </p> </section> <section id="CD004716-sec-0059"> <h6 class="title">10. Adverse effects</h6> <p>10.1 No clinically important general adverse effects<br/> 10.2 Not any general adverse effects<br/> 10.3 Average endpoint general adverse effect score<br/> 10.4 Average change in general adverse effect scores<br/> 10.5 No clinically important change in specific adverse effects<br/> 10.6 Not any change in specific adverse effects<br/> 10.7 Average endpoint specific adverse effects<br/> 10.8 Average change in specific adverse effects </p> </section> <section id="CD004716-sec-0060"> <h6 class="title">11. Engagement with services</h6> <p>11.1 No clinically important engagement<br/> 11.2 Not any engagement<br/> 11.3 Average endpoint engagement score<br/> 11.4 Average change in engagement scores </p> </section> <section id="CD004716-sec-0061"> <h6 class="title">12. Engagement in structured activities</h6> <p>12.1 No clinically important change in engagement in structured activities<br/> 12.2 Not any change in engagement in structured activities<br/> 12.3 Average endpoint engagement in structured activities score<br/> 12.4 Average change in engagement in structured activities scores<br/> 12.5 No clinically important change in specific activities, such as employment, education or attendance at day centres<br/> 12.6 Not any change in specific aspects of functioning, such as employment, education or attendance at day centres<br/> 12.7 Average endpoint specific aspects of functioning, such as employment, education or attendance at day centres<br/> 12.8 Average change in specific aspects of functioning, such as employment, education or attendance at day centres </p> </section> <section id="CD004716-sec-0062"> <h6 class="title">13. Insight</h6> <p>13.1 Average endpoint insight score<br/> 13.2 Average endpoint treatment attitude score<br/> 13.3 Average endpoint adherence score </p> </section> <section id="CD004716-sec-0063"> <h6 class="title">14. Compliance</h6> <p>14.1 Adherence<br/> 14.2 Poor Compliance </p> </section> <section id="CD004716-sec-0064"> <h6 class="title">15. Medication</h6> <p>15.1 Reduction in dose<br/> 15.2 Prescribed intramuscular (IM) depot medication </p> </section> <section id="CD004716-sec-0065"> <h6 class="title">16. Attitude to medication</h6> <p>16.1 Average endpoint attitude to medication score<br/> 16.2 Average endpoint need for treatment </p> </section> <section id="CD004716-sec-0066"> <h6 class="title">17. Economic outcomes</h6> <p>17.1 Average change in total cost of medical and mental health care<br/> 17.2 Total indirect and direct costs. </p> </section> <section id="CD004716-sec-0067"> <h6 class="title">18. 'Summary of findings' table</h6> <p>We used the GRADEapproach to interpret findings (<a href="./references#CD004716-bbs2-0307" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359‐83. ">Schünemann 2008</a>) and used the <a href="http://www.ims.cochrane.org/revman/grade" target="_blank">GRADE</a> profiler to import data from Review Manager (<a href="http://www.ims.cochrane.org/revman" target="_blank">RevMan</a>) to create 'Summary of findings' tables. These tables provide outcome‐specific information concerning the overall quality of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rated as important to patient‐care and decision making. We selected the following main outcomes for inclusion in the 'Summary of findings' tables. </p> <p> <ol id="CD004716-list-0002"> <li> <p>Global state: Relapse</p> </li> <li> <p>Service outcomes: Hospitalisation</p> </li> <li> <p>Leaving the study early</p> </li> <li> <p>Mental state: No clinically important change in general mental state</p> </li> <li> <p>General functioning: No clinically important change in general functioning</p> </li> <li> <p>Satisfaction with treatment: Recipient of care not satisfied with treatment</p> </li> <li> <p>Quality of life: No clinically important change in quality of life</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD004716-sec-0068"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004716-sec-0069"> <h4 class="title">Electronic searches</h4> <section id="CD004716-sec-0070"> <h5 class="title">1. Cochrane Schizophrenia Group Trials Register</h5> <p>The Trials Search Co‐ordinator searched the Cochrane Schizophrenia Group’s Trials Register (28 November 2012) </p> <p>[((*support* OR *advoc*) in title of REFERENCE) and ((*support* or *individual* or *sociotherapy* or *socioenvir*) in intervention of STUDY)] </p> <p>The Cochrane Schizophrenia Group’s Trials Register is compiled by systematic searches of major databases, handsearches of relevant journals and conference proceedings. For details of databases searched see <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/SCHIZ/frame.html" target="_blank">Group Module</a>. </p> </section> </section> <section id="CD004716-sec-0071"> <h4 class="title">Searching other resources</h4> <section id="CD004716-sec-0072"> <h5 class="title">1. Reference searching</h5> <p>We inspected the reference lists of all identified studies, including existing reviews, for relevant citations. </p> </section> <section id="CD004716-sec-0073"> <h5 class="title">2. Personal contact</h5> <p>If necessary we would have contacted the first author of each relevant study for information on unpublished trials. </p> </section> </section> </section> <section id="CD004716-sec-0074"> <h3 class="title" id="CD004716-sec-0074">Data collection and analysis</h3> <section id="CD004716-sec-0075"> <h4 class="title">Selection of studies</h4> <p>For this update review authors NM and KSW independently inspected citations from the new electronic search and identified relevant abstracts. NM and KSW also inspected full articles of the abstracts meeting inclusion criteria. CEA carried out the reliability check of all citations from the new electronic search. </p> </section> <section id="CD004716-sec-0076"> <h4 class="title">Data extraction and management</h4> <section id="CD004716-sec-0077"> <h5 class="title">1. Extraction</h5> <p>For this update, NM extracted data from included studies. If data were presented only in graphs and figures NM extracted these data whenever possible. If studies were multi‐centre, where possible, NM extracted data relevant to each component centre separately. </p> </section> <section id="CD004716-sec-0078"> <h5 class="title">2. Management</h5> <section id="CD004716-sec-0079"> <h6 class="title">2.1 Forms</h6> <p>We extracted data onto standard, simple forms.</p> </section> <section id="CD004716-sec-0080"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:<br/> a. the psychometric properties of the measuring instrument have been described in a peer‐reviewed journal (<a href="./references#CD004716-bbs2-0289" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176:249‐52. ">Marshall 2000</a>); and<br/> b. the measuring instrument has not been written or modified by one of the trialists for that particular trial. </p> <p>Ideally, the measuring instrument should either be i. a self‐report or ii. completed by an independent rater or relative (not the therapist). We realise that this is not often reported clearly; if relevant we noted whether or not this is the case in <a href="#CD004716-sec-0120">Description of studies</a>. </p> </section> <section id="CD004716-sec-0081"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data. Change data can remove a component of between‐person variability from the analysis. On the other hand, calculation of change needs two assessments (baseline and endpoint), which can be difficult in unstable and difficult to measure conditions such as schizophrenia. We decided primarily to use endpoint data, and only use change data if the former were not available. Had we had both change and endpoint data, we would have combined them in the analysis as we used mean differences (MD) rather than standardised mean differences (SMD) throughout (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>, Chapter 9.4.5.2). </p> </section> <section id="CD004716-sec-0082"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non‐parametric data, we aimed to apply the following standards to all data before inclusion: </p> <p> <ul id="CD004716-list-0003"> <li> <p>standard deviations (SDs) and means are reported in the paper or obtainable from the authors; </p> </li> <li> <p>when a scale starts from the finite number zero, the SD, when multiplied by two, is less than the mean (as otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution (<a href="./references#CD004716-bbs2-0243" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313:1200. ">Altman 1996</a>)); </p> </li> <li> <p>if a scale started from a positive value (such as the Positive and Negative Syndrome Scale (PANSS, (<a href="./references#CD004716-bbs2-0281" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>), which can have values from 30 to 210), we modified the calculation described above to take the scale starting point into account. In these cases skew is present if 2 SD &gt; (S‐S min), where S is the mean score and S min is the minimum score. </p> </li> </ul> </p> <p>Endpoint scores on scales often have a finite start and end point and these rules can be applied. We entered skewed endpoint data from studies of fewer than 200 participants as other data within the data and analyses section rather than into a statistical analysis. Skewed data pose less of a problem when looking at mean if the sample size is large; we entered such endpoint data into syntheses. </p> <p>When continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to tell whether data are skewed or not, we entered skewed change data into analyses regardless of size of study. </p> </section> <section id="CD004716-sec-0083"> <h6 class="title">2.5 Common measure</h6> <p>To facilitate comparison between trials, we intended to convert variables that can be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD004716-sec-0084"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Where possible, we made efforts to convert outcome measures to dichotomous data. This can be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there is a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD004716-bbs2-0297" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10:799‐812. ">Overall 1962</a>) or the Positive and Negative Syndrome Scale (PANSS, <a href="./references#CD004716-bbs2-0281" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>), this could be considered as a clinically significant response (<a href="./references#CD004716-bbs2-0284" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelRR . What does the PANSS mean?. Schizophrenia Research2005;79(2‐3):231‐8. [PUBMED: 15982856] ">Leucht 2005</a>; <a href="./references#CD004716-bbs2-0285" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelR . Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry2005;187:366‐71. [PUBMED: 16199797] ">Leucht 2005a</a>). If data based on these thresholds were not available, we used the primary cut‐off presented by the original authors. </p> </section> <section id="CD004716-sec-0085"> <h6 class="title">2.7 Direction of graphs</h6> <p>Where possible, we entered data in such a way that the area to the left of the line of no effect indicated a favourable outcome for supportive therapy. </p> </section> </section> </section> <section id="CD004716-sec-0086"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For this update, NM and KSW worked independently by using criteria described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>) to assess trial quality. This new set of criteria is based on evidence of associations between overestimate of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. </p> <p>Where inadequate details of randomisation and other characteristics of trials were provided, we contacted authors of the studies in order to obtain additional information. </p> <p>We have noted the level of risk of bias in both the text of the review and in the 'Summary of findings' tables. </p> </section> <section id="CD004716-sec-0087"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004716-sec-0088"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes, we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI). It has been shown that RR is more intuitive (<a href="./references#CD004716-bbs2-0253" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie1999;54(4):405‐11. [PUBMED: 10667106] ">Boissel 1999</a>) than odds ratios and that odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD004716-bbs2-0259" title="DeeksJ . Issues in the selection for meta‐analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25‐28; Cape Town. Cape Town: The Cochrane Collaboration, 2000. ">Deeks 2000</a>). The Number Needed to Treat/Harm (NNT/H) statistic with its confidence intervals is intuitively attractive to clinicians but is problematic both in its accurate calculation in meta‐analyses and interpretation (<a href="./references#CD004716-bbs2-0279" title="HuttonJL . Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology2009;146(1):27‐30. ">Hutton 2009</a>). For binary data presented in the 'Summary of findings' tables, where possible, we calculated illustrative comparative risks. </p> </section> <section id="CD004716-sec-0089"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes, we estimated mean difference (MD) between groups. We would prefer not to calculate effect size measures (standardised mean difference (SMD)). However, if scales of very considerable similarity had been used, we would have presumed there was a small difference in measurement, and we would have calculated effect size and transformed the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD004716-sec-0090"> <h4 class="title">Unit of analysis issues</h4> <section id="CD004716-sec-0091"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice), but analysis and pooling of clustered data poses problems. Authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD004716-bbs2-0260" title="DivineGW , BrownJT , FrazierLM . The unit of analysis error in studies about physicians' patient care behaviour. Journal of General Internal Medicine1992;7(6):623‐9. ">Divine 1992</a>) whereby P values are spuriously low, confidence intervals unduly narrow and statistical significance overestimated. This causes type I errors (<a href="./references#CD004716-bbs2-0251" title="BlandJM . Statistics notes. Trials randomised in clusters. BMJ1997;315:600. ">Bland 1997</a>; <a href="./references#CD004716-bbs2-0268" title="GullifordMC , UkoumunneOC , ChinnS . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). </p> <p>We did not include any cluster‐randomised trials in this version of the review. If we had found trials where clustering was not accounted for in primary studies, we would have presented data in a table, with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, if we include cluster‐randomised trials, we will seek to contact first authors of studies to obtain intra‐class correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD004716-bbs2-0268" title="GullifordMC , UkoumunneOC , ChinnS . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149:876‐83. ">Gulliford 1999</a>). </p> <p>If we had included trials where clustering had been incorporated into the analysis of primary studies, we would have presented these data as if from a non‐cluster randomised study, but adjusted for the clustering effect. </p> <p>We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC [Design effect = 1+(m‐1)*ICC] (<a href="./references#CD004716-bbs2-0262" title="DonnerA , KlarN . Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine2002;21:2971‐80. ">Donner 2002</a>). If the ICC is not reported it will be assumed to be 0.1 (<a href="./references#CD004716-bbs2-0308" title="UkoumunneOC , GullifordMC , ChinnS , SterneJAC , BurneyPGJ . Methods for evaluating area‐wide and organisation‐based intervention in health and health care: a systematic review. Health Technology Assessment1999;3(5):1‐75. ">Ukoumunne 1999</a>). </p> <p>If cluster studies have been appropriately analysed taking into account ICCs and relevant data documented in the report, synthesis with other studies would be possible using the generic inverse variance technique. </p> </section> <section id="CD004716-sec-0092"> <h5 class="title">2. Cross‐over trials</h5> <p>A major concern of cross‐over trials is the carry‐over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase the participants can differ systematically from their initial state despite a wash‐out phase. For the same reason, cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD004716-bbs2-0264" title="ElbourneD , AltmanDG , HigginsJPT , CurtinaF , WorthingtondHV , VaileA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). As both effects are very likely in severe mental illness, had we included such trials, we planned to use only the data of the first phase of cross‐over studies. </p> </section> <section id="CD004716-sec-0093"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involves more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. If data were binary, we simply added these and combined within the two‐by‐two table. If data were continuous, we combined data following the formula in section 7.7.3.8 (Combining groups) of the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>). Where the additional treatment arms were not relevant, we did not reproduce these data. </p> </section> </section> <section id="CD004716-sec-0094"> <h4 class="title">Dealing with missing data</h4> <section id="CD004716-sec-0095"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up, data must lose credibility (<a href="./references#CD004716-bbs2-0311" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El‐SayehH , et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254‐7. ">Xia 2009</a>). We chose that, for any particular outcome, should more than 50% of data be unaccounted for, we would not reproduce these data or use them within analyses. If, however, more than 50% of those in one arm of a study were lost, but the total loss was less than 50%, we addressed this within the 'Summary of findings' tables by down‐rating quality. Finally, we also downgraded quality within the 'Summary of findings' tables where loss was 25% to 50% in total. </p> </section> <section id="CD004716-sec-0096"> <h5 class="title">2. Binary</h5> <p>In the case where attrition for a binary outcome was between 0% and 50% and where these data were not clearly described, we presented data on a 'once‐randomised‐always‐analyse' basis (an intention‐to‐treat analysis). Those leaving the study early were all assumed to have the same rates of negative outcome as those who completed, with the exception of the outcome of death and adverse effects. For these outcomes, the rate of those who stayed in the study ‐ in that particular arm of the trial ‐ were used for those who did not. We undertook a sensitivity analysis to test how prone the primary outcomes were to change when 'completer' data only were compared to the intention‐to‐treat analysis using the above assumptions. </p> </section> <section id="CD004716-sec-0097"> <h5 class="title">3. Continuous</h5> <section id="CD004716-sec-0098"> <h6 class="title">3.1 Attrition</h6> <p>In the case where attrition for a continuous outcome is between 0% and 50% and completer‐only data were reported, we reproduced these. </p> </section> <section id="CD004716-sec-0099"> <h6 class="title">3.2 Standard deviations</h6> <p>If standard deviations (SDs) were not reported, we first tried to obtain the missing values from the authors. If not available, where there are missing measures of variance for continuous data, but an exact standard error (SE) and confidence intervals available for group means, and either a P value or T value available for differences in mean, we can calculate them according to the rules described in the <i>Handbook</i> (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>): When only the SE is reported, SDs are calculated by the formula SD = SE * square root (n). Chapters 7.7.3 and 16.1.3 of the <i>Handbook</i> (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>) present detailed formulae for estimating SDs from P values, T or F values, confidence intervals, ranges or other statistics. If these formulae do not apply, we can calculate the SDs according to a validated imputation method, which is based on the SDs of the other included studies (<a href="./references#CD004716-bbs2-0266" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(7):7‐10. ">Furukawa 2006</a>). Although some of these imputation strategies can introduce error, the alternative would be to exclude a given study’s outcome and thus to lose information. We nevertheless examined the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD004716-sec-0100"> <h6 class="title">3.3 Last observation carried forward</h6> <p>We anticipated that in some studies the method of last observation carried forward (LOCF) would be employed within the study report. As with all methods of imputation to deal with missing data, LOCF introduces uncertainty about the reliability of the results (<a href="./references#CD004716-bbs2-0286" title="LeuchtS , EngelRR , BaumlJ , DavisJM . Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin2007;33(1):183‐91. [PUBMED: 16905632] ">Leucht 2007</a>). Therefore, where LOCF data have been used in the trial, if less than 50% of the data have been assumed, we reproduced these data and indicated that they are the product of LOCF assumptions. </p> </section> </section> </section> <section id="CD004716-sec-0101"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD004716-sec-0102"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations which we had not predicted would arise. When such situations or participant groups arose, we fully discussed these. </p> </section> <section id="CD004716-sec-0103"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise. When such methodological outliers arose, we fully discussed these. </p> </section> <section id="CD004716-sec-0104"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD004716-sec-0105"> <h6 class="title">3.1 Visual inspection</h6> <p>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD004716-sec-0106"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>We investigated heterogeneity between studies by considering the I<sup>2</sup> method alongside the Chi<sup>2</sup> P value. The I<sup>2</sup> provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD004716-bbs2-0273" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on i. magnitude and direction of effects and ii. strength of evidence for heterogeneity (e.g. P value from Chi<sup>2</sup> test, or a confidence interval for I<sup>2</sup>). An I<sup>2</sup> estimate greater than or equal to around 50% accompanied by a statistically significant Chi<sup>2</sup> statistic was interpreted as evidence of substantial levels of heterogeneity (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for heterogeneity (<a href="#CD004716-sec-0109">Subgroup analysis and investigation of heterogeneity</a>). Where the I<sup>2</sup> estimate was equal to or greater than 75%, we interpreted this as indicating the presence of high levels of heterogeneity (<a href="./references#CD004716-bbs2-0273" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). We did not summate data if inconsistency was high, but presented the data separately and investigated reasons for heterogeneity. If data were heterogeneous we used a random‐effects model. </p> </section> </section> </section> <section id="CD004716-sec-0107"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD004716-bbs2-0263" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315:629‐34. ">Egger 1997</a>). These are described in Section 10 of the <i>Handbook</i> (<a href="./references#CD004716-bbs2-0275" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.. ">Higgins 2011</a>). We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small‐study effects. We did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots are possible, we sought statistical advice in their interpretation. </p> </section> <section id="CD004716-sec-0108"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random‐effects model takes into account differences between studies even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random‐effects model: it puts added weight onto small studies which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. We chose the fixed‐effect model for all analyses. The reader is, however, able to choose to inspect the data using the random‐effects model. </p> </section> <section id="CD004716-sec-0109"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD004716-sec-0110"> <h5 class="title">1. Subgroup analyses ‐ only primary outcomes</h5> <section id="CD004716-sec-0111"> <h6 class="title">1.1 Clinical state, stage or problem</h6> <p>We proposed to undertake this review and provide an overview of the effects of supportive therapy for people with schizophrenia in general. In addition, however, we tried to report data on subgroups of people in the same clinical state, stage and with similar problems. However, there were not enough included studies in the comparisons to undertake subgroup analyses. </p> </section> </section> <section id="CD004716-sec-0112"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>If inconsistency was high, we have reported this. First, we investigated whether data had been entered correctly. Second, if data were correct, we visually inspected the graph and successively removed outlying studies to see if homogeneity was restored. For this review we decided that should this occur with data contributing to the summary finding of no more than around 10% of the total weighting, we would present these data. If not, then we did not pool data and discussed issues. We know of no supporting research for this 10% cut‐off, but we use prediction intervals as an alternative to this unsatisfactory state. </p> <p>When unanticipated clinical or methodological heterogeneity was obvious, we simply stated hypotheses regarding these for future reviews or versions of this review. We do not anticipate undertaking analyses relating to these. </p> </section> </section> <section id="CD004716-sec-0113"> <h4 class="title">Sensitivity analysis</h4> <p>We applied all sensitivity analyses to the primary outcomes of this review.</p> <section id="CD004716-sec-0114"> <h5 class="title">1. Implication of randomisation</h5> <p>We aimed to include trials in a sensitivity analysis if they were described in some way so as to imply randomisation. For the primary outcomes, we included these studies and if there was no substantive difference when the implied randomised studies were added to those with better description of randomisation, then we entered all data from these studies. </p> </section> <section id="CD004716-sec-0115"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD004716-sec-0094">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumption/s and when we used data only from people who completed the study to that point. If there was a substantial difference, we reported results and discussed them, but continued to employ our assumption. </p> <p>Where assumptions had to be made regarding missing SDs data (see <a href="#CD004716-sec-0094">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumption/s and when we used data only from people who completed the study to that point. A sensitivity analysis was undertaken to test how prone results were to change when completer‐only data only were compared to the imputed data using the above assumption. If there was a substantial difference, we reported results and discussed them, but continued to employ our assumption </p> </section> <section id="CD004716-sec-0116"> <h5 class="title">3. Risk of bias</h5> <p>We analysed the effects of excluding trials that were judged to be at high risk of bias across one or more of the domains of randomisation (implied as randomised with no further details available): allocation concealment, blinding and outcome reporting for the meta‐analysis of the primary outcome. If the exclusion of trials at high risk of bias did not substantially alter the direction of effect or the precision of the effect estimates, then we included data from these trials in the analysis. </p> </section> <section id="CD004716-sec-0117"> <h5 class="title">4. Imputed values</h5> <p>We planned to undertake a sensitivity analysis to assess the effects of including data from trials if we had used imputed values for ICC in calculating the design effect in cluster‐randomised trials, however, no cluster‐randomised trials were included in this version of the review. </p> <p>If we noted substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed above, we did not pool data from the excluded trials with the other trials contributing to the outcome, but presented them separately. </p> </section> <section id="CD004716-sec-0118"> <h5 class="title">5. Fixed‐effect and random‐effects</h5> <p>We synthesised data using a fixed‐effect model, unless data were heterogenous, in which case we used a random‐effects model (see <a href="#CD004716-sec-0101">Assessment of heterogeneity</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004716-sec-0119" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004716-sec-0119"></div> <section id="CD004716-sec-0120"> <h3 class="title">Description of studies</h3> <p>Please see <a href="./references#CD004716-sec-0347" title="">Characteristics of included studies</a>, <a href="./references#CD004716-sec-0348" title="">Characteristics of excluded studies</a>, <a href="./references#CD004716-sec-0349" title="">Characteristics of studies awaiting classification</a>, and<a href="./references#CD004716-sec-0350" title="">Characteristics of ongoing studies</a>. </p> <section id="CD004716-sec-0121"> <h4 class="title">Results of the search</h4> <p>In total, we identified 1396 references from the searches, many of which could be excluded on the basis of their abstracts. We selected 227 references in the previous search and 51 from the update search and obtained full‐text papers for assessment. We included an additional four studies (<a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>; <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>); the review now includes 24 studies with 56 references (see <a href="#CD004716-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD004716-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD004716-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD004716-sec-0122"> <h4 class="title">Included studies</h4> <section id="CD004716-sec-0123"> <h5 class="title">1. Method</h5> <p>Due to the nature of the interventions, none of the 24 included studies were able to use a double‐blind technique. Some (11/24), however, endeavoured to reduce bias by having some or all outcomes rated by people blind to allocation (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>). Two studies attempted to keep therapists blind to the specific study hypothesis (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>). Some studies reported outcomes immediately after therapy, whilst others reported outcomes after a follow‐up period without therapy.  </p> </section> <section id="CD004716-sec-0124"> <h5 class="title">2. Duration</h5> <p>The overall duration of the trials varied between 10 weeks and three years.  Three studies (<a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>) were short term (up to 12 weeks). Five studies (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>) were medium term (13 to 26 weeks), and the remaining 16 studies were long term (more than 26 weeks). </p> </section> <section id="CD004716-sec-0125"> <h5 class="title">3. Participants</h5> <p>Nineteen included studies had less than 100 participants; the range of the number of participants was 12 to 315. A total of 2126 people participated in the 24 trials, most of whom had a diagnosis of schizophrenia. Ten studies included only people with schizophrenia, however two of these (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>) did not describe criteria clearly. Sixteen trials included people with other psychotic illnesses (schizoaffective disorder, delusional disorder and other psychoses). Of these, one study also included people with bipolar disorder (<a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>) and one included severely disturbed psychiatric patients (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>). Twenty‐three studies employed operational criteria for diagnoses (DSM‐II, DSM‐III, DSM‐III‐R, DSM‐IV, ICD‐10, RDC, WHO Discrimination Criteria), however, one of these trials <a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a> did not report how the diagnoses were reached. <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a> described the diagnostic criteria used, but these were not recognised operational criteria. Twenty trials included male and female participants, two studies (<a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>) included men only, and the remaining two studies (<a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>) did not report the sex of participants. Ages of participants ranged from 16 to 72 years. </p> </section> <section id="CD004716-sec-0126"> <h5 class="title">4. Setting</h5> <p>Eleven trials took place in outpatient settings. Three trials were conducted in inpatient settings (<a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>), seven were in a mixture of inpatient and outpatient settings (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>; <a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>), and the rest did not report on setting. </p> <p>Thirteen studies were carried out in the USA (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>; <a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>); seven in the UK (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>, <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>); one in Australia (<a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>); one in Israel (<a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>); one in Italy (<a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>); and one in Sweden (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>).  </p> </section> <section id="CD004716-sec-0127"> <h5 class="title">5. Interventions</h5> <section id="CD004716-sec-0128"> <h6 class="title">5.1 Experimental intervention</h6> <p>All studies used supportive therapy in addition to standard care (including antipsychotic medication). There were variations between studies with regard to frequency and duration of therapy sessions. Most studies used twice‐weekly, weekly and fortnightly sessions, although some studies did not report on the frequency or duration of intervention (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>). The duration of therapy varied between five weeks and three years. Fifteen studies investigated individual treatment, and six studies delivered supportive therapy in a group format (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>). Seven studies reported the use of therapy manuals or protocols (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>). Eight studies reported that therapists were supervised (<a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>), and six that audiotapes of sessions were monitored for quality (<a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>). Six of the studies reported that the same therapists delivered experimental and control interventions, and three studies reported using different therapists for different therapeutic interventions (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>). Therapists delivering the supportive intervention were trained in a different therapeutic modality, such as cognitive behavioural therapy (CBT) or family therapy, in four studies (<a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>). </p> </section> <section id="CD004716-sec-0129"> <h6 class="title">5.2 Control intervention</h6> <p>Five studies compared supportive therapy with standard treatment alone (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>; <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>), the remaining trials used various other psychosocial interventions for comparison. Twelve studies compared supportive therapy with CBT (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>). Two studies used family therapy as a comparison (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>). Skills training was investigated in three studies (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>); other comparisons were personal therapy plus family therapy (<a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>), psychoeducation (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>), milieu rehabilitation programme (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>) and insight‐oriented psychotherapy (<a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>). One study investigated supportive therapy combined with client‐focused case management in comparison with client‐focused case management (<a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>). One trial compared supportive therapy with intensive case management in comparison with intensive case management (<a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a>). Finally, one trial investigated the effect of adding supportive therapy to a combination of social skills training and medication (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>). Fourteen of the studies attempted to match experimental and control psychosocial interventions for the amount of therapist contact (<a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999;</a><a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>). In contrast, four studies took the approach that different interventions by their nature involve different amounts of therapist contact (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>). The other studies did not report on this matter. <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> gave all participants a $28 stipend whether they received supportive care or not to control for possible effects of receiving funds to take part in social activities. </p> </section> </section> <section id="CD004716-sec-0130"> <h5 class="title">6.Outcomes</h5> <p>Listed below are the outcomes for which we could obtain usable data, followed by a summary of data that could not be used in the meta‐analysis. </p> <section id="CD004716-sec-0131"> <h6 class="title">6.2 Outcome scales</h6> <section id="CD004716-sec-0132"> <p><b>6.2.1 Mental state</b></p> <p>i. Positive and Negative Syndrome Scale (PANSS) (<a href="./references#CD004716-bbs2-0282" title="KayS , FitzbeinA , OplerL . The Positive and Negative Syndrome Scale (PANSS). Schizophrenia Bulletin1987;13:261‐73. ">Kay 1987</a>)<br/> This scale assesses the severity of psychotic symptomatology in general. It consists of three subscales, positive symptoms, negative symptoms and general psychopathology, and a total score. This scale was used by <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> and <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>. </p> <p>ii. Brief Psychiatric Rating Scale (BPRS) (<a href="./references#CD004716-bbs2-0287" title="LukoffD , NuechterleinKH , VenturaJ . Manual for the expanded BPRS. Schizophrenia Bulletin1996;12:594‐602. ">Lukoff 1996</a>)<br/> This is a semi‐structured interview, which assesses the major psychiatric symptoms. It is a 16‐item scale, and each item is scored on a seven‐point scale, ranging from ’not present’ to ’extremely severe’. The range of possible scores is 24 to 168, and high scores indicate more severe symptoms. Data from the BPRS is reported by <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; and <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>. <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a> reported data for the full version of the BPRS immediately after treatment. They also used an abridged version of the scale, which contained seven of the 16 items, including psychotic symptoms, negative symptoms and depression. Results for the abridged version were reported immediately after treatment and at six‐month, 12‐month and 18‐month follow‐up. </p> <p>iii. Schedule for Assessment of Negative Symptoms (SANS) (<a href="./references#CD004716-bbs2-0244" title="AndreasenNC . The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa, 1983. ">Andreasen 1983</a>)<br/> This scale assesses the negative symptoms of schizophrenia. A six‐point scale is used to rate alogia, affective blunting, avolition‐apathy, anhedonia‐apathy, anhedonia‐asociality and attention impairment. Higher scores indicate more severe symptoms. This scale was used by <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a> and <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>. </p> <p>iv. Schedule for Assessment of Positive Symptoms (SAPS) (<a href="./references#CD004716-bbs2-0245" title="AndreasenNC . The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa, 1984. ">Andreasen 1984</a>)<br/> This scale selectively assesses the positive symptoms of psychosis and the higher the score, the more severe the symptoms. <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a> used this scale. </p> <p>v. Psychotic Symptoms Rating Scales (PSYRATS) (<a href="./references#CD004716-bbs2-0269" title="HaddockG , McCarronJ , TarrierN , FaragherEB . Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine1999;29(4):879‐89. ">Haddock 1999b</a>)<br/> This consists of two scales, which assess delusional beliefs and auditory hallucinations. There are 11 items in the auditory hallucinations scale, including frequency, duration, level of distress, controllability, loudness, location and beliefs about origin of voices. The delusional beliefs scale has six items, including preoccupation, intensity of distress, conviction and disruption. Each item is rated on a ﬁve‐point scale. The PSYRATS were used by <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a> and <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>. </p> <p>vi. Belief about Voices Questionnaire‐Revised (BAVQ‐R) (<a href="./references#CD004716-bbs2-0254" title="ChadwickP , LeeS , BirchwoodM . The revised Beliefs About Voices Questionnaire (BAVQ‐R). British Journal of Psychiatry2000;177:229‐32. ">Chadwick 2000</a>)<br/> This scale is a 35‐item measure of beliefs about auditory hallucinations and the emotional and behavioural reactions to them. There are five BAVQ‐R subscales: malevolence, benevolence, resistance, engagement, and omnipotence.  Each item is rated on a four‐point scale; a higher score indicates more belief in their voices. This scale was used by <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>. </p> <p>vii. Comprehensive Psychiatric Rating Scale (CPRS) (<a href="./references#CD004716-bbs2-0294" title="MontgomerySA , TaylorP , MontgomeryD . Development of a schizophrenia scale sensitive to change. Neuropharmacology1978;17:1053‐71. ">Montgomery 1978</a>) </p> <p>This is a general psychiatric rating scale, which was used by <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a> and <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>. A high score indicates severe symptoms. <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a> used the schizophrenia subscale, which consists of 45 items and a global rating of degree of illness. The paper reported useable data for only two of the 45 items on this scale. </p> <p>viii. Beck Depression Inventory II (BDI‐II) (<a href="./references#CD004716-bbs2-0248" title="BeckAT , SteerRA , BallR , RanieriW . Comparison of Beck Depression Inventories ‐IA and ‐II in psychiatric outpatients. Journal of Personality Assessment1996;67(3):588‐97. ">Beck 1996</a>)<br/> This scales measures the severity of depression. It has 21 self‐reported items measured on a four point scale. A higher score indicates more severe depression. This scale was used by <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>. </p> <p>ix. Calgary Depression Rating Scale (CDRS) (<a href="./references#CD004716-bbs2-0242" title="AddingtonD , AddingtonJ , Maticka‐TyndaleE . Assessing depression in schizophrenia: the Calgary Depression Scale. British Journal of Psychiatry1993;163(Suppl 22):39‐44. ">Addington 1993</a>)<br/> This is a nine‐item structured interview scale developed specifically for assessing depression in individuals with schizophrenia. The CDRS assesses depression as separate from overlapping negative or extrapyramidal symptoms. Higher scores indicate greater depression. This scale was used by <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>. </p> <p>x. Center for Epidemiological Studies—Depression Scale (CES‐D) (<a href="./references#CD004716-bbs2-0302" title="RadloffLS . The CES‐D Scale: a self‐report depression scale for research in the general population. Applied Psychological Measurement1977;1(3):385‐401. ">Radloff 1977</a>)<br/> This is a 20‐item scale to measure depressive symptomology. The possible range of scores is zero to 60 and higher scores indicate more symptoms. This scale was used by <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>. </p> <p>xi. Montgomery‐Asberg Depression Rating Scale (MADRS) (<a href="./references#CD004716-bbs2-0295" title="MontgomerySA , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134:382‐9. ">Montgomery 1979</a>)<br/> This scale was developed using a 65‐item psychopathology scale to identify the 17 most commonly occurring symptoms in primary depressive illness. The maximum score is 30, and a higher score indicates more severe psychopathology. The scale was used by <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>. </p> </section> <section id="CD004716-sec-0133"> <p><b>6.1.2 General functioning</b></p> <p>i. Global Assessment of Functioning Scale (GAF) (<a href="./references#CD004716-bbs2-0246" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington, DC: APA, 1987. ">APA 1987</a>)<br/> The GAF disability scale is taken from the DSM‐III‐R (<a href="./references#CD004716-bbs2-0246" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington, DC: APA, 1987. ">APA 1987</a>). The scale has 10 deﬁned anchor points relating to social competence, and scores range from zero to 100. A higher score indicates better functioning. <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; and <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a> report data from this scale. <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> uses the GAF‐M, which is a modified version. </p> <p>ii. Global Assessment Scale (GAS) (<a href="./references#CD004716-bbs2-0265" title="EndicottJ , SpitzerRL , FleissJL , CohenJ . Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry1976;33(6):766‐71. ">Endicott 1976</a>)<br/> This scale provides a rating between zero and 100, which reﬂects overall degree of psychological or psychiatric health. A high score indicates better health. This scale was used by <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>. </p> <p>iii. Katz Adjustment Scales (KAS) (<a href="./references#CD004716-bbs2-0280" title="KatzMM , LyerlySB . Methods for measuring adjustment and social behaviour in the community: I. Rationale, description, discriminative validity and scale development. nt. Psychological Repo1963;13:503‐35. ">Katz 1963</a>)<br/> This collection of scales measures social adjustment and behaviour. It was used by <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>. It consists of items which can be grouped into subscales including ’performance of socially expected activities’ (15 items) and ’free‐time activities’ (23 items), the two subscales chosen by <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>. In this study, the items were also grouped into syndromes, entitled ’offensive behaviour’ (two items) and ’withdrawal’ (six items). </p> <p>iv. Social Functioning Scale (SFS ) (<a href="./references#CD004716-bbs2-0250" title="BirchwoodM , SmithJ , CochraneR , WettonS , CopestakeS . The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry1990;157:853‐9. ">Birchwood 1990</a>)<br/> The SFS is a 79‐item self‐report questionnaire to both the patients and the caregiver, about performance in seven areas: Social Engagement (SE), Interpersonal Communication (IC), Recreational Activities (RA), Social Activities (SA), Independence Competence (INC), Independence Performance (IP) and Occupational Activity (OA). The purpose of the scale is to provide an evaluation of strengths and weaknesses of patient functioning, and it may reveal aims for therapeutic intervention. </p> </section> <section id="CD004716-sec-0134"> <p><b>6.1.3 Behaviour</b></p> <p>i. Social Behaviour Adjustment Scale (SBAS) (<a href="./references#CD004716-bbs2-0301" title="PlattS , WeymanA , HirschS , HewettS . The social behaviour assessment schedule (SBAS): rationale, contents, scoring and reliability of a new intervention schedule. Social Psychiatry1980;15:43‐55. ">Platt 1980</a>)<br/> <a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a> was the only study to use this scale. Scoring is based on a structured interview with a key informant from the person's family. Areas covered include household tasks, spare time/leisure activity, work/study, decision making, friendliness/affection, everyday conversation, relationships outside the family, behavioural disturbance, social and interpersonal role performance, and adverse effects on the family and other people in the community. Each item is scored on a scale from zero to two, and higher scores indicate greater impairment or dissatisfaction. </p> </section> <section id="CD004716-sec-0135"> <p><b>6.1.4 Insight</b></p> <p>i. Beck Cognitive Insight Scale ‐ (BCIS) composite (<a href="./references#CD004716-bbs2-0249" title="BeckAT , BaruchE , BalterJM , SteerRA , WarmanDM . A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophrenia research2004;68:319‐30. ">Beck 2004</a>)<br/> The BCIS is a 15‐item self‐report measure composed of two subscales: self‐reflectiveness and self‐certainty.  <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> used a composite index of insight, computed from the BCIS. Higher scores reflect greater cognitive insight. </p> <p>ii. Insight and Treatment Attitudes Questionnaire (ITAQ) (<a href="./references#CD004716-bbs2-0290" title="McEvoyJP , AppersonLJ , AppelbaumPS , OrtlipP , BrecoskyJ , HammillK , et al. Insight in schizophrenia. Its relationship to acute psychopathology. Journal of Nervous and Mental Disease1989;177(1):43‐7. ">McEvoy 1989</a>)<br/> This scale assesses an individual’s recognition of illness and need for treatment and includes 11 questions. Reponses are rated as follows: 2 = good insight, 1 = partial insight, and 0 = no insight, which are summed to provide a total insight score. Higher scores correspond to better insight. <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> reported data on this scale. </p> <p>iii. Schedule for Assessment of Insight (SAI) (<a href="./references#CD004716-bbs2-0258" title="DavidAS . Insight and psychosis. British Journal of Psychiatry1990;156:798‐808. ">David 1990</a>)<br/> The schedule is a semi‐structured interview with three components; treatment compliance, awareness of illness and ability to relabel psychotic symptoms correctly. The range of possible scores is zero to 14, but scores are expressed as a percentage of maximum insight. Low scores therefore indicate poor insight. The expanded version of the SAI was used by <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>. </p> </section> <section id="CD004716-sec-0136"> <p><b>6.1.5 Compliance</b></p> <p>i. Rating of Medication Influences (ROMI) scale (<a href="./references#CD004716-bbs2-0309" title="WeidenP , RapkinB , MottT , ZygmuntA , GoldmanD , Horvitz‐LennonM , et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin1994;20:297‐310. ">Weiden 1994</a>)<br/> The ROMI is a comprehensive measure of attitudes regarding adherence to antipsychotic medications used by <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>. The measure is divided into two subscales, ‘Reasons for Adherence’ (nine items) and ‘Reasons for Nonadherence’ (10 items), each containing attitudinal and behavioural factors thought to influence adherence behaviour. Items are rated on a one through three scale, where 1 = no influence, 2 = mild influence, 3 = strong influence, and 96 = not applicable. Higher scores on the ‘Reasons for Adherence’ subscale correspond to an endorsement of factors influencing the individual to take his/her medication, whereas higher scores on the ‘Reasons for Nonadherence’ subscale correspond to an endorsement of factors influencing the individual to stop taking his/her medication. </p> </section> <section id="CD004716-sec-0137"> <p><b>6.1.6 Attitude to medication</b></p> <p>i. Attitudes to Medication Questionnaire (AMQ) (<a href="./references#CD004716-bbs2-0270" title="HaywardP . Medication self‐management: A preliminary report on an intervention to improve medication compliance. Journal of Mental Health1995;4:511‐8. ">Hayward 1995</a>)<br/> The AMQ is a semi‐structured interview designed to assess attitudes to drug treatment. It was used by <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>. A high score indicates a helpful attitude to treatment. </p> <p>ii. Drug Attitudes Inventory (DAI) (<a href="./references#CD004716-bbs2-0276" title="HoganTP , AwadAG , EastwoodR . A self report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine1983;13:177‐83. ">Hogan 1983</a>)<br/> The DAI is a self‐report scale used to assess attitude to medication. It has been shown to be highly predictive of compliance. A higher score indicates a better attitude to treatment. This scale was used by <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>. </p> </section> <section id="CD004716-sec-0138"> <p><b>6.1.7 Quality of life</b></p> <p>i. Global Health Questionnaire – GHQ (<a href="./references#CD004716-bbs2-0267" title="GoldbergD , McDowellI , NewellC . General Health Questionnaire (GHQ), 12 item version, 20 item version, 30 item version, 60 item version [GHQ12, GHQ20, GHQ30, GHQ60]. Measuring health: A guide to rating scales and questionnaire1972:225‐36. ">Goldberg 1972</a>)<br/> This 60‐item scale measures the severity of nonpsychotic psychiatric symptomatology. It was used by <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>. It assesses the respondent’s current state and asks if that differs from his or her usual state and produces an overall score that can be compared with a prescribed cut‐off score. All items have a four‐point Likert scoring (0‐1‐2‐3) system that ranges from a 'better/healthier than normal' option, through a 'same as usual' and a 'worse/more than usual' to a 'much worse/more than usual' option. The higher the score, the more severe the condition.  </p> <p>ii. Quality of Life Scale ‐ QLS (<a href="./references#CD004716-bbs2-0271" title="HeinrichsDW , HanlonTE , CarpenterWTJr . The quality of life scale. Schizophrenia Bulletin1984;10:388‐98. ">Heinrichs 1984</a>)<br/> This 21‐item scale is based on a semi‐structured interview providing information on symptoms and functioning during the preceding four weeks. There are seven severity steps (zero to six; six being adequately functioning and zero being deficient). Four item categories have been identified by factor analysis i) interpersonal relationships (seven items), ii) instrumental role (four items), iii) intrapsychic function (seven items) and iv) common place objects and activities. Higher scores indicate better quality of life. This scale was used by <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>. </p> <p>iii. Rosenberg Self‐Esteem Scale (RSES) (<a href="./references#CD004716-bbs2-0303" title="RosenbergM . Rosenberg self‐esteem scale (RSE). Acceptance and Commitment Therapy. Measures Package1965:61. ">Rosenberg 1965</a>)<br/> The scale measures state self‐esteem by asking the respondents to reflect on their current feelings, with a 10‐item Likert‐type scale with items answered on a four‐point scale — from strongly agree to strongly disagree. Five of the items have positively worded statements and five have negatively worded ones. The scale ranges from zero to 30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self‐esteem.  This scale was used by <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> and <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>. </p> <p>iv. Well‐Being scale‐ WBS (<a href="./references#CD004716-bbs2-0305" title="Ryff CarolD . Happiness is everything, or is it? Explorations on the meaning of psychological well‐being. Journal of Personality and Social Psychology1989;57:1069‐81. ">Ryff 1989</a>)<br/> This is a scale to measure positive aspects of psychological functioning along six dimensions in which respondents rate statements on a scale of one to six, with one indicating strong disagreement and six indicating strong agreement: independence and self‐determination (autonomy); having satisfying, high quality relationships (positive relations with others); the ability to manage one’s life (environmental mastery); being open to new experiences (personal growth); believing that one’s life is meaningful (purpose in life); and a positive attitude towards oneself and one’s past life (self‐acceptance). A high score indicates that the respondent has a mastery of that area in his or her life. Conversely, a low score shows that the respondent struggles to feel comfortable with that particular concept. <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> reported data for this scale. </p> <p>v. Lehman's Quality‐of‐Life (QOL) Questionnaire (<a href="./references#CD004716-bbs2-0283" title="LehmanAF . A quality of life interview for the chronically mentally ill. Evaluation and Program Planning1988;11:51‐62. ">Lehman 1988</a>)<br/> Lehman's QOL scale uses a response range of one (terrible) to seven (delighted). <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a> used only those domains that had direct applicability ‐ namely, living situation, income, family, friends, social interaction, activities of daily living, and health. They also added a section on drug use, as well as a general list of activities, the response scale was one (daily) to five (never). </p> </section> </section> <section id="CD004716-sec-0139"> <h6 class="title">6.2 Missing outcomes</h6> <p>No studies provided data regarding clinically important change in general functioning, one of our primary outcomes of interest. No studies reported data on time to relapse or hospitalisation, clinically important or any changes in general behaviour scores, adverse events, or in any engagement in structured activities. Economic data, as well as satisfaction with treatment were seldom reported. </p> </section> </section> </section> <section id="CD004716-sec-0140"> <h4 class="title">Excluded studies</h4> <p>We excluded 198 reports ‐ most because the reported interventions did not meet our criteria for supportive therapy. In several studies, all participants received supportive therapy, without a comparison group relevant to this review. We excluded some studies because the participants did not have schizophrenia or schizophrenia‐like illnesses. Some studies were not randomised controlled trials, and we therefore excluded these. We excluded one study due to inadequate allocation concealment (<a href="./references#CD004716-bbs2-0191" title="SlavinskyAT , KraussJB . Two approaches to the management of long‐term psychiatric outpatients in the community. Nursing Research1982;31:284‐9. ">Slavinsky 1982</a>). Eight studies were excluded as they did not report usable data (<a href="./references#CD004716-bbs2-0050" title="CasteleinS , BruggemanR , VanBusschbachJT , Van DerGaagM , StantAD , KnegteringH , et al. The effectiveness of minimally guided peer support groups for people suffering from psychosis: a randomized controlled trial. Schizophrenia Research2008;98:52‐3. ">Castelein 2008</a>; <a href="./references#CD004716-bbs2-0052" title="Castilla‐PuentesRC , ValeroJ , VargasJ , GongoraO , PavaC , PerelJ . Music therapy and medication compliance in psychotic patients. 155th Annual Meeting of the American Psychiatric Association. Philadelphia, PA, USA, 2002. ">Castilla‐Puentes 2002</a>; <a href="./references#CD004716-bbs2-0124" title="KeshavanM , EackSM . Brain structure and cognition in schizophrenia and the effects of treatment. Schizophrenia Bulletin2011;37(Suppl. 1):310. ">Keshavan 2011</a>; <a href="./references#CD004716-bbs2-0127" title="KlingbergS , WittorfA , MeisnerC , WolwerW , WiedemannG , HerrlichJ , et al. Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: The positive study, a multicenter, prospective, single‐blind, randomised controlled clinical trial. Trials2010;11:123. WagnerM . Cognitive biases and cognitive deficits in patients with positive symptoms: Relationship with symptoms and with symptom change during psychotherapy. European Archives of Psychiatry and Clinical Neuroscience2011;261:S14. WittorfA , KlingbergS . The therapeutic alliance in cbt for pychoses: Course and predictive value for outcome. European Archives of Psychiatry and Clinical Neuroscience2011;261:S13‐S4. ">Klingberg 2010</a>; <a href="./references#CD004716-bbs2-0158" title="MeisterK , RietschelL , BurlonM , JannsenH , BockT , WegscheiderK , et al. A cluster‐randomized, parallel group, observer blind trial of a group based motivational‐behavioural therapy for young people with psychosis and substance use disorder. Early Intervention in Psychiatry2010;4:163. ">Meister 2010</a>; <a href="./references#CD004716-bbs2-0169" title="NelsonB , PhillipsLJ , YungAR , FranceySM , LeicesterS , BakerK , et al. A double blind, placebo‐controlled randomized trial of low‐dose risperidone, intensive psychological treatment and supportive therapy in young people with subthreshold symptoms at incipient risk of psychotic disorder: baseline characteristics of the sample. Schizophrenia Bulletin2007;33:450. ">Nelson 2007</a>; <a href="./references#CD004716-bbs2-0192" title="SmithTE , HullJW , RomanelliS , FertuckE , WeissKA . Symptoms and neurocognition as rate limiters in skills training for psychotic patients. American Journal of Psychiatry1999;156(11):1817‐8. ">Smith 1999</a>; <a href="./references#CD004716-bbs2-0203" title="TellesC , KarnoM , MintzJ , PazG , AriasM , TuckerD , et al. Immigrant families coping with schizophrenia. Behavioral family intervention v. case management with a low‐income Spanish‐speaking population. British Journal of Psychiatry1995;167(4):473‐9. [MEDLINE: 96113861; PMID 8829715] ">Telles 1995</a>). Details of excluded studies are detailed in the <a href="./references#CD004716-sec-0348" title="">Characteristics of excluded studies</a>. </p> <section id="CD004716-sec-0141"> <h5 class="title">Awaiting assessment studies</h5> <p>Three studies are awaiting assessment. <a href="./references#CD004716-bbs2-0223" title="BechdolfA , PohlmannB , GuettgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use. Results of a randomised controlled trial. Nervenarzt2012;83:888‐96. ">Bechdolf 2012</a>, and <a href="./references#CD004716-bbs2-0224" title="BlankertzLE , KellerC . The provision of long‐term vocational supports for individuals with severe mental illness. American Sociological Association1997. ">Blankertz 1997</a> are awaiting translation from German and <a href="./references#CD004716-bbs2-0225" title="FalloonIRH , RazaniJ , MossHB , BoydJL , McGillCW , PedersonJ . Community management of schizophrenia. Partnerberatung1983;20(2/3):73‐9. ">Falloon 1983</a> is awaiting assessment until we obtain a full‐text paper. </p> </section> <section id="CD004716-sec-0142"> <h5 class="title">Ongoing studies</h5> <p>Sixteen studies seem to be ongoing. We are obtaining more details to ensure that this is indeed the case. These studies are using a variety of interventions, including behavioural treatment, CBT, cognitive enhancement therapy, body orientated therapy, with supportive therapies and counselling as controls. </p> </section> </section> </section> <section id="CD004716-sec-0143"> <h3 class="title">Risk of bias in included studies</h3> <p>See also 'Risk of bias' tables in <a href="./references#CD004716-sec-0347" title="">Characteristics of included studies</a> and <a href="#CD004716-fig-0002">Figure 2</a> and <a href="#CD004716-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD004716-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="original image" data-id="CD004716-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <div class="figure" id="CD004716-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="original image" data-id="CD004716-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <section id="CD004716-sec-0144"> <h4 class="title">Allocation</h4> <p>All studies were randomised trials. However, most studies did not provide explicit details of the method of randomisation, and were rated as unclear risk of bias. Six studies were rated low risk of bias. <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a> reports the use of a table of random numbers. <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> stratified according to gender, and stratification was also undertaken by <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a> with the following variables: first or second admission; inpatient or day patient admission; male or female; with the first‐episode cases further stratified for duration of symptoms of more or less than six months. <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a> used block randomisation, with a block size of nine, stratified by severity of symptoms and sex. <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a> used permuted blocking.  <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a> matched pairs and assigned each paired participant to one of two groups. The groups were then were randomly assigned to either the treatment or the control intervention. <a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a> describes stratifying participants according to age, sex and race prior to randomisation, but no further details were reported and was rated as unclear. </p> <p>With regard to allocation concealment, most studies did not report any concealment approach, and were rated as unclear risk of bias. Five studies described the method of allocation concealment, four of which we rated as low risk. <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a> provided a clear description of the randomisation procedure, which was administered centrally by a non‐clinical project co‐ordinator, and a sealed envelope technique was used. <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a> reported that randomisation was done by members of the research team not involved with assessment or treatment. <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a> reported that independent, concealed randomisation with minimisation was performed by trial administrators. <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> reported randomisation by a blinded researcher, using random numbers generated by computer. <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a> reported that randomisation was carried out independently by a third party, using sealed envelopes, but not whether the envelopes were opaque and so we rated it as having an unclear risk of bias. </p> </section> <section id="CD004716-sec-0145"> <h4 class="title">Blinding</h4> <p>None of the studies were able to use a double‐blind technique due to the nature of the interventions, since it would not be possible to have therapists and participants blind to treatment allocation. <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>, <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>, and <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a> were the only studies to report appropriate personnel blinding and were rated as low risk of bias. In <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>, ward and project staff were not blinded, and so was rated as high risk of bias. Blinding of personnel for the remaining trials was not adequately reported and these were rated as unclear risk of bias. </p> <p>Nine studies stated that outcome raters were blinded to the treatment group (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>) and were rated as low risk of bias for outcome assessment.  Two studies (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>) attempted to keep patients from reporting their treatment groups to raters, however both reported that some patients disclosed allocation, and these were rated as unclear risk of bias. <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a> reported that some outcomes were assessed blindly and others were not. <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>, <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>, and <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a> reported raters who were not blinded and were rated as high risk of bias. </p> <p>Only <a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a> and <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a> reported that they attempted to keep therapists blinded to the specific study hypothesis. </p> </section> <section id="CD004716-sec-0146"> <h4 class="title">Incomplete outcome data</h4> <p>Overall, eighteen studies were rated as low risk of bias for incomplete outcome data.  <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>, <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>, <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>, and <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> reported outcomes with an intention‐to‐treat method, although <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a> carried out an intention‐to‐treat analysis post‐treatment only, and not at the one‐ or two‐year follow‐ups. <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> reported no participants leaving early. Sixteen studies reported reasons for losses to follow‐up (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>; <a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>). </p> <p>Of the five studies with unclear risk of bias for incomplete outcome data, <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>, <a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>, <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>, <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>, and <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a> did not report on attrition. Only <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a> had a high risk of bias due to high rates of attrition reported without reasons. </p> </section> <section id="CD004716-sec-0147"> <h4 class="title">Selective reporting</h4> <p>Five studies were of low risk of bias with regard to selective reporting (<a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>, <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>, <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>, <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, and  <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>). The remaining 19 studies were of high risk of bias, mainly due to poor data reporting ‐ either they did not report data for outcomes or SDs were missing. </p> </section> <section id="CD004716-sec-0148"> <h4 class="title">Other potential sources of bias</h4> <p>Four trials were unclear if they were subject to other biases (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>).  All other trials appeared free from other sources of bias. </p> </section> </section> <section id="CD004716-sec-0149"> <h3 class="title" id="CD004716-sec-0149">Effects of interventions</h3> <p>See: <a href="./full#CD004716-tbl-0001"><b>Summary of findings for the main comparison</b> SUPPORTIVE THERAPY versus STANDARD CARE for schizophrenia</a>; <a href="./full#CD004716-tbl-0002"><b>Summary of findings 2</b> SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT for schizophrenia</a>; <a href="./full#CD004716-tbl-0003"><b>Summary of findings 3</b> SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY for schizophrenia</a>; <a href="./full#CD004716-tbl-0004"><b>Summary of findings 4</b> SUPPORTIVE THERAPY versus FAMILY THERAPY for schizophrenia</a>; <a href="./full#CD004716-tbl-0005"><b>Summary of findings 5</b> SUPPORTIVE THERAPY versus PSYCHOEDUCATION for schizophrenia</a> </p> <p>For dichotomous outcomes, we calulated risk ratios (RR) and for continuous outcomes, we calculated mean differences (MD), both with 95% confidence intervals (CI). </p> <section id="CD004716-sec-0150"> <h4 class="title">Comparison 1: SUPPORTIVE THERAPY versus STANDARD CARE</h4> <p>Five included studies compared supportive therapy with standard care (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a>; <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>). </p> <section id="CD004716-sec-0151"> <h5 class="title">1.1 Global state: relapse</h5> <p>We found no significant difference in relapse rates between supportive therapy and standard care (<a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>, medium term, n = 54, RR 0.12 CI 0.01 to 2.11; long term, n = 54, RR 0.96 CI 0.44 to 2.11, <a href="./references#CD004716-fig-0004" title="">Analysis 1.1</a>). In this trial, relapses were defined as readmission to hospital for clinical deterioration that lased at least five days and resulted in functional impairment. </p> </section> <section id="CD004716-sec-0152"> <h5 class="title">1.2 Service outcomes: hospitalisation</h5> <p>Hospitalisation rates did not differ significantly between people treated with supportive therapy and standard care (1 RCT, n = 48, RR 1.00 CI 0.07 to 15.08, <a href="./references#CD004716-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD004716-sec-0153"> <h5 class="title">1.3 Mental state: general</h5> <section id="CD004716-sec-0154"> <h6 class="title">1.3.1 No clinically important improvement in general mental state</h6> <p>Medium‐term data for 'no clinically important improvement in general mental state' were not statistically significant (<a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>, n = 54, RR 0.95 CI 0.77 to 1.17), and longer‐term data (2 RCTs, n = 98, RR 0.95 CI 0.82 to 1.11) were also equivocal (<a href="./references#CD004716-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD004716-sec-0155"> <h6 class="title">1.3.2 Average endpoint general mental state score</h6> <p>Total scores on the PANSS were not significantly different at both short‐ (<a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>, n = 131, MD ‐4.42 CI ‐10.1 to 1.29) and long‐term time points (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>, n = 36 MD 4.70 CI ‐6.71 to 16.11, <a href="./references#CD004716-fig-0007" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD004716-sec-0156"> <h5 class="title">1.4 Mental state: specific symptoms</h5> <section id="CD004716-sec-0157"> <h6 class="title">1.4.1 Average endpoint negative symptoms score</h6> <p>Skewed data from the SANS scale are presented in tabular form (<a href="./references#CD004716-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD004716-sec-0158"> <h6 class="title">1.4.2 Average endpoint positive symptoms score</h6> <p>We found that the PANSS positive subscale data from the <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a> study showed no significant difference between supportive therapy and standard care (n = 131, MD ‐1.09 CI ‐2.84 to 0.66, <a href="./references#CD004716-fig-0009" title="">Analysis 1.6</a>). One study measured severity of positive symptoms using selected items from the BPRS, but data are skewed and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD004716-sec-0159"> <h6 class="title">1.4.3 Average endpoint delusions score and hallucinations score</h6> <p>Skewed data from the PSYRATS scale 'delusions score' and 'hallucinations score' were obtained from one trial and are presented in a tabular form (<a href="./references#CD004716-fig-0011" title="">Analysis 1.8</a>; <a href="./references#CD004716-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD004716-sec-0160"> <h6 class="title">1.4.4 Average endpoint depressive symptoms score</h6> <p><a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> found no statistical significance between the treatment groups for Center for Epidemiological Studies‐Depression Scale (CESD) (n = 260, MD 1.61 CI ‐1.61 to 4.83, <a href="./references#CD004716-fig-0013" title="">Analysis 1.10</a>). </p> </section> </section> <section id="CD004716-sec-0161"> <h5 class="title">1.5 Leaving the study early</h5> <p>We found no significant difference in rates of attrition between supportive therapy and standard care (4 RCTs, n = 354, RR 0.86 CI 0.53 to 1.40, <a href="./references#CD004716-fig-0014" title="">Analysis 1.11</a>). </p> </section> <section id="CD004716-sec-0162"> <h5 class="title">1.6 General functioning</h5> <section id="CD004716-sec-0163"> <h6 class="title">1.6.1 Average endpoint in general functioning score</h6> <p>This was assessed by <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a> using the GAS. This study found no significant difference between supportive therapy and standard care (n = 29, MD 1.40 CI ‐5.09 to 7.89, <a href="./references#CD004716-fig-0016" title="">Analysis 1.13</a>). <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> used the GAF‐M and also found no significant results (n = 260, MD ‐2.66 CI ‐6.20 to 0.88 <a href="./references#CD004716-fig-0015" title="">Analysis 1.12</a>). </p> </section> <section id="CD004716-sec-0164"> <h6 class="title">1.6.2 Average endpoint in social functioning score</h6> <p><a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> found no statistical significance between the treatment groups for social functioning measured on the SFS (n = 260, MD ‐0.67 CI ‐7.05 to 5.71, <a href="./references#CD004716-fig-0017" title="">Analysis 1.14</a>). </p> </section> </section> <section id="CD004716-sec-0165"> <h5 class="title">1.7 Satisfaction with treatment: recipient of care not satisfied with treatment</h5> <p>We found no significant difference in the numbers of recipients of care who were not satisfied with their treatment (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>, n = 44, RR 1.83 CI 0.75 to 4.47, <a href="./references#CD004716-fig-0018" title="">Analysis 1.15</a>). </p> </section> <section id="CD004716-sec-0166"> <h5 class="title">1.8 Quality of life</h5> <section id="CD004716-sec-0167"> <h6 class="title">1.8.1 Average endpoint self‐esteem score</h6> <p><a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> found no significant results between standard care and supportive therapy for self‐esteem on the Rosenberg Self‐Esteem Scale (RSES) (n = 260, MD ‐1.21 CI ‐2.85 to 0.43, <a href="./references#CD004716-fig-0019" title="">Analysis 1.16</a><i>),</i> </p> </section> <section id="CD004716-sec-0168"> <h6 class="title">1.8.2 Average endpoint well‐being score</h6> <p><a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> also assessed well‐being on the WBS and found no significant difference in psychological functioning between treatment groups (n = 260, MD ‐2.73 CI ‐6.04 to 0.58, <a href="./references#CD004716-fig-0020" title="">Analysis 1.17</a>)<i>.</i> </p> </section> <section id="CD004716-sec-0169"> <h6 class="title">1.8.3 Average endpoint global health score</h6> <p>Global health was measured by <a href="./references#CD004716-bbs2-0002" title="DavidsonL , ShaharG , StaynerDA , ChinmanMJ , RakfeldtJ , TebesJK . Supported socialization for people with psychiatric disabilities: Lessons from a randomized controlled trial. Journal of Community Psychology2004;32:453‐77. ShaharG , KiddS , StyronTH , DavidsonL . Consumer support and satisfaction with mental health services in severe mental illness: the moderating role of morale. Journal of Social and Clinical Psychology2006;25:945‐62. ">Davidson 2004</a> on the GHQ and found no difference in nonpsychotic psychiatric symptomatology (n = 260, MD ‐2.45 CI ‐2.41 to 7.31, <a href="./references#CD004716-fig-0021" title="">Analysis 1.18</a><i>)</i> </p> </section> </section> <section id="CD004716-sec-0170"> <h5 class="title">1.9 Death</h5> <p>The number of deaths occurring in the <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a> study at medium term, were not significantly different (supportive therapy 1/26, standard care 0/28, n = 54, RR 3.22 CI 0.14 to 75.75). Two trials reporting long‐term data were also non‐significant (n = 92, RR 2.87 CI 0.31 to 26.63, <a href="./references#CD004716-fig-0022" title="">Analysis 1.19</a>). </p> </section> <section id="CD004716-sec-0171"> <h5 class="title">1.10 Medication: no reduction in dose of antipsychotic</h5> <p><a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a> reported on the number of people who had no reduction in the dose of antipsychotic medication at the endpoint of the trial. We found no statistically significant difference between the groups (n = 44, RR 0.81 CI 0.59 to 1.12, <a href="./references#CD004716-fig-0023" title="">Analysis 1.20</a>). </p> </section> <section id="CD004716-sec-0172"> <h5 class="title">1.11 Costs</h5> <p>Most studies did not measure economic outcomes and no studies reported on costs in a way that could be added to the analysis. <a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a> reported that their findings suggest "that if the peer social supporter (the FC) had not been available, the study group may have needed as many inpatient days as the comparison group" and that this would have equated to "250 inpatient days (10 clients x 25 days)" that could have cost $250,000 (based on average cost of $1,000 per day, per client for inpatient psychiatric care) and compare this to "the cost of 10 FCs for 6 months, including administrative and programmatic costs, was about $30,000". </p> </section> </section> <section id="CD004716-sec-0173"> <h4 class="title">Comparison 2: SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT</h4> <p>Twenty included studies compared supportive therapy against any other psychological or psychosocial treatment (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>; <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>). </p> <section id="CD004716-sec-0174"> <h5 class="title">2.1 Global state: relapse</h5> <p>No significant difference in relapse rates were found in the supportive therapy and other therapies in the medium term (2 RCTs, n = 100, RR 2.86 CI 0.32 to 25.24, <a href="./references#CD004716-fig-0024" title="">Analysis 2.1</a>) or the long term (5 RCTs, n = 270, RR 1.19 CI 0.66 to 2.16,, <a href="./references#CD004716-fig-0024" title="">Analysis 2.1</a>). Heterogeneity was high (I<sup>2</sup> = 77%), so a random‐effects model was used. </p> </section> <section id="CD004716-sec-0175"> <h5 class="title">2.2 Global state: no remission</h5> <p><a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a> reported the number of people who did not experience remission of symptoms. We found a statistically significant advantage for other psychological therapies (in this case family therapy) over supportive therapy (n = 39, RR 1.87 CI 1.11 to 3.15, <a href="./references#CD004716-fig-0025" title="">Analysis 2.2</a>). </p> </section> <section id="CD004716-sec-0176"> <h5 class="title">2.3 Service outcomes: hospitalisation</h5> <p>We found medium‐term data for hospitalisation were equivocal (3 RCTs, n = 153, RR 1.60 CI 0.85 to 3.00), but longer‐term data were statistically significant, favouring the other psychological or psychosocial therapies over supportive therapy (4 RCTs, n = 306, RR 1.82 CI 1.11 to 2.99, <a href="./references#CD004716-fig-0026" title="">Analysis 2.3</a>). </p> </section> <section id="CD004716-sec-0177"> <h5 class="title">2.4 Mental state: general</h5> <p><b>2.4.1 No clinically important improvement</b> </p> <p>We found a significant difference favouring other therapies over supportive therapy for 'no clinically important improvement' over the long term (3 RCTs, n = 194, RR 1.27 CI 1.04 to 1.54, <a href="./references#CD004716-fig-0027" title="">Analysis 2.4</a>), but not at medium‐term follow‐up (<a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>, n = 59, RR 1.27 CI 0.95 to 1.70). </p> <p><b>2.4.2 Average endpoint score</b> </p> <section id="CD004716-sec-0178"> <h6 class="title">i) PANSS total</h6> <p>A significant difference in favour of other psychological treatment (in this case cognitive behavioural therapy (CBT)) was found for general mental state in the long term (2 RCTs, n = 105, MD 5.82 CI 1.04 to 10.60, <a href="./references#CD004716-fig-0028" title="">Analysis 2.5</a>). However, in the short term, the data were highly heterogeneous (I<sup>2</sup> = 98%). We have concerns about the data reported in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>, (see discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). We think the data in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> may have been incorrectly reported or may have been an anomaly due to the small numbers in each treatment group. Also the standard deviations were very small, and we believe the authors may have erroneously reported standard errors as standard deviations. However, when we remove <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> from the analysis, heterogeneity is not restored and remains at 83%, therefore data were not pooled for this outcome. </p> </section> <section id="CD004716-sec-0179"> <h6 class="title">ii) BPRS</h6> <p>No significant difference in mental state measured on the BPRS was found in the short term (2 RCTs, n = 92, MD ‐1.07 CI ‐5.08 to 2.94); <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a> found a significant difference in favour of the control group (in this case CBT) in the long term (n = 37, MD 7.60 CI 0.90 to 14.30, <a href="./references#CD004716-fig-0029" title="">Analysis 2.6</a>). </p> </section> <section id="CD004716-sec-0180"> <h6 class="title">iii) BPRS short form</h6> <p><a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a> also used the short form of the BPRS, and found no significant differences at short‐ (n = 74, MD ‐0.90 CI ‐3.02 to 1.22), medium‐ (n = 67, MD 2.20 CI ‐1.18 to 5.58) or long‐term follow‐up (n = 45, MD 2.30 CI ‐0.54 to 5.14, <a href="./references#CD004716-fig-0030" title="">Analysis 2.7</a>). </p> </section> <section id="CD004716-sec-0181"> <h6 class="title">iv) CPRS</h6> <p>One study presented skewed data from the CPRS (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>). We have reported these in a table (<a href="./references#CD004716-fig-0031" title="">Analysis 2.8</a>). </p> </section> <section id="CD004716-sec-0182"> <h6 class="title">v) PANSS general subscale</h6> <p>No significant difference was found for general symptoms measured on the PANSS general subscale in the medium term (1 RCT, n = 19, MD 2.86 CI ‐3.21 to 8.93, (<a href="./references#CD004716-fig-0032" title="">Analysis 2.9</a>); in the long term a significant difference was found in favour of the control group (1 RCT, n = 65, MD 3.60 CI 0.84 to 6.36). For the short term, we did not pool the data as there was high heterogeneity (I<sup>2</sup> = 97%) and we believe the data reported in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> may have been incorrectly reported (see discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). </p> </section> </section> <section id="CD004716-sec-0183"> <h5 class="title">2.5 Mental state: specific symptoms</h5> <section id="CD004716-sec-0184"> <h6 class="title">2.5.1 No clinically important improvement in negative and depressive symptoms</h6> <p>For the outcome of 'no clinically important improvement in negative symptoms', there was no significant difference between supportive therapy and other therapies (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, n = 90, RR 0.95 CI 0.63 to 1.46 <a href="./references#CD004716-fig-0033" title="">Analysis 2.10</a>). Similarly, for the outcome of 'no important improvement in depressive symptoms', no significant differences were observed (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, n = 90, RR 1.53 CI 0.92 to 2.55 <a href="./references#CD004716-fig-0034" title="">Analysis 2.11</a>). However, results show that people who underwent supportive therapy are more likely to have had an episode of affective symptoms than those who underwent other therapies (2 RCTs, n = 151, RR 1.84 CI 1.15 to 2.94, <a href="./references#CD004716-fig-0035" title="">Analysis 2.12</a>). </p> </section> <section id="CD004716-sec-0185"> <h6 class="title">2.5.2 Average endpoint in negative symptoms</h6> <section id="CD004716-sec-0186"> <p><b>i) PANNS negative</b></p> <p>No significant difference was found for general symptoms measured on the PANSS negative subscale in the medium term (1 RCT, n = 19, MD 1.70 CI ‐4.00 to 7.40) or the long term (1 RCT, n = 65, MD 0.30 CI ‐1.96 TO 2.56, <a href="./references#CD004716-fig-0036" title="">Analysis 2.13</a>). For the short term, we did not pool the data as there was high heterogeneity (I<sup>2</sup> = 92%) and we believe the data reported in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> may have been incorrectly reported (see discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). </p> </section> <section id="CD004716-sec-0187"> <p><b>ii) SANS</b></p> <p>SANS medium‐term data (<a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>) were equivocal, <a href="./references#CD004716-fig-0037" title="">Analysis 2.14</a>. Another study also reported SANS data that are skewed, and are therefore reported separately in tabular form, <a href="./references#CD004716-fig-0038" title="">Analysis 2.15</a>. </p> </section> </section> <section id="CD004716-sec-0188"> <h6 class="title">2.5.3 Average endpoint in positive symptoms</h6> <section id="CD004716-sec-0189"> <p><b>i) PANSS positive</b></p> <p>A significant difference in favour of other psychological treatment was found for positive symptoms in the long term (1 RCT, n = 65, MD 2.30 CI 0.60 to 0.40, <a href="./references#CD004716-fig-0039" title="">Analysis 2.16</a>). However, in the medium term no significant difference was found (1 RCT, n = 19, MD 2.71 CI ‐0.71 to 6.13). For the short term we did not pool data as they were highly heterogeneous (I<sup>2</sup> = 83%). Furthermore, we have concerns about the data reported <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>, (see discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). We think the data in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> may have been incorrectly reported or may have been an anomaly due to the small numbers in each treatment group. Also the standard deviations were very small, and we believe the authors may have erroneously reported standard errors as standard deviations. However, when we remove <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> from the analysis, heterogeneity is not restored and remains at 78%. </p> </section> <section id="CD004716-sec-0190"> <p><b>ii) SAPS</b></p> <p>One study reported data obtained from the SAPS. These data are skewed and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0040" title="">Analysis 2.17</a>). </p> </section> <section id="CD004716-sec-0191"> <p><b>iii) BPRS</b></p> <p>One study reported data regarding severity of positive symptoms on the BPRS. However these data are skewed and are reported separately (<a href="./references#CD004716-fig-0041" title="">Analysis 2.18</a>). </p> </section> </section> <section id="CD004716-sec-0192"> <h6 class="title">2.5.4 Average endpoint in delusion, hallucination and voices symptoms</h6> <section id="CD004716-sec-0193"> <p><b>i) PANSS thought disturbance</b></p> <p>Other therapies were found to significantly improve the PANSS thought disturbance cluster score (<a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> n = 12, MD 4.30 CI 1.17 to 7.43, <a href="./references#CD004716-fig-0042" title="">Analysis 2.19</a>, however, we believe these data may have been incorrectly reported (see above and discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). </p> </section> <section id="CD004716-sec-0194"> <p><b>ii) PSYRATS</b></p> <p>Skewed data from the PSYRATS delusions score and hallucinations score are also presented in tabular form (<a href="./references#CD004716-fig-0043" title="">Analysis 2.20</a>; <a href="./references#CD004716-fig-0044" title="">Analysis 2.21</a>). <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> reported data from the voices score and found no significant difference at short term (n = 65, MD 0.10 CI ‐3.63 to 3.83) and long term (n = 65, MD 0.00 CI ‐4.76 to 4.76, <a href="./references#CD004716-fig-0045" title="">Analysis 2.22</a>). </p> </section> <section id="CD004716-sec-0195"> <p><b>iii) BAVQ</b></p> <p><a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> reported skewed data on beliefs about voices using the BAVQ subscales, and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0046" title="">Analysis 2.23</a>). </p> </section> </section> <section id="CD004716-sec-0196"> <h6 class="title">2.5.5 Average endpoint in depressive symptoms</h6> <p>One study reported results from the MADRS and another from the BDI‐II, but data are skewed and are reported in tabular form (<a href="./references#CD004716-fig-0046" title="">Analysis 2.23</a> and <a href="./references#CD004716-fig-0047" title="">Analysis 2.24</a>, respectively). </p> </section> </section> <section id="CD004716-sec-0197"> <h5 class="title">2.6 Leaving the study early</h5> <p>We found no significant differences between supportive therapy and other treatments for leaving the study early (19 RCTs, n = 1412, RR 1.03 CI 0.87 to 1.21, <a href="./references#CD004716-fig-0049" title="">Analysis 2.26</a>). No difference was also found for general reasons for leaving the study early (17 RCTs, n = 1261, RR 0.97 CI 0.83 to 1.15). Treatment‐related reasons for leaving the study early were significantly worse in the supportive therapy group (2 RCTs, n = 151, RR 2.15 CI 1.07 to 4.31). </p> </section> <section id="CD004716-sec-0198"> <h5 class="title">2.7 General functioning</h5> <section id="CD004716-sec-0199"> <h6 class="title">2.7.1 Average endpoint in general functioning</h6> <section id="CD004716-sec-0200"> <p><b>i) GAF &amp; GAS</b></p> <p>We found GAF scores (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>) favoured CBT (short term, n = 70, MD ‐9.50 CI ‐16.11 to ‐2.89, and medium term, n = 67, MD ‐12.60 CI ‐19.43 to ‐5.77, <a href="./references#CD004716-fig-0050" title="">Analysis 2.27</a>). When we combined long term data from the GAF and GAS it was heterogeneous (I<sup>2</sup> = 84%) and so data were not pooled. </p> </section> <section id="CD004716-sec-0201"> <p><b>ii) SFS</b></p> <p><a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> measured social functioning on the SFS, and found no significant difference in the short term (n = 65, MD ‐7.20 CI ‐17.86 to 3.46) and the long term (n = 65, MD ‐8.80 CI ‐21.67 to 4.07, <a href="./references#CD004716-fig-0051" title="">Analysis 2.28</a>). </p> <p><b>2.7.2 Specific aspects</b> </p> <p>No advantage or disadvantages were found for people who had supportive therapy in terms of the number of people not in paid work (2 RCTs, n = 171, RR 1.03 CI 0.84 to 1.25, <a href="./references#CD004716-fig-0052" title="">Analysis 2.29</a>). As regards admission to residential placement (1 RCT, n = 39, RR 1.05 CI 0.24 to 4.59, <a href="./references#CD004716-fig-0053" title="">Analysis 2.30</a>) or admission to jail (1 RCT, n = 39, RR 1.05 CI 0.24 to 4.59, <a href="./references#CD004716-fig-0054" title="">Analysis 2.31</a>), similarly, we found no significant differences. </p> </section> </section> </section> <section id="CD004716-sec-0202"> <h5 class="title">2.8 Satisfaction with treatment</h5> <p>One study looked at the proportion of people who were not satisfied with the care they received. We found a significant difference with participants in the other therapies group being less likely to be unsatisfied (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>, n = 45, RR 3.19 CI 1.01 to 10.7,, <a href="./references#CD004716-fig-0055" title="">Analysis 2.32</a>). </p> </section> <section id="CD004716-sec-0203"> <h5 class="title">2.9 Quality of life</h5> <p>There was no significant difference in quality of life scores between the two groups (<a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>, n = 19, MD ‐0.07 CI ‐21.11 to 20.97, <a href="./references#CD004716-fig-0056" title="">Analysis 2.33</a>). </p> </section> <section id="CD004716-sec-0204"> <h5 class="title">2.10 Death</h5> <p>No significant differences were found for deaths during medium and long‐term follow‐up (<a href="./references#CD004716-fig-0057" title="">Analysis 2.34</a>). </p> </section> <section id="CD004716-sec-0205"> <h5 class="title">2.11 Behaviour</h5> <p>A significant disadvantage was conferred on people who received supportive therapy in terms of social impairment measured on the SBAS (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 1.46 CI 1.04 to 2.04, <a href="./references#CD004716-fig-0058" title="">Analysis 2.35</a>). We found no significant effect on the number of people who showed a poor coping style with relatives (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 0.90 CI 0.37 to 2.20, <a href="./references#CD004716-fig-0059" title="">Analysis 2.36</a>). </p> </section> <section id="CD004716-sec-0206"> <h5 class="title">2.12 Engagement with services</h5> <p>The rates of poor attendance at appointments were recorded in one study, and no significant differences were found between treatment groups (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 1.93 CI 0.89 to 4.17, <a href="./references#CD004716-fig-0060" title="">Analysis 2.37</a>. </p> </section> <section id="CD004716-sec-0207"> <h5 class="title">2.13 Insight</h5> <p>Results from the SAI are skewed, and are presented in tabular form (<a href="./references#CD004716-fig-0061" title="">Analysis 2.38</a>). </p> </section> <section id="CD004716-sec-0208"> <h5 class="title">2.14 Compliance</h5> <section id="CD004716-sec-0209"> <h6 class="title">2.14.1 Poor compliance to therapy</h6> <p>We found compliance to be significantly worse amongst those who received supportive therapy than those in the control group (in this case, family therapy) (2 RCTs, n = 58, RR 2.63 CI 1.30 to 5.35, <a href="./references#CD004716-fig-0062" title="">Analysis 2.39</a>). However, by long‐term follow‐up, data were equivocal (1 RCT, n = 39, RR 1.29 CI 0.69 to 2.39). </p> </section> <section id="CD004716-sec-0210"> <h6 class="title">2.14.2 Medication adherence (self‐report)</h6> <p>No significant difference for self‐reported medication adherence was found (<a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>, n = 19, MD 1.00 CI 0.83 to 1.21, <a href="./references#CD004716-fig-0063" title="">Analysis 2.40</a>). </p> </section> <section id="CD004716-sec-0211"> <h6 class="title">2.14.3 Average endpoint score (ROMI)</h6> <p><a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> found no significant difference for medication adherence (n = 19, MD 0.45 CI ‐3.58 to 4.48, <a href="./references#CD004716-fig-0064" title="">Analysis 2.41</a>) or nonadherence (n = 19, MD 1.75 CI ‐0.61 to 4.11, <a href="./references#CD004716-fig-0065" title="">Analysis 2.42</a>). </p> </section> </section> <section id="CD004716-sec-0212"> <h5 class="title">2.15 Medication</h5> <p>Data from one small trial showed a significant difference, favouring other therapies for prescribed IM depot medication (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 2.11 CI 0.99 to 4.47, <a href="./references#CD004716-fig-0066" title="">Analysis 2.43</a>). </p> </section> <section id="CD004716-sec-0213"> <h5 class="title">2.16 Attitude to medication</h5> <p>On the AMQ, the other therapies group scored significantly better than those allocated to supportive therapy (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>, n = 74, MD ‐4.50 CI ‐6.83 to ‐2.17, <a href="./references#CD004716-fig-0067" title="">Analysis 2.44</a>). The DAI at short‐term (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>, n = 63, MD ‐5.70 CI ‐9.35 to ‐2.05, <a href="./references#CD004716-fig-0068" title="">Analysis 2.45</a>) and long‐term follow‐up (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>, n = 44, MD ‐4.90 CI ‐9.38 to ‐0.42) also favoured the other therapies group. </p> </section> <section id="CD004716-sec-0214"> <h5 class="title">2.17 Economic outcomes</h5> <p>The only study that investigated direct costs of the interventions produced skewed data, which are presented in a table (<a href="./references#CD004716-fig-0069" title="">Analysis 2.46</a>). </p> </section> </section> <section id="CD004716-sec-0215"> <h4 class="title">Comparison 3: SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY (CBT)</h4> <p>Thirteen included studies compared supportive therapy with CBT (<a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a>; <a href="./references#CD004716-bbs2-0007" title="HaddockG , TarrierN , MorrisonAP , HopkinsR , DrakeR , LewisS . A pilot study evaluating the effectiveness of individual inpatient cognitive‐behavioural therapy in early psychosis. Social Psychiatry and Psychiatric Epidemiology1999;34:254‐8. ">Haddock 1999</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>; <a href="./references#CD004716-bbs2-0009" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 2</a>; <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>; <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>; <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>; <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>; <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a>; <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>; <a href="./references#CD004716-bbs2-0019" title="SpauldingWD , ReedD , SullivanM , RichardsonC , WeilerM . Effects of cognitive treatment in psychiatric rehabilitation. Schizophrenia Bulletin1999;25(4):657‐76. ">Spaulding 1999</a>; <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>; <a href="./references#CD004716-bbs2-0022" title="TurkingtonD , KingdonD . Cognitive‐behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry2000;177:101‐6. ">Turkington 2000</a>). </p> <section id="CD004716-sec-0216"> <h5 class="title">3.1 Global state: relapse</h5> <p>Relapse rates did not differ significantly between supportive therapy and CBT at medium term (2 RCTs, n = 100, RR 2.86 CI 0.32 to 25.24, <a href="./references#CD004716-fig-0070" title="">Analysis 3.1</a>). Longer‐term data were heterogeneous (I<sup>2</sup> = 78%) and so were not pooled. </p> </section> <section id="CD004716-sec-0217"> <h5 class="title">3.2 Service outcomes: hospitalisation</h5> <p>Hospitalisations did not differ significantly between supportive therapy and CBT groups (medium term, 3 RCTs, n = 153, RR 1.60 CI 0.85 to 3.00, long term, 1 RCT, n = 65, RR 0.73 CI 0.18 to 3.00, <a href="./references#CD004716-fig-0071" title="">Analysis 3.2</a>). </p> </section> <section id="CD004716-sec-0218"> <h5 class="title">3.3 Mental state: general</h5> <section id="CD004716-sec-0219"> <h6 class="title">3.3.1 No clinically important improvement in general mental state</h6> <p>We found no significant difference for 'no clinically important improvement in general mental state' over the long term (3 RCTs, n = 194, RR 1.23 CI 0.89 to 1.70), and at medium‐term follow‐up (1 RCT, n = 59, RR 1.27 CI 0.95 to 1.70, <a href="./references#CD004716-fig-0072" title="">Analysis 3.3</a>). </p> </section> <section id="CD004716-sec-0220"> <h6 class="title">3.3.2 Average endpoint general mental state score</h6> <section id="CD004716-sec-0221"> <p><b>i) PANSS total</b></p> <p>A significant difference in general mental state between supportive therapy and CBT was demonstrated in the long term (2 RCTs, n = 105, MD 5.82 CI 1.04 to 10.60, <a href="./references#CD004716-fig-0073" title="">Analysis 3.4</a>). However, in the short term, the data were highly heterogeneous (I<sup>2</sup> = 98%). We have concerns about the data reported <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>, (see discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). We think the data in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> may have been incorrectly reported or may have been an anomaly due to the small numbers in each treatment group. Also the standard deviations were very small, and we believe the authors may have erroneously reported standard errors as standard deviations. However, when we remove <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> from the analysis, heterogeneity is not restored and remains at 83% so data were not pooled for this outcome. </p> </section> <section id="CD004716-sec-0222"> <p><b>ii) BPRS</b></p> <p>No significant difference in mental state measured on the BPRS was found in the short term (2 RCTs, n = 92, MD ‐1.07 CI ‐5.08 to 2.94); <a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a> found a significant difference in favour of CBT in the long term (n = 37, MD 7.60 CI 0.90 to 14.30, <a href="./references#CD004716-fig-0074" title="">Analysis 3.5</a>). </p> </section> <section id="CD004716-sec-0223"> <p><b>iii) BPRS short form</b></p> <p><a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a> also used the short form of the BPRS, and found no significant differences at short‐ (n = 74, MD ‐0.90 CI ‐3.02 to 1.22), medium‐ (n = 67, MD 2.20 CI ‐1.18 to 5.58) or long‐term follow‐up (n = 45, MD 2.30 CI ‐0.54 to 5.14, <a href="./references#CD004716-fig-0075" title="">Analysis 3.6</a>). </p> </section> <section id="CD004716-sec-0224"> <p><b>iv) CPRS</b></p> <p>One study presented skewed data from the CPRS (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>). We have reported these in a table, <a href="./references#CD004716-fig-0076" title="">Analysis 3.7</a>. </p> </section> <section id="CD004716-sec-0225"> <p><b>v) PANSS general subscale</b></p> <p><a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> reported PANSS general subscale data, which showed an advantage for other therapies over supportive therapy in the short term (n = 12, MD 17.10 CI 13.76 to 20.44), while <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> showed also showed a significant difference in favour of CBT in the short term (n = 65, MD 4.40 CI 1.36 to 7.44) and long term (n = 65, MD 3.60 CI 0.84 to 6.36, <a href="./references#CD004716-fig-0077" title="">Analysis 3.8</a>). We did not pool data for this outcome as the short‐term results where highly heterogenous (I<sup>2</sup> = 97%), and we believe the <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> data may have been incorrectly reported (see above and discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). </p> </section> </section> </section> <section id="CD004716-sec-0226"> <h5 class="title">3.4 Mental state: specific symptoms</h5> <section id="CD004716-sec-0227"> <h6 class="title">3.4.1 No clinically important improvement in negative and depressive symptoms</h6> <p>We found no significant difference in improvement in negative symptoms between supportive therapy and CBT (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, n = 90, RR 0.95 CI 0.63 to 1.46, <a href="./references#CD004716-fig-0078" title="">Analysis 3.9</a>). Similarly, for depressive symptoms, we found no significant differences (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, n = 90, RR 1.53 CI 0.92 to 2.55, <a href="./references#CD004716-fig-0079" title="">Analysis 3.10</a>). However, results show that people who underwent supportive therapy are more likely to have had an episode of affective symptoms than those who underwent CBT (2 RCTs, n = 101, RR 2.17 CI 1.16 to 4.06, <a href="./references#CD004716-fig-0080" title="">Analysis 3.11</a>). </p> </section> <section id="CD004716-sec-0228"> <h6 class="title">3.4.2 Average endpoint in negative symptoms</h6> <section id="CD004716-sec-0229"> <p><b>i) PANSS negative</b></p> <p>PANSS negative subscale data reported by <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> significantly favoured CBT in the short term (n = 12, MD 7.20 CI 3.78 to 10.62), while <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> showed no significance in the short term (n = 65, MD 0.30 CI ‐1.55 to 2.15) and long term (n = 65, MD 0.30 CI ‐1.96 to 2.56, <a href="./references#CD004716-fig-0081" title="">Analysis 3.12</a>). The short‐term data were highly heterogenous (I<sup>2</sup> = 92%) and we have concerns about Levine's data (see above and discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>) and so data were not pooled. </p> </section> <section id="CD004716-sec-0230"> <p><b>ii) SANS</b></p> <p><a href="./references#CD004716-bbs2-0017" title="PintoA , La‐PiaS , MennellaR , GiorgioD , DeSimoneL . Cognitive behavioral therapy and clozapine for clients with treatment refractory schizophrenia. Psychiatric Services1999;50(7):901‐4. ">Pinto 1999</a> reported SANS data and found no difference between treatment groups (n = 37, MD 6.60 CI ‐5.81 to 19.01). Other skewed SANS data for <a href="./references#CD004716-bbs2-0240" title="SenskyT . A five year follow‐up of patients with schizophrenia with drug‐resistant symptoms treated with cognitive behaviour therapy or a befriending intervention. National Research Register2000. ">Sensky 2000a</a> and <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a> are reported separately in tabular form <a href="./references#CD004716-fig-0083" title="">Analysis 3.14</a>. </p> </section> </section> <section id="CD004716-sec-0231"> <h6 class="title">3.4.3 Average endpoint in positive symptoms</h6> <section id="CD004716-sec-0232"> <p><b>i) PANSS positive</b></p> <p>Three studies evaluated positive symptoms using the PANSS positive subscale, and no significant difference was found <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a> and a significant difference in favour of CBT was found in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> and <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>. The pooled data were highly heterogenous (I<sup>2</sup> = 83%); when we removed <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a>, for which we have concerns about the data reported (see above and discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>), the heterogeneity remain high with I<sup>2</sup> = 78% and so data were not pooled (<a href="./references#CD004716-fig-0084" title="">Analysis 3.15</a>). In the long term, <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> favoured CBT (n = 65, MD 2.30 CI 0.60 to 4.00, <a href="./references#CD004716-fig-0084" title="">Analysis 3.15</a>). </p> </section> <section id="CD004716-sec-0233"> <p><b>ii) SAPS</b></p> <p><a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a> reported data obtained from the SAPS, but data are skewed and presented as 'Other data' in a table (<a href="./references#CD004716-fig-0085" title="">Analysis 3.16</a>). </p> </section> <section id="CD004716-sec-0234"> <p><b>iii) BPRS</b></p> <p>Skewed positive symptoms data from the BPRS were obtained from <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>, and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0086" title="">Analysis 3.17</a>). </p> </section> </section> <section id="CD004716-sec-0235"> <h6 class="title">3.4.4 Average endpoint in delusion, hallucination and voices symptoms</h6> <section id="CD004716-sec-0236"> <p><b>i) PANSS thought disturbance</b></p> <p>Cognitive behavioural therapy did not improve scores on the PANSS thought disturbance cluster significantly more than supportive therapy (<a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> n = 12, MD 4.30 CI 1.17 to 7.43, <a href="./references#CD004716-fig-0087" title="">Analysis 3.18</a>), however, we believe these data may have been incorrectly reported (see above and discussion section <a href="#CD004716-sec-0313">Quality of the evidence</a>). </p> </section> <section id="CD004716-sec-0237"> <p><b>ii) PSYRATS</b></p> <p>Skewed data from the PSYRATS scale, delusions score and hallucinations score are also presented in tabular form (<a href="./references#CD004716-fig-0088" title="">Analysis 3.19</a>; <a href="./references#CD004716-fig-0089" title="">Analysis 3.20</a>). <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> reported data from the voices score and found no significant difference at short term (n = 65, MD 0.10 CI ‐3.63 to 3.83) and long term (n = 65, MD 0.00 CI ‐4.76 to 4.76, <a href="./references#CD004716-fig-0090" title="">Analysis 3.21</a>). </p> </section> <section id="CD004716-sec-0238"> <p><b>iii) BAVQ</b></p> <p><a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> reported skewed data on beliefs about voices using the BAVQ subscales, and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0091" title="">Analysis 3.22</a>). </p> </section> </section> <section id="CD004716-sec-0239"> <h6 class="title">3.4.5 Average endpoint in depressive symptoms</h6> <p><a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a> reported results from the MADRS and <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> from the BDI‐II, but data are skewed and are reported in tabular form (<a href="./references#CD004716-fig-0092" title="">Analysis 3.23</a> and <a href="./references#CD004716-fig-0093" title="">Analysis 3.24</a>, respectively). </p> </section> </section> <section id="CD004716-sec-0240"> <h5 class="title">3.5 Leaving the study early</h5> <p>We found no significant differences (general reasons) for leaving the study early, between supportive therapy (10 RCTs, n = 711, RR 0.93 CI 0.66 to 1.30, <a href="./references#CD004716-fig-0094" title="">Analysis 3.25</a>) and those allocated to CBT. For those who left due to treatment‐related reasons data were again non‐significant (2 RCTs, n = 101, RR 2.34 CI 0.90 to 6.10), but heterogeneous (I<sup>2</sup> = 66%). </p> </section> <section id="CD004716-sec-0241"> <h5 class="title">3.6 General functioning</h5> <p>We found GAF scores (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>) favoured CBT (short term, n = 70, MD ‐9.50 CI ‐16.11 to ‐2.89, and medium term, n = 67, MD ‐12.60 CI ‐19.43 to ‐5.77, <a href="./references#CD004716-fig-0095" title="">Analysis 3.26</a>). When we combined long‐term data from the GAF and GAS they were heterogeneous (I<sup>2</sup> = 84%) and so data were not pooled. </p> <p><a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> measured social functioning on the SFS, and found no significant difference in the short term (n = 65, MD ‐7.20 CI ‐17.86 to 3.46) and the long term (n = 65, MD ‐8.80 CI ‐21.67 to 4.07, <a href="./references#CD004716-fig-0096" title="">Analysis 3.27</a>). </p> </section> <section id="CD004716-sec-0242"> <h5 class="title">3.7 Satisfaction with treatment</h5> <p><a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a> looked at the proportion of people who were not satisfied with the care they received. We found a significant difference between treatment groups, with people receiving CBT less likely to be unsatisfied (n = 45, RR 3.19 CI 1.01 to 10.07, <a href="./references#CD004716-fig-0097" title="">Analysis 3.28</a>). </p> </section> <section id="CD004716-sec-0243"> <h5 class="title">3.8 Quality of life</h5> <p>One study found no significant results for the RSES (<a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a>, n = 65 short term MD ‐0.80 CI ‐3.77 to 2.17; long term MD ‐1.70 CI ‐5.19 to 1.79, <a href="./references#CD004716-fig-0098" title="">Analysis 3.29</a>). </p> </section> <section id="CD004716-sec-0244"> <h5 class="title">3.9 Death</h5> <p>Two deaths occurred in <a href="./references#CD004716-bbs2-0021" title="TarrierN . The use of cognitive behaviour therapy in the treatment of schizophrenia. 8th Congress of the Association of European Psychiatrists; 1996 Jul 7‐12; London, UK. 1996. [MEDLINE: 95050364; PMID 7961550] TarrierN , KinneyC , McCarthyE , HumphreysL , WittkowskiA , MorrisJ . Two‐year follow‐up of cognitive‐behavioral therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. Journal of Consulting and Clinical Psychology2000;68(5):917‐22. [EMBASE 2000386575] TarrierN , KinneyC , McCarthyE , WittkowskiA , YusupoffL , GledhillA . Are some types of psychotic symptoms more responsive to cognitive‐behaviour therapy?. Behavioural and Cognitive Psychotherapy2001;29:45‐55. TarrierN , WittkowskiA , KinneyC , McCarthyE , MorrisJ , HumphreysL . Durability of the effects of cognitive‐behavioural therapy in the treatment of chronic schizophrenia: 12‐Month follow‐up. British Journal of Psychiatry1999;174:500‐4. [EMBASE 1999210779] TarrierN , YusupoffL , KinneyC , McCarthyE , GledhillA , HaddockG , et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ1998;317:303‐7. [MEDLINE: 98350038; PMID 9685273] ">Tarrier 1998</a>, one from each intervention group, and one death occurred in the <a href="./references#CD004716-bbs2-0004" title="DurhamRC , GuthrieM , MortonRV , ReidDA , TrelivingLR , FowlerDMR , et al. Tayside‐Fife clinical trial of cognitive‐behavioural therapy for medication‐resistant psychotic symptoms. Results to 3‐month follow‐up. British Journal of Psychiatry2003;182:303‐11. ">Durham 2003</a> study from the supportive therapy group (<a href="./references#CD004716-fig-0099" title="">Analysis 3.30</a>). </p> </section> <section id="CD004716-sec-0245"> <h5 class="title">3.10 Insight</h5> <p>Results from the Schedule for Assessment of Insight are skewed, and are presented in tabular form <a href="./references#CD004716-fig-0100" title="">Analysis 3.31</a>, as are results from the Beck Cognitive Insight Scale, <a href="./references#CD004716-fig-0101" title="">Analysis 3.32</a>. </p> </section> <section id="CD004716-sec-0246"> <h5 class="title">3.11 Medication</h5> <p>There was no significant difference for no reduction in doses of antipsychotic medication between the CBT and supportive therapy groups (<a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a>, n = 90, MD 0.89 CI 0.68 to 1.17, <a href="./references#CD004716-fig-0102" title="">Analysis 3.33</a>). </p> </section> <section id="CD004716-sec-0247"> <h5 class="title">3.12 Attitude to medication</h5> <p>On the AMQ, people who were allocated to CBT scored significantly better than those allocated to supportive therapy (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>, n = 74, MD ‐4.50 CI ‐6.83 to ‐2.17, <a href="./references#CD004716-fig-0103" title="">Analysis 3.34</a>). Similarly, the DAI at short‐term (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>, n = 63, MD ‐5.70 CI ‐9.35 to ‐2.05, <a href="./references#CD004716-fig-0104" title="">Analysis 3.35</a>) and long‐term follow‐up (<a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a>, n = 44, MD ‐4.90 CI ‐9.38 to ‐0.42) also significantly favoured CBT compared with supportive therapy. </p> </section> <section id="CD004716-sec-0248"> <h5 class="title">3.13 Economic outcomes</h5> <p>The only study investigating direct costs of the interventions produced skewed data and is reported in tables (<a href="./references#CD004716-fig-0105" title="">Analysis 3.36</a>). </p> </section> </section> <section id="CD004716-sec-0249"> <h4 class="title">Comparison 4: SUPPORTIVE THERAPY versus FAMILY THERAPY</h4> <p>Two included studies compared supportive therapy with family therapy (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>; <a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>). </p> <section id="CD004716-sec-0250"> <h5 class="title">4.1 Global state: relapse and remission</h5> <p>Two trials reported relapse rates, but these showed heterogeneity (I<sup>2</sup> = 87.1%) and so data were not pooled (<a href="./references#CD004716-fig-0106" title="">Analysis 4.1</a>). We found participants in the <a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a> study were more likely to experience remission of their symptoms if they had family therapy rather than supportive therapy (n = 39, RR 1.87 CI 1.11 to 3.15, <a href="./references#CD004716-fig-0107" title="">Analysis 4.2</a>). </p> </section> <section id="CD004716-sec-0251"> <h5 class="title">4.2 Service outcome: hospitalisation</h5> <p>No significant differences were found in hospitalisation rates between the treatment groups (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 1.93 CI 0.89 to 4.17, <a href="./references#CD004716-fig-0108" title="">Analysis 4.3</a>). </p> </section> <section id="CD004716-sec-0252"> <h5 class="title">4.3 Mental state: episode of affective symptoms</h5> <p>Data were only available for one outcome relating to mental state ‐ the likelihood of having an episode of affective symptoms. We found no significant difference between family therapy and supportive therapy (<a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>, n = 48, RR 1.71 CI 0.82 to 3.60, <a href="./references#CD004716-fig-0109" title="">Analysis 4.4</a>). </p> </section> <section id="CD004716-sec-0253"> <h5 class="title">4.4 Leaving the study early</h5> <p>We found no significant difference for the number of participants leaving the study early for general reasons (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 0.70 CI 0.13 to 3.75) and treatment‐related reasons (<a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>, n = 48 RR 1.60 CI 0.61 to 4.19, <a href="./references#CD004716-fig-0110" title="">Analysis 4.5</a>). </p> </section> <section id="CD004716-sec-0254"> <h5 class="title">4.5 General functioning</h5> <p>People who had supportive therapy were no more or less likely to have failed to find paid work than people who had family therapy (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 0.96 CI 0.57 to 1.63, <a href="./references#CD004716-fig-0111" title="">Analysis 4.6</a>). Rates of admission to residential placement (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 1.05 CI 0.24 to 4.59, <a href="./references#CD004716-fig-0112" title="">Analysis 4.7</a>) and admission to jail (1 RCT, n = 39, RR 1.05 CI 0.24 to 4.59, <a href="./references#CD004716-fig-0113" title="">Analysis 4.8</a>) did not differ significantly between treatment groups. </p> </section> <section id="CD004716-sec-0255"> <h5 class="title">4.6 Behaviour</h5> <p><a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a> assessed the frequency of social impairment using the Social Behaviour Adjustment Schedule. We found social impairment to be significantly more frequent in the supportive therapy intervention compared with family therapy (n = 39, RR 1.46 CI 1.04 to 2.04, <a href="./references#CD004716-fig-0114" title="">Analysis 4.9</a>). The number of people displaying a poor coping style with relatives did not differ significantly between groups (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 0.90 CI 0.37 to 2.20, <a href="./references#CD004716-fig-0115" title="">Analysis 4.10</a>). </p> </section> <section id="CD004716-sec-0256"> <h5 class="title">4.7 Engagement with services</h5> <p>The proportion of people who were poor attendees at appointments was not significantly different (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 1.93 CI 0.89 to 4.17, <a href="./references#CD004716-fig-0116" title="">Analysis 4.11</a>) between groups. </p> </section> <section id="CD004716-sec-0257"> <h5 class="title">4.8 Compliance</h5> <p>We found compliance to be significantly worse amongst those who received supportive therapy than those in the family therapy group (<a href="./references#CD004716-bbs2-0006" title="DoaneJA , FalloonIR , GoldsteinMJ , MintzJ . Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Archives of General Psychiatry1985;42(1):34‐42. FalloonIR , BoydJL , McGillCW , RazaniJ , MossHB , GildermanAM . Family management in the prevention of exacerbations of schizophrenia: a controlled study. New England Journal of Medicine1982;306(24):1437‐40. FalloonIR , BoydJL , McGillCW , WilliamsonM , RazaniJ , MossHB , et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two‐year longitudinal study. Archives of General Psychiatry1985;42(9):887‐96. FalloonIR , McGillCW , BoydJL , PedersonJ . Family management in the prevention of morbidity of schizophrenia: social outcome of a two‐year longitudinal study. Psychological Medicine1987;17(1):59‐66. FalloonIR , PedersonJ . Family management in the prevention of morbidity of schizophrenia: the adjustment of the family unit. British Journal of Psychiatry1985;147:156‐63. LibermanRP , CardinV , McGillCW , FalloonIR , et al. Behavioral family management of schizophrenia: clinical outcome and costs. University of Maryland School of Medicine Symposium. Psychiatric Annals1987;17(9):610‐9. McGillCW , FalloonIR , BoydJL , SiverioCW . Family educational intervention in the treatment of schizophrenia. Hospital and Community Psychiatry1983;34:934‐8. ReaMM , StrachanAM , GoldsteinMJ , FalloonI , HwangS . Changes in patient coping style following individual and family treatment for schizophrenia. British Journal of Psychiatry1991;158:642‐7. StrangJS , FalloonIRH , MossHB , RazaniJ , BoydJL . Drug treatment and family intervention during the aftercare treatment of schizophrenics. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacology Bulletin1981;17(3):87‐8. ">Falloon 1982</a>, n = 39, RR 2.63 CI 1.30 to 5.35, <a href="./references#CD004716-fig-0117" title="">Analysis 4.12</a>). However, by long term follow‐up data were equivocal (n = 39, RR 1.29 CI 0.69 to 2.39). </p> </section> <section id="CD004716-sec-0258"> <h5 class="title">4.9 Medication</h5> <p>The difference in frequency of prescription of antipsychotic depot medication between groups was not statistically significant (n = 39, RR 2.11 CI 0.99 to 4.47, <a href="./references#CD004716-fig-0118" title="">Analysis 4.13</a>). </p> </section> </section> <section id="CD004716-sec-0259"> <h4 class="title">Comparison 5: SUPPORTIVE THERAPY versus PSYCHOEDUCATION</h4> <p>Two included studies compared supportive therapy with psychoeducation (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>). </p> <section id="CD004716-sec-0260"> <h5 class="title">5.1 Service outcomes: hospitalisation</h5> <p>No significant differences in hospitalisation rates were found (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>, n = 47, RR 0.48 CI 0.05 to 4.93, <a href="./references#CD004716-fig-0119" title="">Analysis 5.1</a>). </p> </section> <section id="CD004716-sec-0261"> <h5 class="title">5.2 Mental state</h5> <p><b>5.2.1 No clinically important improvement in general mental state</b> </p> <p><a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> found no significant difference between supportive therapy and psychotherapy for 'no clinically important improvement in general mental state' ( n = 19, MD 1.61 CI 0.96 to 2.68, <a href="./references#CD004716-fig-0120" title="">Analysis 5.2</a>). </p> <section id="CD004716-sec-0262"> <h6 class="title">5.2.2 Average endpoint general symptoms score</h6> <p>There was no significant difference for PANSS general scores between the groups (n = 19, MD 2.86 CI ‐3.21 to 8.93, <a href="./references#CD004716-fig-0121" title="">Analysis 5.3</a>). </p> </section> <section id="CD004716-sec-0263"> <h6 class="title">5.2.3 Average endpoint negative symptoms score</h6> <p>PANSS negative subscale data from <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> showed no significant difference between supportive therapy and psychoeducation (n = 19, MD 1.70 CI ‐4.00 to 7.40, <a href="./references#CD004716-fig-0122" title="">Analysis 5.4</a>). </p> </section> <section id="CD004716-sec-0264"> <h6 class="title">5.2.4 Average endpoint positive symptoms score</h6> <p>PANSS positive subscale data from <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> study showed no significant difference between supportive therapy and psychotherapy ( n = 19, MD 2.71 CI ‐0.71 to 6.13, <a href="./references#CD004716-fig-0123" title="">Analysis 5.5</a>). </p> <p><b>5.2.5 Average endpoint depression score</b> </p> <p>No significant difference was found for CDRS between supportive therapy and psychotherapy (<a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>, n = 19, MD 1.47 CI ‐1.35 to 4.29, <a href="./references#CD004716-fig-0124" title="">Analysis 5.6</a>) </p> </section> </section> <section id="CD004716-sec-0265"> <h5 class="title">5.3 Leaving the study early</h5> <p>We found no significant difference in the number of people leaving the study early between treatment groups (2 RCTs, n = 71, RR 0.57 CI 0.21 to 1.54, <a href="./references#CD004716-fig-0125" title="">Analysis 5.7</a>). </p> </section> <section id="CD004716-sec-0266"> <h5 class="title">5.4 Quality of Life</h5> <p>There was no significant difference in quality of life scores between the two groups (<a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>, n = 19, MD ‐0.07 CI ‐21.11 to 20.97, <a href="./references#CD004716-fig-0126" title="">Analysis 5.8</a>). </p> </section> <section id="CD004716-sec-0267"> <h5 class="title">5.5 Death</h5> <p>Death rates were not significantly affected by treatment received (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>, n = 47, RR 2.88 CI 0.12 to 67.29, <a href="./references#CD004716-fig-0127" title="">Analysis 5.9</a> ). </p> </section> <section id="CD004716-sec-0268"> <h5 class="title">5.6 Behaviour</h5> <p><a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> found no significant differences in the composite scores from the ROMI and ITAQ for need for treatment (n = 19, MD ‐0.02 CI ‐0.44 to 0.40) and the benefits of medication (n = 19, MD ‐0.19 CI ‐0.56 to 0.18, <a href="./references#CD004716-fig-0128" title="">Analysis 5.10</a>). </p> </section> <section id="CD004716-sec-0269"> <h5 class="title">5.7 Insight</h5> <p>No significant difference in insight into treatment scores were found between supportive therapy and psychotherapy (<a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>, n = 19, MD ‐1.55 CI ‐5.85 to 2.75, <a href="./references#CD004716-fig-0129" title="">Analysis 5.11</a>) </p> </section> <section id="CD004716-sec-0270"> <h5 class="title">5.8. Compliance</h5> <section id="CD004716-sec-0271"> <h6 class="title">5.8.1 Poor compliance to therapy</h6> <p>All participants in <a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> attended at least six of the 14 sessions of therapy (<a href="./references#CD004716-fig-0130" title="">Analysis 5.12</a>). </p> </section> <section id="CD004716-sec-0272"> <h6 class="title">5.8.2 Medication adherence (self‐report)</h6> <p>No significant difference for self‐reported medication adherence was found (<a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a>, n = 19, MD 1.00 CI ‐0.83 to 1.21, <a href="./references#CD004716-fig-0131" title="">Analysis 5.13</a>). </p> </section> <section id="CD004716-sec-0273"> <h6 class="title">5.8.3 Average endpoint score (ROMI)</h6> <p><a href="./references#CD004716-bbs2-0023" title="UzenoffSR . A Preliminary Trial of Adherence‐Coping‐Education (ACE) Therapy for First‐episode Schizophrenia. Chapel Hill: The University of North Carolina, 2007. UzenoffSR , PerkinsDO , HamerRM , WiesenCA , PennDL . A preliminary trial of Adherence‐Coping‐Education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease2008;196:572‐5. ">Uzenoff 2007</a> found no significant difference for medication adherence (n = 19, MD .45 CI ‐3.58 to 4.48, <a href="./references#CD004716-fig-0132" title="">Analysis 5.14</a>) or nonadherence (n = 19, MD 1.75 CI ‐0.61 to 4.11, <a href="./references#CD004716-fig-0133" title="">Analysis 5.15</a>) between supportive therapy and psychotherapy. </p> </section> </section> </section> <section id="CD004716-sec-0274"> <h4 class="title">Comparison 6: SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME</h4> <p>One study looked at supportive therapy compared to a rehabilitation programme (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>). </p> <section id="CD004716-sec-0275"> <h5 class="title">6.1 Service outcomes</h5> <p>Participants in the rehabilitation group were significantly less likely to be hospitalised than those in the supportive therapy group (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>, n = 132, RR 2.71 CI 1.22 to 6.02, <a href="./references#CD004716-fig-0134" title="">Analysis 6.1</a>). </p> </section> <section id="CD004716-sec-0276"> <h5 class="title">6.2 Leaving the study early</h5> <p>There were no significant differences in the numbers who left the study early (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>, n = 132, RR 1.45 CI 0.92 to 2.29, <a href="./references#CD004716-fig-0135" title="">Analysis 6.2</a>). </p> </section> <section id="CD004716-sec-0277"> <h5 class="title">6.3 General functioning: no gainful employment</h5> <p>We found that the therapeutic intervention did not have a significant impact on the number of people not in gainful employment (<a href="./references#CD004716-bbs2-0003" title="DincinJ , WitheridgeTF . Psychiatric rehabilitation as a deterrent to recidivism. Hospital and Community Psychiatry1982;33(8):645‐50. ">Dincin 1982</a>, n = 132, RR 1.04 CI 0.85 to 1.29, <a href="./references#CD004716-fig-0136" title="">Analysis 6.3</a>). </p> </section> </section> <section id="CD004716-sec-0278"> <h4 class="title">Comparison 7: SUPPORTIVE THERAPY versus SKILLS TRAINING</h4> <p>Three included studies compared supportive therapy with skills training (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>; <a href="./references#CD004716-bbs2-0005" title="EckmanTA , WirshingWC , MarderSR , LibermanRP , Johnston‐CronkK , ZimmermannK , et al. Technique for training schizophrenic patients in illness self‐management: a controlled trial. American Journal of Psychiatry1992;149(11):1549‐55. [MEDLINE: 93036079; PMID 1384364] ">Eckman 1992</a>; <a href="./references#CD004716-bbs2-0024" title="MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. 155th Annual Meeting of the American Psychiatric Association; 2002 May 18‐23; Philadelphia, PA, USA. 2002. [No. 3B] MarderSR , WirshingDA , WirshingWC . Psychosocial and pharmacological strategies for improving treatment adherence in schizophrenia. Annual Meeting of the American Psychiatric Association; 2001 May 5‐10; LA, USA. Marathon Multimedia, 2001. [MEDLINE: 21185887; PMID 11290639] MarderSR , WirshingWC , MintzJ , McKenzieJ , JohnstonK , EckmanTA , et al. Two‐year outcome of social skills training and group psychotherapy for outpatients with schizophrenia. American Journal of Psychiatry1996;153(12):1585‐92. WirshingWC , EckmanT , LibermanRP , MarderSR . Management of risk of relapse through skills training of chronic schizophrenics. In: Tamminga CaSSC editor(s). Schizophrenia Research: Advances in Neuropsychiatry and Psychopharmacology. Raven Press, 1991:255‐67. WirshingWC , MarderSR , EckmanT , LibermanRP , MintzJ . Acquisition and retention of skills training methods in chronic schizophrenic outpatients. Psychopharmacology Bulletin1992;28(3):241‐5. [MEDLINE: 93126518; PMID 1480726] ">Wirshing 1991</a>). </p> <section id="CD004716-sec-0279"> <h5 class="title">7.1 Service outcomes: hospitalisation</h5> <p>Hospitalisation rates were not found to differ significantly between supportive therapy and skills training (<a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a>, n = 47, RR 0.96 CI 0.06 to 14.43, <a href="./references#CD004716-fig-0137" title="">Analysis 7.1</a>). </p> </section> <section id="CD004716-sec-0280"> <h5 class="title">7.2 Leaving the study early</h5> <p>Attritions rates showed no significant difference between treatment groups (3 RCTs, n = 168, RR 1.01 CI 0.61 to 1.67, <a href="./references#CD004716-fig-0138" title="">Analysis 7.2</a>). </p> </section> <section id="CD004716-sec-0281"> <h5 class="title">7.3 Death</h5> <p><a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a> reports data on death rates, with no significant difference between groups (n = 47, RR 2.88 CI 0.12 to 67.29, <a href="./references#CD004716-fig-0139" title="">Analysis 7.3</a>). </p> </section> </section> <section id="CD004716-sec-0282"> <h4 class="title">Comparison 8: SUPPORTIVE THERAPY versus PSYCHODYNAMIC PSYCHOTHERAPY</h4> <p><a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a> compared supportive therapy with psychodynamic psychotherapy. </p> <section id="CD004716-sec-0283"> <h5 class="title">8.1 Leaving the study early</h5> <p>In the medium term, people in the psychodynamic therapy group were more likely to leave the study early than those in the supportive therapy arm (1 RCT, n = 164, RR 0.62 CI 0.42 to 0.91). However, by long term follow‐up, the differences were no longer significant (<a href="./references#CD004716-bbs2-0020" title="FrankAF , GundersonJG . The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Archives of General Psychiatry1990;47(3):228‐36. GundersonJG , FrankAF . Effects of psychotherapy in schizophrenia. Yale Journal of Biology and Medicine1985;58(4):373‐81. GundersonJG , FrankAF , KatzHM , VannicelliML , FroschJP , KnappPH . Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophrenia Bulletin1984;10(4):564‐98. StantonAH , GundersonJG , KnappPH , FrankAF , VannicelliML , SchnitzerR , et al. Effects of psychotherapy in schizophrenia: I. Design and implementation of a controlled study. Schizophrenia Bulletin1984;10(4):520‐63. ">Stanton 1984</a>, n = 164, RR 0.89 CI 0.73 to 1.09, <a href="./references#CD004716-fig-0140" title="">Analysis 8.1</a>). </p> </section> </section> <section id="CD004716-sec-0284"> <h4 class="title">Comparison 9: SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS</h4> <p><a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a> compared supportive therapy against a combination of other psychosocial interventions. </p> <section id="CD004716-sec-0285"> <h5 class="title">9.1 Global state: relapse</h5> <p>We found no significant difference for relapse rates between supportive therapy and those receiving a combination of other therapies, in this case CBT and family therapy (<a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>, n = 50, RR 1.48 CI 0.86 to 2.55, <a href="./references#CD004716-fig-0141" title="">Analysis 9.1</a> ). </p> </section> <section id="CD004716-sec-0286"> <h5 class="title">9.2 Mental state</h5> <p>The risk of having an episode of affective symptoms did not differ significantly between groups (<a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>, n = 50 RR 1.63 CI 0.81 to 3.28, <a href="./references#CD004716-fig-0142" title="">Analysis 9.2</a> ). </p> </section> <section id="CD004716-sec-0287"> <h5 class="title">9.3 Leaving the study early</h5> <p>The number of people who left the study early for treatment‐related reasons were significantly higher in the supportive therapy group than in the combination group (<a href="./references#CD004716-bbs2-0008" title="HogartyGE , GreenwaldD , UlrichRF , KornblithSJ , DiBarryAL , CooleyS , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry1997;154(11):1514‐24. HogartyGE , KornblithSJ , GreenwaldD , DiBarryAL , CooleyS , UlrichRF , et al. Three‐year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry1997;154(11):1504‐13. ">Hogarty 1997‐study 1</a>, n = 50, RR 8.67 CI 1.17 to 64.26, <a href="./references#CD004716-fig-0143" title="">Analysis 9.3</a> ). </p> </section> </section> <section id="CD004716-sec-0288"> <h4 class="title">Comparison 10: SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT </h4> <p><a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a> and <a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a> compared supportive therapy and c<b>l</b>ient‐focused case management against client‐focused case management alone. </p> <section id="CD004716-sec-0289"> <h5 class="title">10.1 Global state: relapse</h5> <p>The number of participants experiencing relapse did not differ between groups (<a href="./references#CD004716-bbs2-0011" title="KleinA R , CnaanR A , WhitecraftJ . Significance of peer social support with dually diagnosed clients: findings from a pilot study. Research on Social Work Practice1998;8:529‐51. ">Klein 1998</a>, n = 61, RR 0.32 CI 0.05 to 2.14 <a href="./references#CD004716-fig-0144" title="">Analysis 10.1</a>). </p> </section> <section id="CD004716-sec-0290"> <h5 class="title">10.2 Leaving the study early</h5> <p>The frequency of participants leaving the study early was not significantly different (2 RCTs, n = 145, RR 2.38 CI 1.15 to 4..3,9 <a href="./references#CD004716-fig-0145" title="">Analysis 10.2</a>). </p> </section> <section id="CD004716-sec-0291"> <h5 class="title">10.3 Death</h5> <p>Death rates did not differ significantly between the two treatment groups (<a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>, n = 84, RR 2.61 CI 0.11 to 62.26, <a href="./references#CD004716-fig-0146" title="">Analysis 10.3</a> ). </p> </section> </section> <section id="CD004716-sec-0292"> <h4 class="title">Comparison 11: SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANAGEMENT </h4> <p><a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a> compared supportive therapy and c<b>l</b>ient‐focused case management against standard case management. </p> <section id="CD004716-sec-0293"> <h5 class="title">11.1 Leaving the study early</h5> <p>There were no significant differences between the treatment and control group (<a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>, n = 80, RR 0.88 CI 0.52 to 1.51, <a href="./references#CD004716-fig-0147" title="">Analysis 11.1</a> ). </p> </section> <section id="CD004716-sec-0294"> <h5 class="title">11.2 Death</h5> <p>We found no significant differences in death rates (<a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a>, n = 80, RR 2.35 CI 0.10 to 55.94 <a href="./references#CD004716-fig-0148" title="">Analysis 11.2</a>). </p> </section> </section> <section id="CD004716-sec-0295"> <h4 class="title">Comparison 12: SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING</h4> <p><a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a> compared supportive therapy and skills training with skills training alone. </p> <section id="CD004716-sec-0296"> <h5 class="title">12.1 Global state</h5> <p>Relapse rates were not significantly different between the two treatment regimes (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, RR 1.00 CI 0.49 to 2.04, <a href="./references#CD004716-fig-0149" title="">Analysis 12.1</a>). Similarly, we found no significant difference in the number of people who did not experience remission during the follow‐up period (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, RR 0.78 CI 0.54 to 1.12, <a href="./references#CD004716-fig-0150" title="">Analysis 12.2</a>). </p> </section> <section id="CD004716-sec-0297"> <h5 class="title">12.2 Service outcomes</h5> <p>Data were available for the number of people who were not discharged from hospital during the follow‐up period (all participants were inpatients at the start of the study). No significant differences were found between the two treatment groups (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, RR 1.14 CI 0.46 to 2.85, <a href="./references#CD004716-fig-0151" title="">Analysis 12.3</a>). </p> </section> <section id="CD004716-sec-0298"> <h5 class="title">12.3 Mental state</h5> <p>Data were only reported for two out of 45 items on the CPSRS, 'inability to feel' and 'derealisation'. For 'inability to feel', results showed no significant difference between the two treatment groups (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, MD 0.10 CI ‐0.08 to 0.28, <a href="./references#CD004716-fig-0152" title="">Analysis 12.4</a>). Data for 'derealisation' are skewed, and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0153" title="">Analysis 12.5</a>). </p> </section> <section id="CD004716-sec-0299"> <h5 class="title">12.4 Leaving the study early</h5> <p>No significant difference was found for this outcome (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, RR 1.00 CI 0.35 to 2.84, <a href="./references#CD004716-fig-0154" title="">Analysis 12.6</a>). </p> </section> <section id="CD004716-sec-0300"> <h5 class="title">12.5 General functioning</h5> <p>Data from the KAS were reported for the subscale entitled 'free‐time activities' and for the syndrome entitled 'withdrawal'. For 'free‐time activities', we found a statistically significant advantage for supportive therapy plus skills training, compared with skills training alone (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, MD 0.10 CI 0.02 to 0.18, <a href="./references#CD004716-fig-0156" title="">Analysis 12.8</a>). Data for 'withdrawal' are skewed, and are presented as 'Other data' in a table (<a href="./references#CD004716-fig-0156" title="">Analysis 12.8</a>). </p> </section> <section id="CD004716-sec-0301"> <h5 class="title">12.6 Death</h5> <p>No significant differences were found in death rates between the two treatment groups (<a href="./references#CD004716-bbs2-0014" title="MalmU . The influence of group therapy on schizophrenia. Acta Psychiatrica Scandinavica Supplementum1982;Suppl 297:1‐65. [MEDLINE: 82280715; PMID 6126069] ">Malm 1982</a>, n = 80, RR 2.00 CI 0.19 to 21.18, <a href="./references#CD004716-fig-0157" title="">Analysis 12.9</a>). Three deaths occurred, all of which were due to suicide. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004716-sec-0302" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004716-sec-0302"></div> <section id="CD004716-sec-0303"> <h3 class="title" id="CD004716-sec-0303">Summary of main results</h3> <section id="CD004716-sec-0304"> <h4 class="title">1. Supportive therapy versus standard care</h4> <p>There was a lack of data for this comparison, with only five studies included. Overall, the quality of the evidence was very low for the outcomes in the <a href="./full#CD004716-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>We found no evidence of significant differences between supportive therapy and standard care for rates of relapse and hospitalisation, clinical improvement in mental state, leaving the study early and quality of life and no studies reported data on general functioning and satisfaction with treatment. </p> </section> <section id="CD004716-sec-0305"> <h4 class="title">2. Supportive therapy versus any other psychological or psychosocial treatment</h4> <p>Twenty studies were included in the comparison, which combines data from the comparisons for other psychological interventions, including cognitive behavioural therapy (CBT), family therapy and the quality of the evidence was very low for all outcomes except leaving the study early, which we rated as moderate in the <a href="./full#CD004716-tbl-0002">summary of findings Table 2</a>. </p> <p>For the outcomes rate of hospitalisations, clinical improvement in mental state and satisfaction of treatment for the recipient of care, we found evidence favouring any other psychological or psychosocial treatment. We found no evidence of significant differences for rate of relapse, leaving the study early and quality of life. </p> </section> <section id="CD004716-sec-0306"> <h4 class="title">3. Supportive therapy versus cognitive behavioural therapy (CBT)</h4> <p>Thirteen studies compared supportive therapy with CBT. Again, the quality of the evidence was very low for all outcomes except leaving the study early, which we rated as moderate (see <a href="./full#CD004716-tbl-0003">summary of findings Table 3</a>). </p> <p>We found no evidence of significant differences between supportive therapy and CBT for rates of relapse and hospitalisation, clinical improvement in mental state, leaving the study early and quality of life. For general functioning, we could not pool data as it showed high heterogeneity; one study showed equivocal data, the other found in favour of supportive therapy. </p> </section> <section id="CD004716-sec-0307"> <h4 class="title">4. Supportive therapy versus family therapy</h4> <p>There was a lack of data for this comparison, with only two studies included. Overall, the quality of the evidence was very low for the outcomes in the <a href="./full#CD004716-tbl-0004">summary of findings Table 4</a>. </p> <p>We were not able to pool the data for rate of relapse due to high heterogeneity; one study found no difference in relapse rates, the other study found a difference in favour of family therapy. We found no differences for the rate of hospitalisation and leaving the study early. As there were limited data for this comparison, we had to use proxy data for two outcomes: for mental state we had data for participants experiencing an episode of affective symptoms and for general functioning we had data for participants with no paid work. Neither of the studies reported data for satisfaction with treatment and quality of life. </p> </section> <section id="CD004716-sec-0308"> <h4 class="title">5. Supportive therapy versus psychoeducation</h4> <p>Again, we were only able to include two studies in this comparison and the quality of the evidence was very low (see <a href="./full#CD004716-tbl-0005">summary of findings Table 5</a>). </p> <p>We found that there was no evidence of significant differences between supportive therapy and psychoeducation for the outcomes with data – rate of hospitalisation, no clinical improvement in mental state and leaving the study early. No studies reported data for rate of relapse, general functioning, satisfaction with treatment and quality of life. </p> </section> </section> <section id="CD004716-sec-0309"> <h3 class="title" id="CD004716-sec-0309">Overall completeness and applicability of evidence</h3> <section id="CD004716-sec-0310"> <h4 class="title">1. Few data</h4> <p>It is important to point out that the findings in this review are significantly weakened by the limited amount of available data. The search strategy identified five trials, involving 822 people, comparing supportive therapy with standard care. However, few data regarding the predetermined primary outcomes of interest could be extracted. The important clinical question, whether supportive therapy confers any advantage over standard care in the treatment of people with schizophrenia, remains unanswered. It is important to answer this question before results of research comparing supportive therapy with other psychological or psychosocial therapies can be interpreted fully and meaningfully. </p> <p>More studies compared supportive therapy with other psychological or psychosocial interventions. There were, however, many comparison interventions. The number of studies comparing supportive therapy with each intervention was generally small, the main exception being CBT, for which we identified 13 studies. </p> </section> <section id="CD004716-sec-0311"> <h4 class="title">2. Delivery of therapy</h4> <p>In trials of psychological interventions, there is question about whether the same therapists should provide two different interventions, potentially allowing factors such as level of experience of the therapists and individual differences in personality to be evenly distributed between groups. However, an alternative, and in our opinion more persuasive, argument is that different therapists should provide different therapies. This takes into account the likelihood that therapists have a loyalty to, and training and experience in, one particular type of therapy. This may be particularly important if they have been involved in generating the hypotheses which are being tested. The majority of studies in this review used the same therapists for supportive therapy and other psychological interventions. Most studies did not specify what training the therapists had received or what level of experience they had. Where studies did report details of therapist training, therapists who delivered supportive therapy were sometimes trained in other modalities, such as CBT, but not in supportive therapy. The studies which described standardised supportive therapy, with the use of a manual, were in the minority; as were the studies that evaluated or monitored adherence to the treatment model. </p> <p>Not all studies attempted to match the amount of therapist contact. For example, <a href="./references#CD004716-bbs2-0001" title="CoyleP . A comparative analysis of varying treatment approaches on the level of community adjustment among schizophrenic outpatients. PhD dissertation:submitted to the Adelphi University, USA1988. ">Coyle 1988</a> compared supportive therapy with social skills training and psychoeducation. Supportive therapy sessions, however, were half as long as other therapy sessions, and were delivered individually rather than in a group. </p> <p>More recent studies, such as <a href="./references#CD004716-bbs2-0013" title="KingdonD . SOCRATES ‐ a multicentre, randomized controlled trial of cognitive behavioural therapy in early schizophrenia. National Research Register2000. [National Research Register N0172004444] LewisS , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Randomised controlled trial of cognitive‐behavioural therapy in early schizophrenia: acute‐phase outcomes. British Journal of Psychiatry ‐ Supplementum2002;suppl. 43:S91‐7. [MEDLINE: 22233037; PMID 12271807] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD . Cognitive therapy improves outcomes in first episode psychosis. XIIth World Congress of Psychiatry. Yokohama, Japan, 2002. LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. A randomised controlled trial of cognitive behaviour therapy in early schizophrenia. Schizophrenia Research2001, issue 1,2:263‐4. [MEDLINE: 21083242; PMID 11215542; PsycINFO 2001‐16630‐011] LewisSW , TarrierN , HaddockG , BentallR , KindermanP , KingdonD , et al. Cognitive therapy improves 18‐month outcomes but not time to relapse in first episode schizophrenia. Schizophrenia Research2002;53:14. MandelsonM . A multi‐centre, randomised, controlled trial of cognitive behavioural therapy in early schizophrenia (SOCRATES). National Research Register2000. ">Lewis 2002b</a>, <a href="./references#CD004716-bbs2-0016" title="PennD L , MeyerPS , EvansE , WirthRJ , CaiK , BurchinalM . A randomized controlled trial of group cognitive‐behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophrenia Research2009;109:52‐9. ">Penn 2009</a> and <a href="./references#CD004716-bbs2-0018" title="SenskyT , TurkingtonD , KingdonD , ScottJL , ScottJ , SiddleR , et al. A randomized controlled trial of cognitive behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry2000;57(2):165‐72. ">Sensky 2000b</a> are of a much better quality. It seems likely that methodology and reporting have improved considerably over recent years, which will be valuable for future versions of this review. The concerns described above mean that only tentative conclusions can be drawn from this review. </p> </section> <section id="CD004716-sec-0312"> <h4 class="title">3. Applicability</h4> <p>All trials used entry criteria to define who would be included in the study. These, however, varied from study to study. The studies involved people with schizophrenia and schizophrenia‐like illnesses defined by a range of criteria. Most studies, but not all, used some form of diagnostic criteria. Settings also varied, and both inpatients and outpatients were included. This suggests that the results would be valid for people with a diagnosis of schizophrenia or a related psychotic illness, whether they are being treated as an inpatient or on an outpatient basis. However, the possibility that patients typically studied in randomised controlled trials may differ in important ways from patients typically seen in mental health services should also be considered (<a href="./references#CD004716-bbs2-0304" title="RothA , FonagyP , ParryG , TargetM , et al. What Works for Whom? A Critical Review of Psychotherapy 0Research. New York: Guilford Press, 1996. ">Roth 1996</a>). The results of this review should ideally be considered alongside results of effectiveness research. In effectiveness research, generalisability may be higher that for randomised controlled trials, although internal validity is lower (<a href="./references#CD004716-bbs2-0288" title="MargisonF , BarkhamM , EvansC , McGrathG , MellorCJ , AudinK , et al. Measurement and Psychotherapy. Evidence‐based practice and practice‐based evidence. British Journal of Psychiatry2000;177:123‐30. ">Margison 2000</a>). </p> <p>One aspect of trial setting which might be particularly important is the country in which trials are conducted. In this review, the majority were set in the USA. Seven were set in the UK, and one each in Israel, Italy, Sweden and Australia. There may be a difference in what is regarded as supportive therapy in the USA and in the UK (<a href="./references#CD004716-bbs2-0277" title="HolmesJ . Supportive psychotherapy. The search for positive meanings. British Journal of Psychiatry1995;167(4):439‐45; 446‐7. [MEDLINE: 96113855] ">Holmes 1995</a>), with, for example, supportive therapy in the USA perhaps being more frequent and more closely related to a psychodynamic approach than in the UK. </p> <p>One of the difficulties in attempting this systematic review has been finding a clinically useful definition of supportive therapy. Despite the lack of a universally accepted definition, we felt it was important to define the intervention and identify the available evidence. Throughout the process, we have been aware of the risk that interventions included in the review would be too diverse. Readers of this review need to know what is meant by supportive therapy, and to be able to apply the findings in clinical practice. The included interventions do vary, and we have some concerns about whether they have enough in common to be grouped together in a useful way. The wide variation in the duration and frequency of sessions could be taken as evidence of differences between interventions in the included studies. Nevertheless, we note the lack of research in this field, and the lack of specific meta‐analyses on supportive therapy. We feel the use of a broad definition of supportive therapy in this review is justified as producing an initial analysis of the available data. It is possible that narrower definitions of supportive therapy, perhaps used in more specific settings, could produce different results. For example, it may be possible that an untrained support worker within a community team could reduce the input required for a patient from other members of the team, or may increase the leisure and community activities of a patient. In this review we are unable to make comments on specific questions such as these. </p> <p>Treatment manuals, training of therapists and monitoring of treatment fidelity, all help to enhance internal validity of trials. These were used in a minority of trials in this review. However, it can be argued that these measures may increase the apparent effectiveness of interventions over what is possible to reproduce in clinical practice. In many reports, little description of the supportive intervention was provided. </p> <p>Two studies in particular described interventions which are different from the other supportive interventions. <a href="./references#CD004716-bbs2-0010" title="HealeyA , KnappM , AstinJ , BeechamJ , KempR , KirovG , et al. Cost‐effectiveness evaluation of compliance therapy for people with psychosis.. British Journal of Psychiatry1998;172(5):420‐4. KempR , HaywardP , ApplewhaiteG , EverittB , DavidA . Compliance therapy in psychotic patients: randomised controlled trial. BMJ1996;312:345‐9. [MEDLINE: 96190158; PMID 8611831] KempR , KirovB , HaywardP , DavidA . Randonised controlled trial of compliance therapy. 18‐month follow‐up. British Journal of Psychiatry1998;172:413‐9. ">Kemp 1996</a> reports that therapists delivering supportive therapy were specifically instructed to decline to discuss treatment with people. <a href="./references#CD004716-bbs2-0015" title="O'DonnellM , ParkerG , ProbertsM , MatthewsR , FisherD , JohnsonB , et al. A study of client focused case management and consumer advocacy: The community and consumer service project. Australian and New Zealand Journal of Psychiatry1999;33(5):684‐93. [EMBASE 1999362945] ">O'Donnell 1999</a> also describes a somewhat different intervention. In this study, supportive therapy is more like a client‐focused case management with advocacy. Advocacy, which comes within our definition of supportive therapy, was provided by consumer advocates, who could be people who had experienced mental illness, relatives or carers of people with mental illnesses, or interested lay people. No particular frequency or duration of sessions was specified. </p> </section> </section> <section id="CD004716-sec-0313"> <h3 class="title" id="CD004716-sec-0313">Quality of the evidence</h3> <p>There was little consensus between studies over which outcome variables to use. Definition of outcomes such as relapse also varied between trials. </p> <p>Sample sizes were small for most studies, perhaps resulting in true beneficial or harmful effects going undetected. </p> <p>The quality of the available data is also a cause for concern which needs to be borne in mind when interpreting the results of this review. Twenty of the 24 studies did not adequately report the use of allocation concealment, raising concerns about selection bias. We suspect that this would be most likely to act in the direction of biasing results against supportive therapy, as supportive therapy is used as a control treatment in the majority of studies in this review. Although double‐blind trials are not possible when testing a psychological intervention, it is possible for therapists to be blinded to the study hypothesis. Only two studies attempted this. Not all studies rated outcomes blindly, resulting in a risk of detection biases. Attrition bias cannot be discounted either, as losses to follow‐up were generally poorly reported, and intention‐to‐treat analyses were the exception rather than the rule. </p> <p>These potential biases are particularly important in this review. This is because studies are almost all designed with supportive therapy as a comparator for other treatments, rather than being the primary treatment of interest to investigators. The hypothesis and the expectation of investigators is therefore likely to be that supportive therapy will not perform as well as the other treatment under investigation. </p> <p>Heterogeneity was present, as judged by visual inspection and the I<sup>2</sup> statistic, for the outcomes: mental state measured on the Positive and Negative Syndrome Scale (PANSS), general functioning on the Global Assessment of Function disability scale (GAF) and Global Assessment Scale (GAS) when supportive therapy was compared with other psychological interventions or CBT alone; relapse when supportive therapy was compared with other psychological interventions CBT alone and family therapy; and leaving the study early when supportive therapy was compared with CBT. This may be due in part to the diversity of the interventions. There is a possibility that our attempt to investigate the effects of supportive therapy may not have been as successful as we might have hoped due to the variety of interventions meeting our criteria for supportive therapy or care. However, as high rates of heterogeneity were not found for other outcomes, this does not seem likely to be a major problem. Another possibility, and probably one that is more likely, is that the heterogeneity was due to diversity of control interventions (family therapy or CBT). Although homogeneity was not restored when data from <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> were excluded from the pooled analyses (due to the presence of heterogeneity). We think the data in <a href="./references#CD004716-bbs2-0012" title="LevineJ , BarakY , GranekI . Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy1998;12(1):3‐12. ">Levine 1998</a> may have been incorrectly reported or may have been an anomaly due to the small numbers in each treatment group (n = 7). Also the standard deviations were very small, and we believe the authors may have erroneously reported standard errors as standard deviations. </p> </section> <section id="CD004716-sec-0314"> <h3 class="title" id="CD004716-sec-0314">Potential biases in the review process</h3> <section id="CD004716-sec-0315"> <h4 class="title">1. The limitations of randomised trials of psychotherapy</h4> <p>In doing this review, we explicitly aimed to include only randomised controlled trials. However, it is important to recognise that evidence from randomised controlled trials is not the only form of evidence which can be used to guide clinical practice. There are particular problems with randomised controlled trials for psychological therapies. Psychotherapy relies on the uniqueness of the clinician‐patient relationship, and ways of measuring outcomes which take account of this need to be developed (<a href="./references#CD004716-bbs2-0278" title="HolmesJ . Fitting the biopsychosocial jigsaw together. British Journal of Psychiatry2000;177:93‐4. ">Holmes 2000</a>). Randomised controlled trials employ techniques to enhance internal validity, such as frequent monitoring, the use of therapy manuals and excluding patients with dual diagnoses. These techniques may increase the apparent effectiveness of the intervention above what would routinely be achieved in clinical practice (<a href="./references#CD004716-bbs2-0304" title="RothA , FonagyP , ParryG , TargetM , et al. What Works for Whom? A Critical Review of Psychotherapy 0Research. New York: Guilford Press, 1996. ">Roth 1996</a>). In randomised controlled trials of long‐term therapy, there is a risk of contamination by other treatments (<a href="./references#CD004716-bbs2-0288" title="MargisonF , BarkhamM , EvansC , McGrathG , MellorCJ , AudinK , et al. Measurement and Psychotherapy. Evidence‐based practice and practice‐based evidence. British Journal of Psychiatry2000;177:123‐30. ">Margison 2000</a>). </p> </section> <section id="CD004716-sec-0316"> <h4 class="title">2. Definition of supportive therapy</h4> <p>Distinguishing supportive therapy from standard treatment has also been an issue in this review. We have largely relied on authors' descriptions of the interventions, and have classified some interventions described as treatment as usual as supportive therapy. Similarly, some interventions which were described as supportive in nature were not felt to meet the pre‐determined inclusion criteria for this review. Descriptions have not always been of sufficient detail to judge whether a control intervention should be classified as supportive therapy or not, leaving the possibility that some data were in appropriately omitted. The lack of differences in outcomes between supportive therapy and standard care could suggest that this distinction is not a valid one. However, this is not the only interpretation of the results, and a real difference in effectiveness could exist, but may not have been identified due to paucity of data. </p> </section> <section id="CD004716-sec-0317"> <h4 class="title">3. Strengths</h4> <p>Despite the reservations and difficulties outlined above, it is important that this review has been attempted. Supportive therapy is commonly used in clinical practice for people with schizophrenia. It may be cheaper than other therapies, such as CBT but is probably more costly and intensive than what is generally provided as standard care in many places. We also feel it to be a prevalent approach so it is important to systematically examine the effects of supportive therapy as a specific intervention. As far as we are aware, the only published study previously to have attempted this was the meta‐analysis undertaken by the Department of Health for the purposes of the NICE Guideline on Schizophrenia (<a href="./references#CD004716-bbs2-0296" title="The National Collaborating Centre for Mental Health. Schizophrenia. Full national clinical guideline on core interventions in primary and secondary care. London: Gaskell, The Royal College of Psychiatrists, 2003. ">NICE 2003</a>). The scope of this systematic review is not quite as focused as this work and therefore the <a href="./references#CD004716-bbs2-0296" title="The National Collaborating Centre for Mental Health. Schizophrenia. Full national clinical guideline on core interventions in primary and secondary care. London: Gaskell, The Royal College of Psychiatrists, 2003. ">NICE 2003</a> review is larger with more studies included. We feel our tighter definitions of supportive therapy are justified, workable and give a clearer picture of the evidence. </p> </section> </section> <section id="CD004716-sec-0318"> <h3 class="title" id="CD004716-sec-0318">Agreements and disagreements with other studies or reviews</h3> <p>We know of no other reviews on supportive therapy.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004716-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD004716-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD004716-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD004716-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 1 Global state: Relapse." data-id="CD004716-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 1 Global state: Relapse.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 2 Service outcomes: Hospitalisation." data-id="CD004716-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 2 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 3 Mental state. 1. No clinically important improvement in general mental state." data-id="CD004716-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 3 Mental state. 1. No clinically important improvement in general mental state. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 4 Mental state: 2. Average endpoint general mental state score (PANSS, high = poor)." data-id="CD004716-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 4 Mental state: 2. Average endpoint general mental state score (PANSS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0008"> <p> <div class="table" id="CD004716-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.19</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.34</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 5 Mental state: 3. Average endpoint negative symptoms score (SANS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0008">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 6 Mental state: 4. Average endpoint positive symptoms score (PANSS positive subscale, high = poor)." data-id="CD004716-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 6 Mental state: 4. Average endpoint positive symptoms score (PANSS positive subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0010"> <p> <div class="table" id="CD004716-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.62</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Davidson 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.92</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Davidson 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.92</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.51</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 7 Mental state: 5. Average endpoint positive symptoms score (BPRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0010">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0011"> <p> <div class="table" id="CD004716-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 8 Mental state: 6. Average endpoint delusions score (PSYRATS delusions score, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0011">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0012"> <p> <div class="table" id="CD004716-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 9 Mental state: 7. Average endpoint hallucinations score (PSYRATS hallucinations score, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0012">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 10 Mental state: 8. Average endpoint depressive symptoms score (CESD, high = poor)." data-id="CD004716-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 10 Mental state: 8. Average endpoint depressive symptoms score (CESD, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 11 Leaving the study early." data-id="CD004716-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 11 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 12 General functioning: 2. Average endpoint general functioning score (GAF‐M, high = good)." data-id="CD004716-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 12 General functioning: 2. Average endpoint general functioning score (GAF‐M, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 13 General functioning: 1. Average endpoint general functioning score (GAS, high = good)." data-id="CD004716-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 13 General functioning: 1. Average endpoint general functioning score (GAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 14 General functioning: 3. Average endpoint social functioning score (SFS, high = good)." data-id="CD004716-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 14 General functioning: 3. Average endpoint social functioning score (SFS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 15 Satisfaction with treatment: Recipient of care not satisfied with treatment." data-id="CD004716-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 15 Satisfaction with treatment: Recipient of care not satisfied with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 16 Quality of life: 1. Average endpoint self‐esteem score (RSES, high = good)." data-id="CD004716-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 16 Quality of life: 1. Average endpoint self‐esteem score (RSES, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 17 Quality of life: 2. Average endpoint well‐being score (WBS, high = good)." data-id="CD004716-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 17 Quality of life: 2. Average endpoint well‐being score (WBS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 18 Quality of life: 3. Average endpoint global health score (GHQ, high = poor)." data-id="CD004716-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 18 Quality of life: 3. Average endpoint global health score (GHQ, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 19 Death." data-id="CD004716-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 19 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 20 Medication: No reduction in dose of antipsychotic medication." data-id="CD004716-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 SUPPORTIVE THERAPY versus STANDARD CARE, Outcome 20 Medication: No reduction in dose of antipsychotic medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 1 Global state: 1. Relapse." data-id="CD004716-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 1 Global state: 1. Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 2 Global state: 2. No remission." data-id="CD004716-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 2 Global state: 2. No remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 3 Service outcomes: Hospitalisation." data-id="CD004716-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 3 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 4 Mental state: 1. No clinically important improvement in general mental state." data-id="CD004716-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 4 Mental state: 1. No clinically important improvement in general mental state. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 5 Mental state: 2. Average endpoint general mental state score (PANSS, high = poor)." data-id="CD004716-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 5 Mental state: 2. Average endpoint general mental state score (PANSS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 6 Mental state: 3. Average endpoint general mental state score (BPRS, high = poor)." data-id="CD004716-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 6 Mental state: 3. Average endpoint general mental state score (BPRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 7 Mental state: 4. Average endpoint general mental state score (BPRS short form, high = poor)." data-id="CD004716-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 7 Mental state: 4. Average endpoint general mental state score (BPRS short form, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0031"> <p> <div class="table" id="CD004716-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.1</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.0</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 8 Mental state: 5. Average endpoint general mental state score (CPRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0031">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 9 Mental state: 6. Average endpoint general mental state score (PANSS general subscale, high = poor)." data-id="CD004716-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 9 Mental state: 6. Average endpoint general mental state score (PANSS general subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 10 Mental state: 7. No clinically important improvement in negative symptoms." data-id="CD004716-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 10 Mental state: 7. No clinically important improvement in negative symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 11 Mental state: 8. No clinically important improvement in depressive symptoms." data-id="CD004716-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 11 Mental state: 8. No clinically important improvement in depressive symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 12 Mental state: 9. Episode of affective symptoms." data-id="CD004716-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 12 Mental state: 9. Episode of affective symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 13 Mental state: 10. Average endpoint negative symptoms score (PANSS negative, high=poor)." data-id="CD004716-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 13 Mental state: 10. Average endpoint negative symptoms score (PANSS negative, high=poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 14 Mental state: 11. Average endpoint negative symptoms score (SANS, high=poor)." data-id="CD004716-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 14 Mental state: 11. Average endpoint negative symptoms score (SANS, high=poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0038"> <p> <div class="table" id="CD004716-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.79</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 15 Mental state: 12. Average endpoint negative symptoms score (SANS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0038">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 16 Mental state: 13. Average endpoint positive symptoms score (PANSS positive subscale, high = poor)." data-id="CD004716-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 16 Mental state: 13. Average endpoint positive symptoms score (PANSS positive subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0040"> <p> <div class="table" id="CD004716-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pinto 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pinto 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 17 Mental state: 14. Average endpoint positive symptoms score (SAPS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0040">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0041"> <p> <div class="table" id="CD004716-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.42</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.10</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 18 Mental state: 15. Average endpoint positive symptoms score (BPRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0041">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 19 Mental state: 16. Average endpoint score (PANSS thought disturbance cluster, high = poor)." data-id="CD004716-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 19 Mental state: 16. Average endpoint score (PANSS thought disturbance cluster, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0043"> <p> <div class="table" id="CD004716-tblf-0009"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 20 Mental state: 17. Average endpoint delusions score (PSYRATS delusions score, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0043">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0044"> <p> <div class="table" id="CD004716-tblf-0010"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.21</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 21 Mental state: 18. Average endpoint hallucinations score (PSYRATS hallucinations score, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0044">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 22 Mental state: 19. Average endpoint voices score (PSYRATS voices score, high = poor)." data-id="CD004716-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.22</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 22 Mental state: 19. Average endpoint voices score (PSYRATS voices score, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0046"> <p> <div class="table" id="CD004716-tblf-0011"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up length</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Malevolence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Benevolence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Resistance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Engagement</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Omnipotence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.23</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 23 Mental state: 20. Average endpoint beliefs about voices score (BAVQ, high = poor, skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0046">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0047"> <p> <div class="table" id="CD004716-tblf-0012"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.24</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 24 Mental state: 21. Average endpoint depression score (MADRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0047">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0048"> <p> <div class="table" id="CD004716-tblf-0013"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up length</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.25</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 25 Mental state: 22. Average endpoint depression score (BDI‐II, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0048">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 26 Leaving the study early." data-id="CD004716-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.26</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 26 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 27 General functioning: 1. Average endpoint general functioning score (GAF &amp; GAS, high = good)." data-id="CD004716-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.27</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 27 General functioning: 1. Average endpoint general functioning score (GAF &amp; GAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 28 General functioning: 2. Average endpoint social functioning score (SFS, high = good)." data-id="CD004716-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.28</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 28 General functioning: 2. Average endpoint social functioning score (SFS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 29 General functioning: 3. No paid work." data-id="CD004716-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.29</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 29 General functioning: 3. No paid work. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 30 General functioning: 4. Admission to residential placement." data-id="CD004716-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.30</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 30 General functioning: 4. Admission to residential placement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 31 General functioning: 5. Admission to jail." data-id="CD004716-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.31</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 31 General functioning: 5. Admission to jail. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 32 Satisfaction with treatment: Recipient of care not satisfied with treatment." data-id="CD004716-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.32</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 32 Satisfaction with treatment: Recipient of care not satisfied with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 33 Quality of life: Average endpoint quality of life score (QLS, high = good)." data-id="CD004716-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.33</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 33 Quality of life: Average endpoint quality of life score (QLS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 34 Death." data-id="CD004716-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.34</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 34 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 35 Behaviour: 1. Social impairment on SBAS." data-id="CD004716-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.35</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 35 Behaviour: 1. Social impairment on SBAS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 36 Behaviour: 2. Poor coping style with relatives." data-id="CD004716-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.36</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 36 Behaviour: 2. Poor coping style with relatives. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 37 Engagement with services: Poor attendance at appointments." data-id="CD004716-fig-0060" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.37</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 37 Engagement with services: Poor attendance at appointments. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0061"> <p> <div class="table" id="CD004716-tblf-0014"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.38</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 38 Insight: Average endpoint insight score (SAI, high = good, skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0061">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 39 Compliance: 1. Poor compliance to therapy." data-id="CD004716-fig-0062" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.39</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 39 Compliance: 1. Poor compliance to therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 40 Compliance: 2. adherence to medication (self‐report)." data-id="CD004716-fig-0063" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.40</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 40 Compliance: 2. adherence to medication (self‐report). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 41 Compliance: 3. average endpoint adherence score (ROMI, high = good)." data-id="CD004716-fig-0064" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.41</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 41 Compliance: 3. average endpoint adherence score (ROMI, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-42" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-42.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 42 Compliance: 4. average endpoint non‐adherence score (ROMI, high = poor)." data-id="CD004716-fig-0065" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-42.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.42</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 42 Compliance: 4. average endpoint non‐adherence score (ROMI, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-42.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-43" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-43.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 43 Medication: Prescribed IM depot medication." data-id="CD004716-fig-0066" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-43.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.43</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 43 Medication: Prescribed IM depot medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-43.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-44" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-44.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 44 Attitude to medication: 1. Average endpoint attitude to medication score (AMQ, high = good)." data-id="CD004716-fig-0067" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-44.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.44</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 44 Attitude to medication: 1. Average endpoint attitude to medication score (AMQ, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-44.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-002-45" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-002-45.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 45 Attitude to medication: 2. Average endpoint attitude to medication score (DAI, high = good)." data-id="CD004716-fig-0068" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-45.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.45</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 45 Attitude to medication: 2. Average endpoint attitude to medication score (DAI, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-002-45.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0069"> <p> <div class="table" id="CD004716-tblf-0015"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.46</div> <div class="figure-caption"> <p>Comparison 2 SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT, Outcome 46 Economic outcomes: Direct costs (skewed data, not ITT). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0069">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 1 Global state: Relapse." data-id="CD004716-fig-0070" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 1 Global state: Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 2 Service outcomes: Hospitalisation." data-id="CD004716-fig-0071" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 2 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 3 Mental state: 1. No clinically important improvement in general mental state." data-id="CD004716-fig-0072" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 3 Mental state: 1. No clinically important improvement in general mental state. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 4 Mental state: 2. Average endpoint general mental state score (PANSS total, high = poor)." data-id="CD004716-fig-0073" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 4 Mental state: 2. Average endpoint general mental state score (PANSS total, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 5 Mental state: 3. Average endpoint general mental state score (BPRS, high = poor)." data-id="CD004716-fig-0074" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 5 Mental state: 3. Average endpoint general mental state score (BPRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 6 Mental state: 4. Average endpoint general mental state score (BPRS short form, high = poor)." data-id="CD004716-fig-0075" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 6 Mental state: 4. Average endpoint general mental state score (BPRS short form, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0076"> <p> <div class="table" id="CD004716-tblf-0016"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.1</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.0</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 7 Mental state: 5. Average endpoint general mental state score (CPRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0076">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 8 Mental state: 6. Average endpoint general mental state score (PANSS general subscale, high = poor)." data-id="CD004716-fig-0077" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 8 Mental state: 6. Average endpoint general mental state score (PANSS general subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 9 Mental state: 7. No clinically important improvement in negative symptoms." data-id="CD004716-fig-0078" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 9 Mental state: 7. No clinically important improvement in negative symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 10 Mental state: 8. No clinically important improvement in depressive symptoms." data-id="CD004716-fig-0079" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 10 Mental state: 8. No clinically important improvement in depressive symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 11 Mental state: 9. Episode of affective symptoms." data-id="CD004716-fig-0080" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 11 Mental state: 9. Episode of affective symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 12 Mental state: 10. Average endpoint negative symptoms score (PANSS negative subscale, high = poor)." data-id="CD004716-fig-0081" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 12 Mental state: 10. Average endpoint negative symptoms score (PANSS negative subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 13 Mental state: 11. Average endpoint negative symptoms score (SANS, high = poor)." data-id="CD004716-fig-0082" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 13 Mental state: 11. Average endpoint negative symptoms score (SANS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0083"> <p> <div class="table" id="CD004716-tblf-0017"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.58</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.0</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.01</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 14 Mental state: 12. Average endpoint negative symptoms score (SANS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0083">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 15 Mental state: 13. Average endpoint positive symptoms score (PANSS positive subscale, high = poor)." data-id="CD004716-fig-0084" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 15 Mental state: 13. Average endpoint positive symptoms score (PANSS positive subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0085"> <p> <div class="table" id="CD004716-tblf-0018"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pinto 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pinto 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 16 Mental state: 14. Average endpoint positive symptoms score (SAPS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0085">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0086"> <p> <div class="table" id="CD004716-tblf-0019"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.42</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarrier 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.10</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 17 Mental state: 15. Average endpoint positive symptoms score (BPRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0086">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 18 Mental state: 16. Average endpoint score (PANSS thought disturbance cluster, high = poor)." data-id="CD004716-fig-0087" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 18 Mental state: 16. Average endpoint score (PANSS thought disturbance cluster, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0088"> <p> <div class="table" id="CD004716-tblf-0020"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lewis 2002b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>s6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 19 Mental state: 17. Average endpoint delusions score (PSYRATS delusions score, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0088">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0089"> <p> <div class="table" id="CD004716-tblf-0021"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Durham 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 20 Mental state: 18. Average endpoint hallucinations score (PSYRATS hallucinations score, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0089">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 21 Mental state: 19. Average endpoint voices score (PSYRATS voices score, high = poor)." data-id="CD004716-fig-0090" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 21 Mental state: 19. Average endpoint voices score (PSYRATS voices score, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0091"> <p> <div class="table" id="CD004716-tblf-0022"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up length</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Malevolence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Benevolence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Resistance</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Engagement</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Omnipotence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 22 Mental state: 20. Average endpoint beliefs about voices score (BAVQ, high = poor, skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0091">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0092"> <p> <div class="table" id="CD004716-tblf-0023"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensky 2000b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.23</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 23 Mental state: 21. Average endpoint depression score (MADRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0092">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0093"> <p> <div class="table" id="CD004716-tblf-0024"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up length</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.24</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 24 Mental state: 22. Average endpoint depression score (BDI‐II, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0093">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 25 Leaving the study early." data-id="CD004716-fig-0094" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.25</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 25 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 26 General functioning: 1. Average endpoint general functioning score (GAF &amp; GAS, high = good)." data-id="CD004716-fig-0095" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.26</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 26 General functioning: 1. Average endpoint general functioning score (GAF &amp; GAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 27 General functioning: 2. Average endpoint social functioning score (SFS, high = good)." data-id="CD004716-fig-0096" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.27</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 27 General functioning: 2. Average endpoint social functioning score (SFS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 28 Satisfaction with treatment: Recipient of care not satisfied with treatment." data-id="CD004716-fig-0097" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.28</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 28 Satisfaction with treatment: Recipient of care not satisfied with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 29 Quality of life: Average endpoint score (RSES, high = good)." data-id="CD004716-fig-0098" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.29</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 29 Quality of life: Average endpoint score (RSES, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 30 Death." data-id="CD004716-fig-0099" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.30</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 30 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0100"> <p> <div class="table" id="CD004716-tblf-0025"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>short term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.31</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 31 Insight:1. Average endpoint insight score (SAI, skewed data, high = good). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0100">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0101"> <p> <div class="table" id="CD004716-tblf-0026"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Follow‐up length</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penn 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.32</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 32 Insight: 2. Average endpoint insight score (BCIS composite, skewed data, high = good). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0101">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 33 Medication: no reduction in dose of antipsychotic medication." data-id="CD004716-fig-0102" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.33</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 33 Medication: no reduction in dose of antipsychotic medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 34 Attitude to medication: 1. Average endpoint attitude to medication score (AMQ, high = good)." data-id="CD004716-fig-0103" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.34</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 34 Attitude to medication: 1. Average endpoint attitude to medication score (AMQ, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-003-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-003-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 35 Attitude to medication: 2. Average endpoint attitude to medication score (DAI, high = good)." data-id="CD004716-fig-0104" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.35</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 35 Attitude to medication: 2. Average endpoint attitude to medication score (DAI, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-003-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0105"> <p> <div class="table" id="CD004716-tblf-0027"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>medium term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.36</div> <div class="figure-caption"> <p>Comparison 3 SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY, Outcome 36 Economic outcomes: Direct costs (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0105">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 1 Global state: 1. Relapse." data-id="CD004716-fig-0106" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 1 Global state: 1. Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 2 Global state: 2. No remission." data-id="CD004716-fig-0107" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 2 Global state: 2. No remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 3 Service outcomes: Hospitalisation." data-id="CD004716-fig-0108" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 3 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 4 Mental state: Episode of affective symptoms." data-id="CD004716-fig-0109" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 4 Mental state: Episode of affective symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 5 Leaving the study early (by long term)." data-id="CD004716-fig-0110" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 5 Leaving the study early (by long term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 6 General functioning: 1. No paid work." data-id="CD004716-fig-0111" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 6 General functioning: 1. No paid work. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 7 General functioning: 2. Admission to residential placement." data-id="CD004716-fig-0112" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 7 General functioning: 2. Admission to residential placement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 8 General fuctioning: 3. Admission to jail." data-id="CD004716-fig-0113" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 8 General fuctioning: 3. Admission to jail. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 9 Behaviour: 1. Social impairment on SBAS." data-id="CD004716-fig-0114" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 9 Behaviour: 1. Social impairment on SBAS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 10 Behaviour: 2. Poor coping style with relatives." data-id="CD004716-fig-0115" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 10 Behaviour: 2. Poor coping style with relatives. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 11 Engagement with services: Poor attendance at appointments." data-id="CD004716-fig-0116" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 11 Engagement with services: Poor attendance at appointments. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 12 Compliance: Poor compliance to therapy." data-id="CD004716-fig-0117" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 12 Compliance: Poor compliance to therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 13 Medication: Prescribed IM depot medication." data-id="CD004716-fig-0118" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 SUPPORTIVE THERAPY versus FAMILY THERAPY, Outcome 13 Medication: Prescribed IM depot medication. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 1 Service outcomes: Hospitalisation." data-id="CD004716-fig-0119" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 1 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 2 Mental state. 1. No clinically important improvement in general mental state." data-id="CD004716-fig-0120" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 2 Mental state. 1. No clinically important improvement in general mental state. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 3 Mental state: 2. Average endpoint general score (PANSS general subscale, high = poor)." data-id="CD004716-fig-0121" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 3 Mental state: 2. Average endpoint general score (PANSS general subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 4 Mental state: 3. Average endpoint negative symptoms score (PANSS negative subscale, high = poor)." data-id="CD004716-fig-0122" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 4 Mental state: 3. Average endpoint negative symptoms score (PANSS negative subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 5 Mental state: 4. Average endpoint positive symptoms score (PANSS positive subscale, high = poor)." data-id="CD004716-fig-0123" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 5 Mental state: 4. Average endpoint positive symptoms score (PANSS positive subscale, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 6 Mental state: 5. Average endpoint depression score (CDRS, high = poor)." data-id="CD004716-fig-0124" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 6 Mental state: 5. Average endpoint depression score (CDRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 7 Leaving the study early." data-id="CD004716-fig-0125" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 7 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 8 Quality of life: Average endpoint quality of life score (QLS, high = good)." data-id="CD004716-fig-0126" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 8 Quality of life: Average endpoint quality of life score (QLS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 9 Death." data-id="CD004716-fig-0127" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 9 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 10 Behaviour: Average endpoint score (composed of ROMI and ITAQ items, high = good)." data-id="CD004716-fig-0128" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 10 Behaviour: Average endpoint score (composed of ROMI and ITAQ items, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 11 Insight: Average endpoint treatment attitude score (ITAQ, high = good)." data-id="CD004716-fig-0129" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 11 Insight: Average endpoint treatment attitude score (ITAQ, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 12 Compliance: 1. Poor compliance to therapy." data-id="CD004716-fig-0130" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 12 Compliance: 1. Poor compliance to therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 13 Compliance: 2. Adherence to medication (self‐report)." data-id="CD004716-fig-0131" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 13 Compliance: 2. Adherence to medication (self‐report). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 14 Compliance: 3. Average endpoint adherence score (ROMI, high = good)." data-id="CD004716-fig-0132" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 14 Compliance: 3. Average endpoint adherence score (ROMI, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-005-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-005-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 15 Compliance: 4. Average endpoint nonadherence score (ROMI, high = poor)." data-id="CD004716-fig-0133" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5 SUPPORTIVE THERAPY versus PSYCHOEDUCATION, Outcome 15 Compliance: 4. Average endpoint nonadherence score (ROMI, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-005-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME, Outcome 1 Service outcomes: Hospitalisation." data-id="CD004716-fig-0134" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME, Outcome 1 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME, Outcome 2 Leaving the study early." data-id="CD004716-fig-0135" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME, Outcome 2 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME, Outcome 3 General functioning: No gainful employment." data-id="CD004716-fig-0136" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME, Outcome 3 General functioning: No gainful employment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SUPPORTIVE THERAPY versus SKILLS TRAINING, Outcome 1 Service outcomes: Hospitalisation." data-id="CD004716-fig-0137" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 SUPPORTIVE THERAPY versus SKILLS TRAINING, Outcome 1 Service outcomes: Hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SUPPORTIVE THERAPY versus SKILLS TRAINING, Outcome 2 Leaving the study early." data-id="CD004716-fig-0138" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 SUPPORTIVE THERAPY versus SKILLS TRAINING, Outcome 2 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 SUPPORTIVE THERAPY versus SKILLS TRAINING, Outcome 3 Death." data-id="CD004716-fig-0139" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 SUPPORTIVE THERAPY versus SKILLS TRAINING, Outcome 3 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 SUPPORTIVE THERAPY versus PSYCHODYNAMIC PSYCHOTHERAPY, Outcome 1 Leaving the study early." data-id="CD004716-fig-0140" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 SUPPORTIVE THERAPY versus PSYCHODYNAMIC PSYCHOTHERAPY, Outcome 1 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS, Outcome 1 Global state: Relapse." data-id="CD004716-fig-0141" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS, Outcome 1 Global state: Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS, Outcome 2 Mental state: Episode of affective symptoms." data-id="CD004716-fig-0142" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS, Outcome 2 Mental state: Episode of affective symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS, Outcome 3 Leaving the study early: Treatment‐related reasons." data-id="CD004716-fig-0143" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS, Outcome 3 Leaving the study early: Treatment‐related reasons. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT, Outcome 1 Global state: Relapse." data-id="CD004716-fig-0144" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT, Outcome 1 Global state: Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT, Outcome 2 Leaving the study early." data-id="CD004716-fig-0145" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT, Outcome 2 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT, Outcome 3 Death." data-id="CD004716-fig-0146" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT, Outcome 3 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANGEMENT, Outcome 1 Leaving the study early." data-id="CD004716-fig-0147" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANGEMENT, Outcome 1 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANGEMENT, Outcome 2 Death." data-id="CD004716-fig-0148" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANGEMENT, Outcome 2 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 1 Global state: 1. Relapse." data-id="CD004716-fig-0149" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 1 Global state: 1. Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 2 Global state: 2. No remission." data-id="CD004716-fig-0150" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 2 Global state: 2. No remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 3 Service outcomes: Not discharged from hospital." data-id="CD004716-fig-0151" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 3 Service outcomes: Not discharged from hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 4 Mental state: 1. Average endpoint score for 'inability to feel' (CPRS, high = poor)." data-id="CD004716-fig-0152" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 4 Mental state: 1. Average endpoint score for 'inability to feel' (CPRS, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0153"> <p> <div class="table" id="CD004716-tblf-0028"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Malm 1982</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy + skills training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Malm 1982</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Skills training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 5 Mental state: 2. Average endpoint score for 'derealisation' (CPRS, skewed data, high = poor). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0153">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 6 Leaving the study early." data-id="CD004716-fig-0154" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.6</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 6 Leaving the study early. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 7 General functioning: 1. Average endpoint score for 'free time activities' (KAS, high = good)." data-id="CD004716-fig-0155" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.7</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 7 General functioning: 1. Average endpoint score for 'free time activities' (KAS, high = good). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004716-fig-0156"> <p> <div class="table" id="CD004716-tblf-0029"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>long term</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Malm 1982</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Supportive therapy + skills training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Malm 1982</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Skills training</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.45</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.8</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 8 General functioning: 2. Average endpoint score for 'withdrawal' (KAS, skewed data, high = good). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0156">Navigate to figure in review</a></div> </div> <div class="figure" id="CD004716-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/urn:x-wiley:14651858:media:CD004716:CD004716-CMP-012-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_t/tCD004716-CMP-012-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 9 Death." data-id="CD004716-fig-0157" src="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.9</div> <div class="figure-caption"> <p>Comparison 12 SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING, Outcome 9 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/media/CDSR/CD004716/image_n/nCD004716-CMP-012-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD004716-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Design of a future study</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: centralised sequence generation with table of random numbers or computer‐generated code, stratified by severity of illness, sequence concealed till interventions assigned.<br/> Blinding: those recruiting and assigning participants, those assessing outcomes, all blind to allocated group, blinding could be tested.<br/> Duration: minimum of 24 weeks. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: schizophrenia, if operational criteria used these should be in the context of routine care.<br/> N = 450*.<br/> Age: adults.<br/> Sex: men and women.<br/> Setting: anywhere. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Supportive therapy: the nature and frequency of this approach should be clearly described. N = 150.<br/> 2. Routine therapy. N = 150. This also should be clearly described. </p> <p>3. Cognitive behavioural therapy. N = 150.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quality of life: healthy days,** SF‐36***.<br/> Service outcomes: days in hospital, time attending psychiatric outpatient clinic.<br/> Satisfaction with care: patients/carers.<br/> Global state: CGI.***<br/> Mental state: CGI.<br/> Social functioning: to include occupational status.<br/> Adverse effects: including mortality.<br/> Economic data. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* size of study to detect a 10% difference in improvement with 80% certainty.<br/> <br/> ** Primary outcome.<br/> <br/> *** If scales are used to measure outcome then there should be binary cut off points, defined before study starts, of clinically important improvement. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>N = number of participants, BPRS = Brief Psychiatric Rating Scale, CGI = Clinical Global Impressions Scale </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Design of a future study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004716-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SUPPORTIVE THERAPY versus STANDARD CARE for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus STANDARD CARE for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus STANDARD CARE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>321 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>309 per 1000</b> <br/> (141 to 678) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.44 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low</b><sup>1,2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (3 to 628) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1</b> <br/> (0.07 to 15.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: no clinically important improvement</b> <br/> Follow‐up: 1 to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>898 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>853 per 1000</b> <br/> (736 to 997) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.95</b> <br/> (0.82 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 10 weeks to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>166 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b> <br/> (88 to 232) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.86</b> <br/> (0.53 to 1.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>354<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> <br/> GAS<br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean general functioning in the intervention groups was<br/> <b>1.4 higher</b> <br/> (5.09 lower to 7.89 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment: Recipient of care not satisfied with treatment</b> <br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>238 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>436 per 1000</b> <br/> (179 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.83</b> <br/> (0.75 to 4.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> WBS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>2.73 lower</b> <br/> (6.04 lower to 0.58 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>260<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>2</sup> Publication bias: strongly suspected ‐ four studies or fewer reported data for this outcome.<br/> <sup>3</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation, allocation concealment and blinding.<br/> <sup>4</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation and allocation concealment; two studies had an unclear risk for blinding.<br/> <sup>5</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for blinding.<br/> <sup>6</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SUPPORTIVE THERAPY versus STANDARD CARE for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004716-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY<br/> <b>Comparison:</b> ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>435 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>517 per 1000</b> <br/> (287 to 939) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.19</b> <br/> (0.66 to 2.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 12 weeks to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>122 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>222 per 1000</b> <br/> (135 to 365) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.82</b> <br/> (1.11 to 2.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>306<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: No clinically important improvement</b> <br/> Follow‐up: 1 to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>594 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>754 per 1000</b> <br/> (618 to 915) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/> (1.04 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 10 weeks to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>249 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>257 per 1000</b> <br/> (217 to 302) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b> <br/> (0.87 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1412<br/> (19 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> <br/> GAF and GAS<br/> Follow‐up: 12 to 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,8,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was very high heterogeneity for this outcome so data were not pooled. <sup>11</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment: Recipient of care not satisfied with treatment</b> <br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>435 per 1000</b> <br/> (138 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.19</b> <br/> (1.01 to 10.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,12,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> QLS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>0.07 lower</b> <br/> (21.11 lower to 20.97 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,10,13,14</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: serious ‐ four studies had an unclear risk of bias for randomisation and allocation concealment. All studies had an unclear risk of bias for blinding of participants and two had a high risk of bias for blinding of outcome assessments.<br/> <sup>2</sup> Inconsistency: serious ‐ there was high heterogeneity for this outcome.<br/> <sup>3</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>4</sup> Publication bias: strongly suspected ‐ four studies or fewer reported data for this outcome.<br/> <sup>5</sup> Risk of bias: serious ‐ three studies had an unclear risk of bias for randomisation and allocation concealment. All studies had an unclear risk of bias for blinding of participants and two were unclear for blinding of outcome assessments.<br/> <sup>6</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation. All studies had an unclear risk of bias for blinding of participants and one had an unclear risk of bias for blinding of outcome assessments.<br/> <sup>7</sup> Risk of bias: serious ‐ 13 studies had an unclear risk of bias for randomisation and 14 for allocation concealment. Fifteen studies had an unclear risk of bias for blinding of participants and one had a high risk of bias. Three studies two had a high risk of bias for blinding of outcome assessments and eight were unclear. One study had a high risk of bias for incomplete outcome data, and in three it was unclear.<br/> <sup>8</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for allocation concealment. Both studies had an unclear risk of bias for blinding of participants and outcome assessments.<br/> <sup>9</sup> Inconsistency: very serious ‐ there was high heterogeneity for this outcome and data were not pooled.<br/> <sup>10</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available.<br/> <sup>11</sup> One study found no difference in general functioning on the GAS, the other study found a difference in favour of supportive therapy on the GAF.<br/> <sup>12</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for blinding of participants and outcome assessors.<br/> <sup>13</sup> Imprecision: very serious ‐ relatively few participants were included and few events; confidence intervals are very wide.<br/> <sup>14</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for blinding of participants and outcome assessments. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004716-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> COGNITIVE BEHAVIOURAL THERAPY </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>429 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>471 per 1000</b> <br/> (219 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.1</b> <br/> (0.51 to 2.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>181<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 12 weeks to 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>249 per 1000</b> <br/> (132 to 468) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.6</b> <br/> (0.85 to 3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>153<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: No clinically important improvement</b> <br/> Follow‐up: 1 to 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>594 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>731 per 1000</b> <br/> (529 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.23</b> <br/> (0.89 to 1.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 10 weeks to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>150 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>158 per 1000</b> <br/> (116 to 217) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.05</b> <br/> (0.77 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>812<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> <br/> GAF and GAS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,8,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was very high heterogeneity for this outcome so data were not pooled. <sup>11</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment: Recipient of care not satisfied with treatment</b> <br/> Follow‐up: 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>435 per 1000</b> <br/> (138 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.19</b> <br/> (1.01 to 10.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>4,12,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> RSES<br/> Follow‐up: 12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>1.7 lower</b> <br/> (5.19 lower to 1.79 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: serious ‐ three trials had an unclear risk of bias for randomisation and allocation concealment. All studies had an unclear risk for blinding of participants, while two studies were rated as high risk for blinding of outcome assessors.<br/> <sup>2</sup> Inconsistency: serious ‐ there was high heterogeneity for this outcome.<br/> <sup>3</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>4</sup> Publication bias: strongly suspected ‐ four studies or fewer reported data for this outcome.<br/> <sup>5</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation and two for allocation concealment. All were unclear risk for blinding of participants and two for blinding of outcome assessors.<br/> <sup>6</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for randomisation. All three had an unclear risk of blinding of participants and one for blinding of outcome assessors.<br/> <sup>7</sup> Risk of bias: serious ‐ seven studies had an unclear risk of bias for randomisation and allocation concealment. Nine studies had an unclear risk of bias for blinding of participants. Two studies two had a high risk of bias for blinding of outcome assessments and four were unclear.<br/> <sup>8</sup> Risk of bias: serious ‐ one study had an unclear risk of bias for allocation concealment. Both studies had an unclear risk of bias for blinding of participants and outcome assessments.<br/> <sup>9</sup> Inconsistency: very serious ‐ there was high heterogeneity for this outcome and data were not pooled.<br/> <sup>10</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available.<br/> <sup>11</sup> One study found no difference in general functioning on the GAS, the other study found a difference in favour of supportive therapy on the GAF.<br/> <sup>12</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for blinding of participants and outcome assessors.<br/> <sup>13</sup> Imprecision: very serious ‐ relatively few participants were included and few events; confidence intervals are very wide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004716-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">SUPPORTIVE THERAPY versus FAMILY THERAPY for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus FAMILY THERAPY for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> FAMILY THERAPY </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus FAMILY THERAPY</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> <br/> Follow‐up: 2 to 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was high heterogeneity for this outcome and data were not pooled.<sup>5</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>300 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>579 per 1000</b> <br/> (267 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.93</b> <br/> (0.89 to 4.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: Episode of affective symptoms</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>292 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>499 per 1000</b> <br/> (239 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.71</b> <br/> (0.82 to 3.6) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>182 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>231 per 1000</b> <br/> (102 to 525) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/> (0.56 to 2.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning: No paid work</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>600 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>576 per 1000</b> <br/> (342 to 978) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.57 to 1.63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,6,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for satisfaction with treatment.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for quality of life.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: very serious ‐ both studies had an unclear risk of bias for randomisation, allocation concealment and blinding of participants. One study was rated high risk of bias for blinding of outcome assessors.<br/> <sup>2</sup> Inconsistency: very serious ‐ there was high heterogeneity for this outcome and data were not pooled.<br/> <sup>3</sup> Imprecision: serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>4</sup> Publication bias: strongly suspected ‐ two studies or fewer reported data for this outcome.<br/> <sup>5</sup> One study found no difference in relapse rates, the other study found a difference in favour of family therapy.<br/> <sup>6</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants.<br/> <sup>7</sup> Risk of bias: very serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants. It was rated high risk of bias for blinding of outcome assessors.<br/> <sup>8</sup> Indirectness: serious ‐ we wanted to collect binary data for no clinical improvement in general symptoms, however, only a proxy measure was available.<br/> <sup>9</sup> Indirectness: serious ‐ we wanted to collect binary data for no overall improvement in general functioning, however, only a proxy measure was available. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">SUPPORTIVE THERAPY versus FAMILY THERAPY for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004716-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHOEDUCATION for schizophrenia</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUPPORTIVE THERAPY versus PSYCHOEDUCATION for schizophrenia</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with schizophrenia<br/> <b>Settings:</b> inpatients and outpatients<br/> <b>Intervention:</b> SUPPORTIVE THERAPY </p> <p><b>Comparison:</b> PSYCHOEDUCATION </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUPPORTIVE THERAPY versus PSYCHOEDUCATION</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: Relapse</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data on relapse.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service outcomes: Hospitalisation</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>87 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (4 to 429) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.48</b> <br/> (0.05 to 4.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state. No clinically important improvement</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>600 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>966 per 1000</b> <br/> (576 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.61</b> <br/> (0.96 to 2.68) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early</b> <br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>142 per 1000</b> <br/> (52 to 385) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.57</b> <br/> (0.21 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>General functioning</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for general functioning.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction with treatment</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies reported data for satisfaction with treatment.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> <br/> QLS </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention groups was<br/> <b>0.07 lower</b> <br/> (21.11 lower to 20.97 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants and outcome assessors.<br/> <sup>2</sup> Imprecision: very serious ‐ relatively few participants were included and few events; confidence intervals are wide.<br/> <sup>3</sup> Publication bias: strongly suspected ‐ two studies or fewer reported data for this outcome.<br/> <sup>4</sup> Risk of bias: serious ‐ the study had an unclear risk of bias for randomisation, allocation concealment and blinding of participants.<br/> <sup>5</sup> Risk of bias: serious ‐ both studies had an unclear risk of bias for randomisation, allocation concealment and blinding of participants and one study was unclear risk for outcome assessors.<br/> <sup>6</sup> Indirectness: serious ‐ we wanted to collect binary data for this outcome, however, only a proxy scale measure was available. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHOEDUCATION for schizophrenia</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/full#CD004716-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SUPPORTIVE THERAPY versus STANDARD CARE</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.44, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 15.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state. 1. No clinically important improvement in general mental state <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.77, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.82, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 2. Average endpoint general mental state score (PANSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.42 [‐10.13, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.70 [‐6.71, 16.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 3. Average endpoint negative symptoms score (SANS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 4. Average endpoint positive symptoms score (PANSS positive subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.09 [‐2.84, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 5. Average endpoint positive symptoms score (BPRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mental state: 6. Average endpoint delusions score (PSYRATS delusions score, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mental state: 7. Average endpoint hallucinations score (PSYRATS hallucinations score, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 8. Average endpoint depressive symptoms score (CESD, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [‐1.61, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.53, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 General functioning: 2. Average endpoint general functioning score (GAF‐M, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.66 [‐6.20, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 General functioning: 1. Average endpoint general functioning score (GAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [‐5.09, 7.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 General functioning: 3. Average endpoint social functioning score (SFS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.67 [‐7.05, 5.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Satisfaction with treatment: Recipient of care not satisfied with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [0.75, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Quality of life: 1. Average endpoint self‐esteem score (RSES, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.21 [‐2.85, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Quality of life: 2. Average endpoint well‐being score (WBS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.73 [‐6.04, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Quality of life: 3. Average endpoint global health score (GHQ, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.45 [‐2.41, 7.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.22 [0.14, 75.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.87 [0.31, 26.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Medication: No reduction in dose of antipsychotic medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.59, 1.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SUPPORTIVE THERAPY versus STANDARD CARE</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.32, 25.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.66, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. No remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.11, 3.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.85, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [1.11, 2.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. No clinically important improvement in general mental state <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.95, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.04, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 2. Average endpoint general mental state score (PANSS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 3. Average endpoint general mental state score (BPRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.07 [‐5.08, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.60 [0.90, 14.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 4. Average endpoint general mental state score (BPRS short form, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐3.02, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [‐1.18, 5.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐0.54, 5.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mental state: 5. Average endpoint general mental state score (CPRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mental state: 6. Average endpoint general mental state score (PANSS general subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 7. No clinically important improvement in negative symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.63, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mental state: 8. No clinically important improvement in depressive symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.92, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 9. Episode of affective symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [1.15, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 10. Average endpoint negative symptoms score (PANSS negative, high=poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mental state: 11. Average endpoint negative symptoms score (SANS, high=poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [‐5.81, 19.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mental state: 12. Average endpoint negative symptoms score (SANS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Mental state: 13. Average endpoint positive symptoms score (PANSS positive subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Mental state: 14. Average endpoint positive symptoms score (SAPS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Mental state: 15. Average endpoint positive symptoms score (BPRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mental state: 16. Average endpoint score (PANSS thought disturbance cluster, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.3 [1.17, 7.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Mental state: 17. Average endpoint delusions score (PSYRATS delusions score, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Mental state: 18. Average endpoint hallucinations score (PSYRATS hallucinations score, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Mental state: 19. Average endpoint voices score (PSYRATS voices score, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐3.63, 3.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐4.76, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Mental state: 20. Average endpoint beliefs about voices score (BAVQ, high = poor, skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 Malevolence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 Benevolence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.3 Resistance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.4 Engagement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.5 Omnipotence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Mental state: 21. Average endpoint depression score (MADRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Mental state: 22. Average endpoint depression score (BDI‐II, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.87, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 general reasons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1261</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 treatment‐related reasons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.15 [1.07, 4.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 General functioning: 1. Average endpoint general functioning score (GAF &amp; GAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 General functioning: 2. Average endpoint social functioning score (SFS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.20 [‐17.86, 3.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.80 [‐21.67, 4.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 General functioning: 3. No paid work <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.84, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 General functioning: 4. Admission to residential placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.24, 4.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 General functioning: 5. Admission to jail <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.24, 4.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Satisfaction with treatment: Recipient of care not satisfied with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>32.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.19 [1.01, 10.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Quality of life: Average endpoint quality of life score (QLS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐21.11, 20.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.08, 19.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.99 [0.44, 36.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Behaviour: 1. Social impairment on SBAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [1.04, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Behaviour: 2. Poor coping style with relatives <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.37, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Engagement with services: Poor attendance at appointments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.89, 4.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Insight: Average endpoint insight score (SAI, high = good, skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>38.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Compliance: 1. Poor compliance to therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.63 [1.30, 5.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>39.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.69, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Compliance: 2. adherence to medication (self‐report) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.83, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Compliance: 3. average endpoint adherence score (ROMI, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐3.58, 4.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">42 Compliance: 4. average endpoint non‐adherence score (ROMI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [‐0.61, 4.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">43 Medication: Prescribed IM depot medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>43.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.99, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">44 Attitude to medication: 1. Average endpoint attitude to medication score (AMQ, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>44.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.50 [‐6.83, ‐2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">45 Attitude to medication: 2. Average endpoint attitude to medication score (DAI, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.70 [‐9.35, ‐2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>45.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐9.38, ‐0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">46 Economic outcomes: Direct costs (skewed data, not ITT) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>46.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUPPORTIVE THERAPY versus ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.85, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.18, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 1. No clinically important improvement in general mental state <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.95, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.89, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 2. Average endpoint general mental state score (PANSS total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 3. Average endpoint general mental state score (BPRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.07 [‐5.08, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.60 [0.90, 14.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 4. Average endpoint general mental state score (BPRS short form, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐3.02, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [‐1.18, 5.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐0.54, 5.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 5. Average endpoint general mental state score (CPRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Mental state: 6. Average endpoint general mental state score (PANSS general subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mental state: 7. No clinically important improvement in negative symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.63, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 8. No clinically important improvement in depressive symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.92, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mental state: 9. Episode of affective symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [1.16, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 10. Average endpoint negative symptoms score (PANSS negative subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 11. Average endpoint negative symptoms score (SANS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [‐5.81, 19.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mental state: 12. Average endpoint negative symptoms score (SANS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mental state: 13. Average endpoint positive symptoms score (PANSS positive subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Mental state: 14. Average endpoint positive symptoms score (SAPS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Mental state: 15. Average endpoint positive symptoms score (BPRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Mental state: 16. Average endpoint score (PANSS thought disturbance cluster, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.3 [1.17, 7.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Mental state: 17. Average endpoint delusions score (PSYRATS delusions score, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Mental state: 18. Average endpoint hallucinations score (PSYRATS hallucinations score, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Mental state: 19. Average endpoint voices score (PSYRATS voices score, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐3.63, 3.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐4.76, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Mental state: 20. Average endpoint beliefs about voices score (BAVQ, high = poor, skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Malevolence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 Benevolence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.3 Resistance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.4 Engagement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.5 Omnipotence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Mental state: 21. Average endpoint depression score (MADRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Mental state: 22. Average endpoint depression score (BDI‐II, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.1 general reasons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>711</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>25.2 treatment‐related reasons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.34 [0.90, 6.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 General functioning: 1. Average endpoint general functioning score (GAF &amp; GAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>26.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 General functioning: 2. Average endpoint social functioning score (SFS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.20 [‐17.86, 3.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>27.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.80 [‐21.67, 4.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Satisfaction with treatment: Recipient of care not satisfied with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>28.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.19 [1.01, 10.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Quality of life: Average endpoint score (RSES, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐3.77, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>29.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐5.19, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.08, 19.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>30.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.12, 67.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Insight:1. Average endpoint insight score (SAI, skewed data, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.2 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>31.3 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Insight: 2. Average endpoint insight score (BCIS composite, skewed data, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Medication: no reduction in dose of antipsychotic medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.68, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Attitude to medication: 1. Average endpoint attitude to medication score (AMQ, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>34.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.50 [‐6.83, ‐2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Attitude to medication: 2. Average endpoint attitude to medication score (DAI, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.1 short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.70 [‐9.35, ‐2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>35.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.90 [‐9.38, ‐0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Economic outcomes: Direct costs (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>36.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SUPPORTIVE THERAPY versus COGNITIVE BEHAVIOURAL THERAPY</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SUPPORTIVE THERAPY versus FAMILY THERAPY</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. No remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [1.11, 3.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.89, 4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: Episode of affective symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [0.82, 3.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Leaving the study early (by long term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 general reasons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.13, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 treatment‐related reasons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.6 [0.61, 4.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 General functioning: 1. No paid work <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.57, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 General functioning: 2. Admission to residential placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.24, 4.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 General fuctioning: 3. Admission to jail <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.24, 4.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Behaviour: 1. Social impairment on SBAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [1.04, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Behaviour: 2. Poor coping style with relatives <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.37, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Engagement with services: Poor attendance at appointments <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.89, 4.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Compliance: Poor compliance to therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.63 [1.30, 5.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.69, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Medication: Prescribed IM depot medication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.99, 4.47]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SUPPORTIVE THERAPY versus FAMILY THERAPY</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHOEDUCATION</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 4.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mental state. 1. No clinically important improvement in general mental state <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.96, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mental state: 2. Average endpoint general score (PANSS general subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [‐3.21, 8.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 3. Average endpoint negative symptoms score (PANSS negative subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐4.00, 7.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 4. Average endpoint positive symptoms score (PANSS positive subscale, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [‐0.71, 6.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 5. Average endpoint depression score (CDRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [‐1.35, 4.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.21, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Quality of life: Average endpoint quality of life score (QLS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐21.11, 20.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.12, 67.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Behaviour: Average endpoint score (composed of ROMI and ITAQ items, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Need for treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.44, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Benefits of medication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.56, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Insight: Average endpoint treatment attitude score (ITAQ, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.55 [‐5.85, 2.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Compliance: 1. Poor compliance to therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Compliance: 2. Adherence to medication (self‐report) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.83, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Compliance: 3. Average endpoint adherence score (ROMI, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐3.58, 4.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Compliance: 4. Average endpoint nonadherence score (ROMI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [‐0.61, 4.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHOEDUCATION</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [1.22, 6.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.92, 2.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 General functioning: No gainful employment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.85, 1.29]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">SUPPORTIVE THERAPY versus REHABILITATION PROGRAMME</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SUPPORTIVE THERAPY versus SKILLS TRAINING</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Service outcomes: Hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.06, 14.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.61, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.12, 67.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">SUPPORTIVE THERAPY versus SKILLS TRAINING</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHODYNAMIC PSYCHOTHERAPY</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.42, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.73, 1.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">SUPPORTIVE THERAPY versus PSYCHODYNAMIC PSYCHOTHERAPY</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [0.86, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mental state: Episode of affective symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.81, 3.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Leaving the study early: Treatment‐related reasons <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.67 [1.17, 64.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">SUPPORTIVE THERAPY versus COMBINATION OF OTHER PSYCHOSOCIAL INTERVENTIONS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.05, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.38 [1.15, 4.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.61 [0.11, 62.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus CLIENT‐FOCUSED CASE MANAGEMENT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANGEMENT</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.52, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.35 [0.10, 55.94]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">SUPPORTIVE THERAPY PLUS CLIENT‐FOCUSED CASE MANAGEMENT versus STANDARD CASE MANGEMENT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004716-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.49, 2.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. No remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.54, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Service outcomes: Not discharged from hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.46, 2.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mental state: 1. Average endpoint score for 'inability to feel' (CPRS, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.08, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 2. Average endpoint score for 'derealisation' (CPRS, skewed data, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Leaving the study early <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.35, 2.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 General functioning: 1. Average endpoint score for 'free time activities' (KAS, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.02, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 General functioning: 2. Average endpoint score for 'withdrawal' (KAS, skewed data, high = good) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">SUPPORTIVE THERAPY PLUS SKILLS TRAINING versus SKILLS TRAINING</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004716.pub4/references#CD004716-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004716.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004716-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004716-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004716-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD004716-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD004716-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004716-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD004716-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004716-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004716\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004716\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004716\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004716\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004716\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004716.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004716.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004716.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004716.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004716.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717599592"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004716.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717599596"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004716.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbbd958dd9371',t:'MTc0MDcxNzYwMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 